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Abstract  
Pancreatic acinar cell exocytosis requires precise calcium (Ca2+) signals. When cytosolic Ca2+ 
levels remain high, cellular functions are disrupted, which is associated with initiation of 
pancreatitis. Ca2+ signals are achieved through regulating endoplasmic reticulum (ER) stores, 
Ca2+ATPases, and store-operated Ca2+ entry (SOCE). However, how these pathways interact to 
create precise signals is not well understood. In a pancreatic model of dysregulated Ca2+ 
homeostasis, secretory pathway Ca2+ATPase 2 (SPCA2) expression is significantly decreased. In 
the pancreas, only a C-terminally truncated form of SPCA2 (termed SPAC2C) exists. Recent 
studies indicate a role for SPCA2 in increasing Ca2+ influx involving Orai1 in breast cancer. The 
goal of this study was to determine the effects of SPCA2C on Ca2+ homeostasis.  
Here, epitope-tagged SPCA2C was expressed in HEK293A cells. Co-immunofluorescence (Co-
IF) determined subcellular localization. Using Fura2 imaging, cytosolic Ca2+ concentration 
[Ca2+] was examined during rest, SOCE and secretagogue-stimulated signaling. Effects of 
SPCA2C over-expression were also examined in 266.6 pancreatic acinar cells. In pancreatic 
cancer-derived cells, the abundance of the SPCA2C gene transcript (ATP2C2C) was assessed. 
Effects of SPCA2C over-expression was examined in cancer-derived cells to understand the 
functional role of SPCA2C in pancreatic pathology. Finally, an unbiased protein proximity assay 
was used to evaluate the SPCA2C interactome and broaden the understanding of SPCA2C 
function.   
In HEK293A cells, exogenous SPCA2C expression localized to ER and Golgi compartments and 
increased resting cytosolic [Ca2+], Ca2+ release in response to carbachol, ER Ca2+ stores, and 
! ii!
Ca2+ influx. Co-immunoprecipitation (co-IP) detected Orai1-SPCA2C interactions. However, 
SPCA2C's effect on cytosolic and ER Ca2+ levels are Orai1-independent. In pancreatic cancer, 
cell lines with increased endogenous ATP2C2 expression had increased ER Ca2+ stores and 
increased constitutive Ca2+ influx, while exogenous over-expression of SPCA2C increased 
resting Ca2+ levels. Examination of identified putative protein interactors using Gene Ontology 
(GO) and Reactome analysis predicted endoplasmic reticulum cellular compartment localization 
and Ca2+ ion homeostasis as a pathway SPCA2C may be involved. These findings indicate 
SPCA2C influences Ca2+ homeostasis through multiple mechanisms. By delineating the Atp2c2c 
sequence and functionally characterizing SPCA2C's role in Ca2+ regulation, I have uncovered a 
novel mechanism that pancreatic acinar cells use to regulate cytosolic and ER Ca2+ levels.   
Keywords 
calcium homeostasis, calcium signaling, secretory pathway calcium ATPase 2C, Orai1, store 
operated calcium entry, store independent calcium entry, STIM1 
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Summary for Lay Audiences  
The pancreas is important for the regulation of blood glucose and the production and delivery of 
substances necessary for digestion. A specific cell type, called the pancreatic acinar cell, has the 
primary function of producing and secreting substances called enzymes, that digest the food 
particles you ingest. Enzymes are released from these cells when you eat, which requires a 
specific signal that can be transmitted to the inside of the cell. Calcium (Ca2+) is required to 
transmit this signal inside of the cell. Pancreatitis can develop if the Ca2+ signal is not transmitted 
properly. The regulation of Ca2+ in pancreatic acinar cells is not fully understood. A novel 
pancreas-specific protein isoform, termed secretory pathway Ca2+ ATPase 2 C (SPCA2C) has 
been found by my lab. Previous research in breast cancer indicates a role for a related protein 
SPCA2, to increase Ca2+ levels inside cells, leading to disease. The goal of this thesis was to 
determine the effects of SPCA2C on cellular Ca2+ homeostasis.  
 
In this study, the protein sequence of SPCA2C was determined and expressed in cells to 
determine the effect it has on Ca2+ levels within the cell. Cellular Ca2+ levels were measured and 
Ca2+ signals were analyzed during stimulation for enzyme exocytosis. In cells isolated from 
pancreatic cancer patients, the expression level of ATP2C2, transcript from which the SPCA2 
protein is made, was analyzed. The level of expression was compared to cellular Ca2+ levels to 
understand how SPCA2C influences Ca2+ homeostasis in pancreatic disease. Finally, proteins 
that might interact with SPCA2C were determined to broaden our understanding how SPCA2C 
functions in cells.  
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I found that expressing SPCA2C in cells increased cellular Ca2+ levels and increased the amount 
of Ca2+ signal after stimulation for enzyme release. In pancreatic cancer cells, increased 
expression of ATP2C2 increase the amount of Ca2+ that was being brought into the cell. Finally, 
SPCA2C was predicted to interact with ~263 other proteins within cells. These findings indicate 
that SPCA2C influences Ca2+ homeostasis through multiple mechanisms. Through this research I 
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Calcium (Ca2+) is a critical messenger in cells, particularly in pancreatic acinar cells, which 
depend on specific spatiotemporal signals for their primary function of regulated exocytosis. 
Disruptions in Ca2+ regulation affect cellular function and survival. Therefore, cells depend on 
the expression of specific protein sensors, buffers, exchangers, pumps and channels to regulate 
Ca2+ signaling and homeostasis. In pancreatic acinar cells, extracellular stimuli cause global 
oscillatory Ca2+ signals, released from the endoplasmic reticulum (ER). Ca2+ oscillations promote 
the movement of vesicles containing proenzymes to the apical plasma membrane and exocytosis 
of their contents. In pancreatic acinar cells, the regulation of intracellular Ca2+ signaling patterns 
is complex. The type of Ca2+ signal depends on stimulus type, concentration and duration and 
each pattern requires a different combination of regulatory proteins, some of which are still yet to 
be determined. Mitochondria and Ca2+ buffering proteins modulate Ca2+ signals, while 
membrane pumps and channels promote Ca2+ movement within the cell and surrounding 
environment. Upon release of Ca2+ from the ER, Ca2+ influx across the plasma membrane is also 
activated. This extracellular Ca2+ influx allows for the refilling of ER stores. Ca2+ATPases 
promote rapid removal of Ca2+ from the cytosol, refilling ER stores or extruding Ca2+ across the 
plasma membrane, to maintain cytosolic Ca2+ homeostasis.  
 
Our laboratory has identified a pancreas-specific isoform of secretory pathway Ca2+ATPase 2 
(SPCA2), termed SPCA2C that has not been characterized to date. Contrary to traditional roles 
of Ca2+ ATPases, SPCA2 increases cytosolic Ca2+ levels independent of an ATPase function, by 
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regulating Ca2+ channels on the plasma membrane. The goal of this thesis is to assess the 
function of the pancreas-specific SPCA2C isoform in Ca2+ homeostasis.  
  
1.1 Calcium as a critical second messenger 
!
Ca2+ is critical to multicompartment cells, where it aids in communication between 
compartments and provides information of the extracellular environment. Ca2+ is also an 
important second messenger affecting cellular proliferation, apoptosis, and general cell function 
(Berridge et al., 2000). Intracellular Ca2+ signals depend on the existence of Ca2+ concentration 
gradients. Basal or resting Ca2+ concentrations of free cytoplasmic Ca2+ are ~75-150 nM (Yule, 
2015), while the extracellular Ca2+ is typically ~1.8 mM. The ER has the largest intracellular 
Ca2+ store with free concentrations reaching ~1 mM (Burdakov et al., 2005). These concentration 
gradients created between the cytoplasm and ER stores or across the plasma membrane allow 
Ca2+ to be used as a messenger. In pancreatic acinar cells signals are generated by stimulation on 
the basal membrane (see below). Upon stimulation, Ca2+ is released from the ER to the cytosol, 
where it will regulate Ca2+-dependent effector proteins, such as kinases or phosphatases, or Ca2+-
dependent functions, such as regulated exocytosis. The ER makes close connections with other 
organelles that also control Ca2+ homeostasis. Mitochondrial Ca2+ uptake shapes cytosolic Ca2+ 
dynamics (Rizzuto et al., 2012) and lysosomes have been suggested to participate in the 
regulation of Ca2+ homeostasis by acting as Ca2+ stores (Gerasimenko et al., 2003, 2006). 
Therefore, pathways exist to move Ca2+ into and out of these organelles.  
 
In the exocrine pancreas, acinar cells must strictly regulate Ca2+ levels to allow for proper 
secretion of digestive enzymes. Acinar cells control Ca2+ through multiple pathways [reviewed 
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in (Wen et al., 2016; Yule, 2015)], with the ER acting as a critical Ca2+ store within these cells. 
This thesis provides insight into how SPCA2C may affect acinar cell function and Ca2+ 
homeostasis. 
 
1.1.1 Relationship between calcium homeostasis and pancreatic pathologies 
 
Understanding how Ca2+ is regulated in pancreatic acinar cells is critical since aberrant Ca2+ 
regulation is associated with increased susceptibility and severity of pancreatic disease (Tepikin 
et al., 1992). Stable increases in cytosolic Ca2+ above resting level are proposed to initiate acinar 
cell injury by inducing premature activation of intracellular enzymes (Criddle et al., 2006), 
mitochondrial dysfunction (Niederau & Grendell, 1988), vacuolization and necrosis (Shalbueva 
et al., 2013). Cellular damage promotes an inflammatory response, inducing pancreatitis (Kang, 
et al., 2014). Pancreatitis is a debilitating disease involving tissue digestion, inflammation and 
fibrosis. Chronic or recurrent forms of pancreatitis are a leading cause of pancreatic ductal 
adenocarcinoma, the most common and deadliest form of pancreatic cancer. Pancreatitis and 
pancreatic ductal adenocarcinoma severely reduce quality of life and life expectancy and insight 
into their potential mechanisms is crucial for improving outcomes (Anderson et al., 2009). 
Therefore, it is important that intracellular Ca2+ levels be controlled both temporally and 
spatially. Although potential treatments targets cytosolic Ca2+ using Ca2+ influx channel 







The pancreas is a glandular organ that consists of two major functional compartments: endocrine 
and exocrine. The endocrine pancreas is comprised of islets of Langerhans and accounts for 1-
2% of total pancreatic mass. Five primary cell types are found within islets: insulin-producing β-
cells, glucagon-secreting α-cells, somatostatin-secreting δ-cells, pancreatic polypeptide-secreting 
F-cells, and ghrelin-secreting ε-cells. The levels of glucose in the blood are rapidly and precisely 
regulated by hormone production from islets. The exocrine pancreas constitutes almost 98% of 
total pancreatic mass and is comprised of acinar cells, centroacinar cells and duct cells. 
Centroacinar cells lie at the interface between the acinar cells and duct cells and resemble a 
hybrid between those two cell types. Centroacinar cells secrete aqueous bicarbonate solution 
when stimulated by the hormone secretin. They also secrete mucin (Longnecker, 2014). Along 
with providing a structural function, duct cells also secrete bicarbonate, which is carried along 
with pancreatic enzymes and microbials to the duodenum. Bicarbonate neutralizes the acidic 
contents emptying from the stomach. This thesis focuses on acinar cells as this is the primary site 
of SPCA2C expression. 
 
1.2.1 Acinar cell structure and function 
!
Acinar cells are polarized and form small clusters called acini. Acinar cells produce proteases, 
lipases and amylases, the materials required for digestion and absorption of nutrients in the small 
intestine. In most cases, acinar cells store these pancreatic enzymes as proenzymes in zymogen 
granules near the apical membrane. When stimulated, acinar cells empty their contents into the 
lumen of intralobular ducts (Figure 1.1). Acinar cells also secrete antimicrobials, including 
cathelicidin-related peptide, which inhibit intestinal bacterial overgrowth (Ahuja et al., 2017). To 
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regulate exocytosis, acinar cells have established a network of signaling pathways that can 
promote different spatial and temporal Ca2+ signals within the cell.  
 
1.2.2 Types of calcium release  
!
Global Ca2+ signals, including oscillations, are established from basic elementary Ca2+ signalling 
events. Almost all global Ca2+ signals are produced by the release of Ca2+ from the ER (Berridge, 
2007). A single elementary event can be used to perform a highly localized signalling function. 
For example, the release of a neurotransmitter from a neuron, which requires a brief localized 
pulse of Ca2+ delivered directly to the docked vesicle by a Ca2+ channel associated with the 
exocytosis machinery. Such an event is called a sparklet and it is formed as a result of the brief 
opening of voltage operated Ca2+ channels (Berridge, 2007). A spark however, is formed by the 
opening of a group of ryanodine receptors (RyRs). Sparks can be used to activate a Ca2+ wave. 
These Ca2+ waves spread throughout the cell, through calcium induced calcium release (CICR; 
Berridge, 2007). A puff, similar to a spark, is formed by the release of Ca2+ from a small group of 
inositol 1,4,5-trisphosphate receptors (IP3Rs). They are also the building blocks of Ca2+ waves, 
resulting in global Ca2+ signals.  Intercellular Ca2+ waves are thought to be spread through gap 
junctions by the passage of Ca2+ or IP3, which result in the propagation of waves into 





























The acinar cells (AC) are arranged into acini and contain apically localized zymogen granules 
(ZG). The nuclei (N) are located in the basal portion of the acinar cell. Centroacinar cells (CAC) 
contain no ZG. The apical poles of acinar cells face the duct (D) and ductal cells (DC) surround 




Figure 1.1 Pancreatic tissue with acinar, centroacinar and ductal cells. 
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 1.2.3 Acinar cell organization related to calcium homeostasis 
!
The intracellular organization of pancreatic acini is essential for proper function. The lateral 
aspects of acinar cells are connected to each other via tight and adherens junctions, and 
communication occurs through gap junctions. The basal poles are associated with a basal lamina 
and often endothelial cells of the vasculature (Longnecker, 2014). The basal membrane contains 
muscarinic or cholecystokinin receptors (CCKR) that receive signals from the nervous system 
via acetylcholine (Ach; Dormer & Williams 1981) or cholecystokinin (CCK; Matozaki et al., 
1991; Streb et al., 1985), respectively, for exocytosis of enzymes.  
 
More than 90% of newly synthesized proteins in pancreatic acinar cells are targeted to the 
secretory pathway and packed into large secretory granules, called zymogen granules (ZG). 
These granules are relatively large (i.e. ~1 µm in diameter) and are responsible for transport, 
storage and secretion of digestive enzymes. The ZGs reside in the apical pole of the cell until it is 
stimulated for enzyme release (Longnecker, 2014). Individual acini are extensively coupled by 
gap junctions that allow the passage of ions and small molecules (i.e. 1-2 kDa) and provide 
electrical coupling between cells, to facilitate exocytosis (Meda et al., 1983).  
 
The highly organized intracellular compartments are also important for healthy pancreatic 
function. The ER is predominantly located within the basal aspect of the cell with projections of 
the ER that extend to the apical portion of the acinus. Acinar cells are the highest protein 
producing cell in the body, and the ER plays a pivotal role as the site of translation, folding and 
covalent modification of proteins either destined for secretion or expressed on the surface of 
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organelles or the plasma membrane. The ER is also the major site of intracellular Ca2+ storage, 
which is essential for regulated exocytosis, the main function of acinar cells.  
 
1.2.4 Role of mitochondria in Ca2+ homeostasis 
!
Mitochondria accumulate in three distinct locations within acinar cells. Mitochondria are 
concentrated in a peri granular belt basal to the zymogen granules, with further sub-populations 
surrounding the nucleus and immediately adjacent the basolateral membrane. Mitochondria in 
the peri granular belt play a critical role in limiting the spread of Ca2+ signals upon stimulation 
with agonist (Park et al., 2001; Rizzuto et al., 1998). Mitochondria are able to quickly uptake 
Ca2+ to help modulate a Ca2+ signal (Gonzalez et al., 2000). In mitochondria, large capacity Ca2+ 
uptake occurs through the mitochondria Ca2+ uniporter (MCU), a highly selective Ca2+ channel 
on the inner mitochondrial membrane (Baughman et al., 2011). MCU is primarily regulated by 
mitochondrial Ca2+ uptake 1 (MICU1), MICU2 and essential MCU regulator (EMRE). EMRE is 
a 10 kDa protein that mediates the interaction between MCU and regulator subunits MICU1/2, 
without EMRE, MCU does not allow Ca2+ influx (Sancak et al., 2013). MICU1/2 functions as 
"gate keepers", permitting and inhibiting Ca2+ flux at high and resting cytosolic/intermembrane 
space Ca2+ levels, respectively (Csordas et al., 2013; Mallilankaraman et al., 2012; Plovanich et 
al., 2013). The mitochondria are also able to exchange Ca2+ with the ER at sites of ER-
mitochondrial contacts (Rizzuto et al., 2012). Experimentally, high doses of CCK or bile acids 
cause the release of Ca2+ from the ER and a stable broad increase in cytosolic Ca2+ (Murphy et 
al., 2008; Voronina et al., 2005). With the mitochondrial membrane tightly localized to the ER, 
the continual release of Ca2+ leads to Ca2+ overload in the mitochondrial matrix, initiating the 
opening of the mitochondrial permeability transition pore (MPTP). The MPTP is a non-specific 
! 10!
channel that forms in the inner mitochondrial membrane. Opening of the MPTP causes a loss of 
the inner mitochondrial membrane potential and a halt in ATP production (Halangk et al., 2000). 
Without adequate ATP, Ca2+ATPases cannot function to decrease cytosolic Ca2+ and Ca2+ 
continues to accumulate in the cytosol reaching pathogenic levels (Mukherjee et al., 2016). 
Furthermore, MPP opening results in the release of pro-apoptotic factors, which can mediate cell 
death independent of the cytoplasmic Ca2+ increases (Tait & Green, 2013).  
 
Molecular pathways ensure proper Ca2+ movement within the cell and between stores. Some 
pathways, such as IP3 mediated Ca2+ release from the ER, are very well established, while the 
receptors and proteins involved in mediating other pathways and responses, such as store 
operated Ca2+ entry and Ca2+ oscillations, are still not fully understood within pancreatic acinar 
cells. Understanding the molecules and mechanisms underlying these pathways is essential for 
understanding the fundamental basis for regulated exocytosis.  
 
1.3 Regulated Exocytosis 
!
The release of enzymes from pancreatic acinar cells involves stimulus-secretion coupling, where 
the primary stimulant for secretion occurs at the basal membrane and causes local increases of 
Ca2+ at the apical border. The continual release of Ca2+ from the ER and subsequent removal of 
Ca2+ from the cytosol cause transient Ca2+ signals. The cyclic pattern of Ca2+ signals is 
associated with the fusion of ZGs to the apical membrane and release of their contents into ducts 
(Tepikin et al., 1992). ZG fusion to the plasma membrane is mediated through soluble N-




1.3.1 SNARE hypothesis for membrane fusion 
!
Membrane fusion events between cellular compartments within a cell is directed by strict 
compartmentalized targeting of different SNARE isoforms. Vesicle-associated membrane 
proteins (VAMPs or vSNAREs), specifically VAMP2, are found on ZG membranes (Gaisano et 
al., 1996). Syntaxins (Syn) and synaptosomal associated proteins (SNAPs), specifically Syn2, are 
found on the apical plasma membrane (Gaisano et al., 1996). VAMPs and SNAPs form trans-
SNARE complexes that are activated by other regulatory proteins, Ca2+ sensors and proteins 
coupled to second messengers including Ca2+, cAMP, protein kinases C (PKC) and protein 
kinase A (PKA). These trans-snare complexes organize and activate membrane fusion by 
functioning as either fusion clamps and/or Ca2+ sensors capable of responding to a particular 
Ca2+ release event such as oscillatory Ca2+ spikes (Sudhof & Rothman, 2009). 
 
Experimental evidence shows that supramaximal stimulation of acinar cells causes 
phosphorylation of Munc18c by PKC-", which induces its assembly and activation of the trans-
SNARE complex syn-4/VAMP-8/SNAP-23, mediating pathological basolateral exocytosis. 
Basolateral exocytosis events are usually preceded by dysregulated Ca2+ levels, stimulated by 
pathological extracellular signals (Dolai et al., 2012; Gaisano et al., 2001).  
 
1.3.2 Secretagogue influence on cellular Ca2+ 
!
The spatiotemporal pattern of Ca2+ signals elicited in pancreatic acinar cells is dependent on the 
concentration of agonists such as CCK, Ach, bombesin or secretin (Pralong et al., 1988; Stuenkel 
et al., 1989). For example, physiological concentrations of agonist (i.e. ~1-50 pM CCK or 50-
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300 nM Ach) result in the initiation of Ca2+ oscillations characterized by repetitive, regular 
cycles of elevated and subsequently decreasing Ca2+ levels (Osipchuk et al., 1990). Maximal 
stimulation with agonist causes peak increases of Ca2+ to ~1 µM and an elevated plateau after the 
peak at ~100 nM above basal Ca2+ concentrations. This elevated cytosoplasmic Ca2+ plateau is 
maintained as long as the agonist is present and is dependent on extracellular Ca2+, while the 
peak is not dependent on extracellular Ca2+.  
 
Each agonist binds a specific, cognate, 7-transmembrane domain G-protein couple receptor 
(GPCR) on the plasma membrane that couples to the heterotrimeric G protein, G"q. Activation of 
G"q results in the activation of phospholipases that catalyze the hydrolysis of phosphoinositide 
bisphosphate (PIP2) in the plasma membrane, generating the second messenger IP3 (Yule, 2015). 
Binding of IP3 to IP3R on the apical ER causes Ca2+ flux through the receptor, with Ca2+ moving 
out of the ER and into the apical aspect of the cytosol (Straube al., 2002; Thorne al., 1993). 
Increased Ca2+ in the cytoplasm activates RyRs, which are also located on the ER membrane, 
further enhancing Ca2+ release from the ER into the cytoplasm (Kasai et al., 1993). The 
mechanism by which oscillatory Ca2+ signals are controled is not well understood but involves a 
combination of oscillating IP3 levels (Straub et al., 2002), regulator of G protein signaling (RGS) 
control over GTPase activity of G" subunits (Luo et al., 2005; Xu et al., 1999; Zeng et al., 1996) 
and IP3R inactivation (Bezprozvanny et al., 1991). This thesis probes the role of SPCA2C 
isoform in regulating cytosolic Ca2+ levels and oscillations.  
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1.4 Pathways regulating Ca2+ in acinar cells 
!
Stimulus-secretion coupling in acinar cells involves specific spatiotemporal Ca2+ signals, which 
involves both Ca2+ release from the ER and removal from the cytosol. Important pathways also 
exist to replenish ER Ca2+ stores and to regulate resting Ca2+ homeostasis.  
 
1.4.1 Ca2+ Release from the ER 
!
The apical initiation of Ca2+ release in pancreatic acini is due to the abundant expression of IP3R 
in the extreme apical region of the cell. There are three IP3R subtypes, including IP3R1, IP3R2 
and IP3R3, all of which are expressed in pancreatic acinar cells and accumulate on the ER near 
the apical and lateral plasma membrane (Lee et al., 1997; Yule et al., 1997). Expression of either 
IP3R2 or IP3R3 is essential for proper enzyme exocytosis. Individual knock out of genes 
encoding IP3R2 or IP3R3 are phenotypically normal, while the compound IP3R2/IP3R3 null 
animal dies soon after weaning due to pancreatic insufficiency. IP3R1 cannot compensate for the 
loss of other sub-types as secretagogue-simulated Ca2+ signals and secretion of fluid and protein 
are essentially absent in IP3R2/IP3R3 null animals (Futatsugi et al., 2005). Ca2+ release through 
IP3Rs are influenced by many factors including Ca2+ itself. Increases in cytosolic Ca2+ between 
the ranges of 0.5-1 µM increases the steady-state open probability, while higher Ca2+ 
concentrations decrease IP3R activity (Bezprozvanny et al., 1991; Finch et al., 1991). IP3Rs are 
also regulated by interactions with other proteins, adenine nucleotides (Pandol et al., 1987), 
phosphorylation by cyclic nucleotide dependent kinases (Camello et al, 1996; Giovannucci et al., 
2000), PKA (Giovannucci et al., 2000; Tsunoda et al., 1990) and PKC (Patel et al., 1999; 
Patterson et al., 2004). 
 
! 14!
RyRs are modulated by similar regulators and share some sequence and structural homology to 
IP3Rs. However, RyRs do not depend on specific ligands and only require Ca2+ to open, 
producing CICR (Kasai et al., 1993). Pharmacological blocking of RyRs dampens, but does not 
block, secretagogue-induced Ca2+ signals (Nathanson et al., 1992; Straub et al., 2000). Cellular 
localization of RyR differs from IP3R, distributed diffusely through the acinar cell with a higher 
concentration in the basal aspect of the cell. This expression pattern suggests activation of RyR 
plays a role in the propagation of Ca2+ signals from the initial release of Ca2+ at the apical 
projections of ER to other peripheral regions of the cell (Husain et al., 2005; Leite et al., 1999; 
Straub et al., 2000).  
 
1.4.2 Maintaining endoplasmic reticulum Ca2+ homeostasis  
!
Since not all of the Ca2+ that leaves the ER upon stimulation is returned, there is an overall net 
loss of Ca2+ in the ER. To accommodate this, acinar cells have a store-operated Ca2+ entry 
(SOCE) pathway, which is activated when ER stores begin to empty, to maintain ER Ca2+ 








































































































A) Unstimulated cells at rest maintain ER and cytoplasmic Ca2+ at ~0.1 µM and ~1mM 
respectively, (B) Upon GPCR-mediated IP3 production, ER Ca2+ moves through IP3Rs down the 
steep concentration from the lumen to the cytoplasm. (C) SERCA and PMCAs, function to clear 
cytosolic Ca2+; decreased ER Ca2+ causes STIMs to cluster and accumulate at ER-plasma 
membrane junctions. (D) Coupling of STIMs to Orai1 at ER-plasma membrane junctions opens 
these Ca2+ channels, causing Ca2+ to move down the steep concentration gradient. Ca2+ is then 
pumped back into the ER by SERCAs.  




ER Ca2+ stores are replenished through SOCE, which mediates Ca2+ uptake by cells from the 
extracellular stores. This involves movement of Ca2+ first into the cytosol down the steep 
concentration gradient, followed by active uptake into the ER by sarco/endoplasmic reticulum 
Ca2+ATPases (SERCA) against the concentration gradient. The two vital protein components of 
the SOCE pathway are the ER resident, Ca2+-sensing protein stromal interaction molecule 1 
(STIM1) and the plasma membrane, Ca2+-selective channel forming subunit Orai1(Feske et al., 
2006; Hong et al., 2011; Liou et al., 2005; Roos et al., 2005; Vig et al., 2006; Zhang et al., 2006). 
The Orai1 family of membrane proteins form the conductive pore of Ca2+ release-activated Ca2+ 
channels (CRAC; Feske et al., 2006; Hong et al., 2011; Vig et al., 2006). STIM1 consists of a 
cytoplasmic C-terminal domain, one transmembrane domain that spans the ER membrane, and 
an N-terminal portion residing in the ER lumen. An EF-hand domain is located within the N-
terminal portion of STIM1, which senses ER Ca2+ stores decreases through the unbinding of 
Ca2+, resulting in structural changes that lead to oligomerization and propagate to the C-terminal 
end of the protein. The STIM1/Orai1 activating region within the cytoplasmic C-terminal end of 
STIM1 is responsible for moving STIM1 oligomers to ER-plasma membrane junctions, where 
they interact and activate Orai1(Liou et al., 2005; Wu et al., 2006). Crystal structure analysis 
shows the Orai1-composed CRAC channel is formed from a hexamer of Orai subunits. Each 
subunit contains four transmembrane alpha helices (M1-M4) and a helix following M4 termed 
the M4 extension that extends into the cytosol (Hou et al., 2012). Interactions between STIM1 
and both the N- and C-terminal helix extensions of Orai1are involved in opening the channel. 
Orai1 achieves its high Ca2+ selectivity through high-affinity binding of Ca2+ to a glutamate ring, 
which likely acts as the ion selectivity filter. When Orai1 is not bound to STIM1, it is inactive.  
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In pancreatic acinar cells, SOCE is required for continued cytosolic Ca2+ oscillations typical of 
those that occur to drive enzyme secretion (Yule et al., 1991). If SOCE is inhibited during 
stimulation of enzyme secretion, Ca2+ oscillations will not continue, even if stimulus is present 
(Yule et al., 1991). Although STIM1 and Orai1 are the key components in SOCE, other proteins 
can mediate this process. For example, transient receptor potential channel 1/3 (TRPC1/3) can 
also be part of the SOCE pathway by acting as a Ca2+ influx channel when activated by STIM1 




In addition to the involvement in SOCE, Orai1 plays a key role in other pathways. Orai1 along 
with Orai3 can be activated by other molecules or proteins, independent of ER Ca2+ stores. This 
pathway is termed the store-independent Ca2+ entry (SICE) pathway. SICE is a newly discovered 
phenomenon with much of the research focusing on the role of this process in cancer. In SICE, 
Orai1 contributes to Ca2+ currents activated by arachidonic acid or the metabolite leukotriene C4, 
along with Orai3, through ARC/LRC channels (Mignen et al., 2008). Other channels have also 
been linked to SICE including the small conductance Ca2+ activated K+ channel (SK3). In bone 
cancer, SK3 controls Ca2+ through Orai1 (Chantome et al., 2013) and recently, a functional 
interaction between Kv10.1 and Orai1, which allows constitutive Ca2+ influx in a breast cancer 
cell line has been defined (Badaoui et al., 2018).  
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1.4.3 cADP and NAADP pathways for Ca2+ release from lysosomal stores 
!
In mouse pancreatic acinar cells, the global temporal Ca2+ signal stimulated by Ach differs from 
stimulation by CCK, suggesting different pathways initiate Ca2+ release. In mouse pancreatic 
acinar cells, CCK and ACh stimulate activity of cytosolic ADP-ribosyl cyclase activity resulting 
in the production of cyclic adenosine diphosphate ribose (cADPR), which then results in Ca2+ 
release from basal aspects of the cell. Physiological levels of CCK result in the production of 
nicotinic acid adenine dinucleotide phosphate (NAADP). NAADP is a potent Ca2+ mobilizer, 
releasing Ca2+ from stores, independent of IP3 and CICR, suggesting NAADP elicits Ca2+ release 
from different stores (Churchill et al., 2002; Genazzani & Galione, 1996). While the endocytic 
and hydrolytic functions of the endolysosomal system are well established (reviewed by Luzio, 
el.,  2007), the Ca2+ signalling functioning of these organelles remains unclear. A general 
consensus does exist on a model for functional coupling between the lysosome-ER interface. 
This model suggests that NAADP mobilizes localized Ca2+ signals from lysosome-related Ca2+ 
stores. The Ca2+ release from lysosome-related Ca2+ stores at the lysosome-ER interface initiates 
global Ca2+ waves through recruitment of Ca2+ release from RyR through CICR (Galione, 2015; 
Penny et al., 2015). The measurement of Ca2+ concentrations in the lysosome is difficult, since 
fluorescent probes for measuring Ca2+ are pH sensitive, however, estimates for lysosomal Ca2+ 
concentrations have been made between 400-600 µM (Lloyd-Evans et al., 2008; Ronco et al., 
2015). Ca2+ enters the lysosome through the H+/Ca2+ exchanger (Luzio et al., 2007). The two-
pore channel (TPC) family of proteins, expressed in an endo-lysosomal compartment of the 
pancreatic acinar cells, has been proposed as the candidate receptor for Ca2+ release by NAADP 
(Hooper & Patel, 2012). TPC2 has been shown to recruit CICR channels (IP3R and RyR) to the 
ER-lysosomal junctions (Galione, 2011). The family of transient receptor potential cation 
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channel, mucolipin subfamily (TRPML) channels has also been proposed as a Ca2+ release 
channel on lysosomes; however, TRPML dependence on NAADP for Ca2+ release is highly 
debated (Dong et al., 2010).  
 
Combined, the pathways described above promote increased cytosolic Ca2+. Since high cytosolic 
levels of Ca2+ trigger many unwanted consequences, additional mechanisms are required to clear 




Stimulated Ca2+ release from subcellular stores and Ca2+ influx through SOCE is modulated by 
buffering proteins and mitochondria, while Ca2+ATPases work to return cytosolic levels back to 
resting levels. There are three families of P-Type Ca2+ATPases; Plasma Membrane Ca2+ATPases 
(PMCAs), SERCAs and SPCAs, all of which have a primary function in moving Ca2+ out of the 
cytosol against a concentration gradient, using energy from the hydrolysis of ATP. In general, P-
Type Ca2+-ATPases contain a cation-binding domain, hydrolase domain and ATPase domain to 
carry out this process. 
 
1.5.1 Sarco/endoplasmic reticulum Ca2+ ATPase 
!
SERCAs are transcribed from the Atp2a gene family which include Atp2a1, 2a2, and 2a3 
(Wuytack et al., 2002). SERCA2 (Atp2a2) is the most widely expressed isoform and exists as 
four different splice variant isoforms: SERCA2a-d. SERCA2b is ubiquitously expressed. 
SERCA3 splice variants are always co-expressed with SERCA2b and found in the pancreas, as 
well as other secretory cells including the trachea, colon, lymphocytes, platelets, mast cells and 
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thyroid [reviewed in (Altshuler et al. 2012)]. The primary function of SERCAs is to move Ca2+ 
from the cytosol into the lumen of the ER, where the ion can be stored (Mogami et al., 1997). In 
pancreatic acinar cells, SERCA2a and SERCA2b are expressed in the luminal pole. Inhibiting 
SERCA pumps hinders physiologically stimulated Ca2+ oscillations (Lee et al., 1997). All 
SERCA pumps are inhibited by thapsagargin (TG), which causes passive ER Ca2+ store 
depletion (Lee et al., 1997). TG is a sesquiterpene lactone (Rogers et al., 1995). Treating cells 
with TG results increased levels of cytoplasmic Ca2+, as the ion leaks out of the lumen and 
cannot be pumped back in due to SERCA inactivation. Therefore, the increase in cytoplasmic 
Ca2+ levels after TG treatment of cells is often used as a gauge of ER Ca2+ store levels in 
experiments.  
 
1.5.2 Plasma membrane Ca2+ ATPases 
!
There are four different genes encoding PMCAs - Atp2b1, 2b2, 2b3, and 2b4. PMCA1, 
transcribed from Atp2b1, is ubiquitously expressed beginning in the earliest stages of embryonic 
development. PMCA2 is expressed in lactating mammary glands and the nervous system, while 
PMCA3 is expressed in skeletal muscles and the nervous system. PMCA4 is expressed in the 
heart, brain and, at high concentrations, in the spermatozoa. Due to alternative splicing, over 30 
PMCA isoforms have been identified to date, accounting for tissue-specific cellular localization, 
Ca2+ regulatory abilities and calmodulin affinity [reviewed in (Brini et al. 2013)].  In pancreatic 
acinar cells, PMCA1 appears to be most abundant, accumulating in the apical and lateral plasma 
membrane, and correlating with the preferential site of Ca2+ extrusion on the apical aspect of the 
cell (Lee et al., 1997). PMCA1 is active even while the pancreatic acinar cell is at rest, implying 
that PMCAs are important for maintaining basal cytosolic Ca2+ levels (Camello et al., 1996). The 
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rate of Ca2+ pumping by PMCAs has a steep dependence on intracellular Ca2+ concentrations and 
is saturated above 400 nM (Camello et al., 1996). Clearance of Ca2+ can be attenuated using 
PMCA inhibitor (Bruce, 2013); however, no pancreatic phenotype has been reported for Pmca1, 
Pmca2 or Pmca4 homozygous or heterozygous knockout mice, suggesting there is redundancy in 
function between PMCA isoforms in the pancreas.  
 
 
1.5.3 Secretory Pathway Ca2+ ATPase 
!
The secretory pathway Ca2+ ATPase was first identified in yeast Saccharomyces cerevisiae as 
plasma membrane ATPase-related 1 (Pmr1; Antebi & Fink 1992). Pmr1 is biochemically distinct 
from the other Ca2+ATPases, as it has an unusual selectivity for Mn2+ and plays a prominent role 
in detoxification (Xiang et al. , 2005).  
 
There are two SPCA isoforms SPCA1 and SPCA2, transcribed from different genes. SPCA1 is 
ubiquitously expressed in tissues, while SPCA2 shows limited expression to a few tissues/cell 
types (Pestov et al., 2012). Homozygous loss of ATP2C1, the gene encoding SPCA1, results in 
fetal mortality. Haploinsufficiency causes Hailey-Hailey disease, a debilitating blistering 
disorder of the skin characterized by disruption of desmosome contacts in keratinocytes (Deng & 
Xiao, 2017). Although the exon/intron layout is perfectly conserved between ATP2C1 and 
ATP2C2 and the two proteins encoded by the respective genes share a 64% amino acid sequence 
identity, it is clear that SPCA2 carries out other physiological functions compared to SPCA1 
since it is not able to compensate for reductions in SPCA1 expression or activity (Dode et al., 
2006). In fact, recent studies suggest a unique role for SPCA2 in SICE (Feng et al., 2010), 
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though, the existence of this pathway has not yet been confirmed in pancreatic acinar cells. This 
thesis will investigate a possible physiological role for SPCA2C, an SPCA2 isoform, in the SICE 
pathway.   
 
1.5.3.1 Secretory Pathway Ca2+ATPase 2 
!
SPCA2 is only expressed in higher eukaryotes. The highest accumulation of SPCA2 is found 
throughout the gastrointestinal tract (Pestov et al., 2012). Other tissues expressing SPCA2 
include the brain, stomach, large and small intestine, prostate, salivary and mammary glands 
(Pestov et al., 2012). ATP2C2, the gene that encodes SPCA2, spans a region of 95.5 kb on 
human chromosome 16 and consists of 27 exons ranging from 36-393 bp. The SPCA2 protein is 
946 amino acids long. Due to the close homology between SPCA2 and SPCA1, Golgi 
subcellular localization is presumed, similar to SPCA1; however, subcellular localization seems 
to depend on cell type. In C2C12 cells (Vanoevelen et al., 2005), a mouse myoblast cell line, 
human HT-29 and CHO cells (Jenkins, Papkovsky, & Dmitriev, 2016), SPCA2 exhibited a 
Golgi-like localization. However, in the skin of rat there was strong labeling in the perinuclear 
region, and in the rat duodenum, SPCA2 was strongly associated with the plasma membrane 
(Pestov et al., 2012). In the MCF7 breast cancer cell line, SPCA2 partially localized to the 
plasma membrane, showing up to 10% of SPCA2 protein being cell surface biotinylated (Feng et 
al., 2010).  
 
Immunofluorescence (IF) analysis showed SPCA2 expression in mouse pancreatic acini and 
subsets of islet cells, but not in duct cells or blood vessels (Garside et al., 2010). Subcellular 
localization of SPCA2 in pancreatic acinar cells showed expression similar to ER associated 
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protein calreticulin, rather than Golgi resident proteins such as GM130 (Garside et al., 2010). 
Interestingly, in pancreatic tissue the Atp2c2 transcript is significantly smaller than the predicted, 
full-length sequence. Northern and Western blot analysis both confirmed a shorter transcript and 
no expression of the full-length Atp2c2 gene and protein was observed in the pancreas (Garside 
et al., 2010). Additional analysis suggested this smaller Atp2c2 transcript and SPCA2, termed 
SPCA2C, protein was pancreas-specific and that the protein contained at least the carboxy 
terminus of the full length protein. However, it is unclear if this isoform is the product of a splice 
variant or is produced through an alternative transcriptional start site. Determination of the exact 
DNA coding sequence of the isoform is essential for interpretation of its amino acid sequence 
and to propose a function for SPCA2C through interpretation of its amino acid sequence. The 
first question that this study addresses is defining the coding sequence of the Atp2c2 gene 
expressed in pancreatic tissue.  
 
1.6 Alternative functions of SPCA2 
!
Given the high degree of homology between SPCA1 and SPCA2, it was postulated that their 
functions complemented each other (Vanoevelen et al., 2005). However, based on recent studies, 
it is clear that SPCA2 is functionally distinct from SPCA1. Studies show SPCA2 has different 
subcellular localization patterns, is expressed as unique isoforms, and is involved in SICE, 
depending on cell type, making SPCA2 an intriguing protein for Ca2+ regulation. Given that Ca2+ 
is key to pancreatic acinar cell function and survival and that SPCA2C is the only isoform 




As mentioned, the general function of P-Type Ca2+ATPases is to move Ca2+ away from the 
cytosol. However, in breast cancer cells, 10% of SPCA2 is localized to the plasma membrane, 
and surface residence of SPCA2 correlates with elevation of basal cytosolic Ca2+ concentrations 
(Feng et al., 2010). Remarkably, the ability of SPCA2 to increase cytosolic Ca2+ concentrations 
was found to be independent of Ca2+ATPase activity. Instead, this function was associated with 
an interaction of its C-terminal region with the plasma membrane store operated Ca2+ channel 
Orai1 (Feng et al., 2010). This information further distinguished SPCA2 function from SPCA1 
and exemplified a potentially important alternate role in specific cell types, such as acinar cells. 
 
Co-localization of endogenous SPCA2 and Orai1 was shown in MCF7 cells, and an interaction 
was confirmed between these two proteins. Unlike the interaction between STIM1 and Orai1 in 
SOCE, localization and the ability to activate Orai1 was independent of ER Ca2+ store levels and 
did not require STIM1 or STIM2 (Feng et al., 2010). Furthermore, knock-down of endogenous 
expression of SPCA2 expression in MCF7 cells significantly decreased resting cytosolic Ca2+ 
concentrations. This supports an alternate function for SPCA2 in increasing cytosolic Ca2+ 
concentrations in a store and STIM-independent manner (Feng et al., 2010). 
 
Interestingly, enhanced expression of endogenous SPCA2 has a physiological role in lactation. 
Specifically, in mammary epithelia, SPCA2 expression is driven by prolactin, a polypeptide 
hormone indispensable for the growth and development of mammary glands, synthesis of milk 
and maintenance of milk secretion. An increase in SPCA2 expression in mammary epithelial 
cells increased the concentration of Ca2+ in the Golgi apparatus. SPCA2 was increased during 
lactation, while SPCA1 was not (Anantamongkol et al., 2007).                      
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Despite these studies, there is still much that is unknown regarding SPCA2 function. This is 
particularly true regarding SPCA2C, which is the only isoform expressed in pancreatic cells.  
Based on the short nature of SPCA2C and seemingly pancreas-specific expression, several 
questions need to be addressed. Does this short C-terminal isoform SPCA2C have a function; 
does it perform similar or different functions as SPCA2; and do these functions depend on cell 
type? The goal of my thesis was to address, in part, some of these questions regarding SPCA2C 
biology.   
 
1.7 Rational, hypothesis and objectives 
!
The first recognition of SPCA2 in pancreatic tissue originated from a screen comparing gene 
expression between wild type and Mist1-/- mice (Garside et al., 2010), which present phenotypes 
of cellular disorganization (Pin et al., 2001), an increased susceptibility to pancreatitis (Kowalik 
et al., 2007) and pancreatic cancer (Zhu et al., 2004) and defects in Ca2+ handling (Luo et al., 
2005). This comparison identified Atp2c2 as being the most significantly decreased mRNA in the 
absence of Mist1-/-, model of pancreatic pathology. Further characterization of SPCA2 in 
pancreatic tissue indicated a significantly smaller protein compared to the predicted full length 
SPCA2, which is 944 amino acids in length. The goal of my study was to understand the 
function of SPCA2C.  
 
1.7.1 Governing hypothesis  
!
My governing hypothesis is that SPCA2C influences Ca2+ influx and cytosolic Ca2+ levels. 
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The goals of the first results chapter were to delineate the DNA sequence of Atp2c2c and to 
determine if the transcript generates a protein that functions in Ca2+ homeostasis. Mouse 
pancreatic RNA was analyzed by RNA-seq and the Atp2c2sequence mapped to the carboxy 
terminus of the full length SPCA2. SPCA2C sequence was then expressed in HEK293A cells 
and Fura2 ratiometric imaging was used to determine the effects of SPCA2C on cytosolic Ca2+ 
levels.  
 
The goals of the second results chapter were to determine subcellular localization of SPCA2C 
and test the functional role SPCA2C plays in specific Ca2+ signaling pathways, including SOCE 
and SICE. SPCA2C was transiently expressed in HEK293A and in HEK293A cells stably 
expressing Orai1 fused to yellow fluorescence protein (YFP) (HEK-Orai1YFP). Cells were treated 
with a physiological agonist (carbachol) and pathological SERCA inhibitor (TG) agonist to 
promote altered Ca2+ signaling. Cytosolic Ca2+ concentrations were measured by Fura2 
ratiometric imaging to test Ca2+ influx rates, organelle Ca2+ stores, STIM1-Orai1 mediated 
SOCE and store independent Ca2+ influx.  
 
In the third results chapter, the experiments were extended in cell lines more relevant to the 
pancreas. Mouse 266.6 cells, a cell line derived from acinar cells, and pancreatic cancer patient-
derived cell lines, were examined in a similar fashion as HEK293A cells. As part of this chapter, 
an unbiased protein-protein interaction assay was used to establish the SPCA2C interactome. 
Specifically, biotinylating identification (BioID) protein interaction assay was used to identify 
proteins in close proximity to SPCA2C. The list of interaction candidates identified by BioID 
was assessed bioinformatically using GO and Kyoto encyclopedia of genes and genomes 
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(KEGG) pathway analysis to confirm our findings on SPCA2C biology and predict novel roles 
for SPCA2C.  
 
By delineating the Atp2c2c sequence and functionally characterizing the role of SPCA2C in Ca2+ 
homeostasis, I have uncovered a novel mechanism that pancreatic acinar cells use to regulate 
cytosolic and ER Ca2+ levels.  
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Chapter 2 
Atp2c2 is transcribed from a unique transcriptional start site in mouse 
pancreatic acinar cells 
!
The work in this Chapter was published as "Atp2c2 is transcribed from a unique transcriptional 
start site in mouse pancreatic acinar cells" Fenech et al (2016) in the Journal of Cellular 
Physiology. The contributing authors on this manuscript includes Caitlin Sullivan, Dr. Lucimar 
Ferreira, Dr. Rashid Mehmood, Dr. William MacDonald, Dr. Peter Stathopulos and Dr. 
Christopher Pin. The work performed by those individuals has been omitted with the exception 
of Figures 5C, which was completed by C. Johnson. The text within this Chapter related to the 




Pancreatic acinar cells are polarized with highly organized intracellular compartments that 
permit rapid receptor-regulated exocytosis of enzymes. The precise spatial and temporal control 
of Ca2+ release is fundamental for proper exocytosis of enzymes (Lee et al., 1997). The ability of 
Ca2+ to act as a second messenger in enzyme release is provided by the maintenance of cytosolic 
Ca2+ gradient with greater concentrations of Ca2+ outside the cell or within intracellular 
compartments such as the ER, relative to the cytosol. Transient increases in cytosolic Ca2+ are 
coupled to exocytosis of zymogen granules (ZG) containing enzymes (Burnham et al., 1984), 
while dysregulation of intracellular Ca2+ concentration affects gene transcription, cell 
proliferation, apoptosis, or necrosis and is associated with the initiation of pancreatitis (Kruger et 
al., 2000; Li et al., 2014; Zhou et al., 1996). The ability to restore the cytosolic Ca2+ gradient 
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after ER release is due, in part, to P-type Ca2+ATPases that remove Ca2+ from the cytosol (Lee et 
al., 1997). There are three families of P-type Ca2+ATPases. Sarco/endoplasmic reticulum 
Ca2+ATPases (SERCAs: encoded by three Atp2a genes) translocate Ca2+ into the ER 
(Arredouani et al., 2002; Beauvois et al., 2004; Zhao et al. , 2001). Plasma membrane 
Ca2+ATPases (PMCAs; encoded by four Atp2b genes) translocate Ca2+ out of the cell. The third 
type of Ca2+ATPase (SPCAs, encoded by two Atp2c genes), which translocate Ca2+ into the 
Golgi [reviewed in (He & Hu, 2012; Vanoevelen et al., 2005). SPCA1/Atp2c1 is a homolog of 
Pmr1 /PMRI first described in Saccharomyces cervisiae (Rudolph et al., 1989). SPCA1 is 
ubiquitously expressed and targeted deletion of Atp2c1 in mice results in gestational growth 
retardation and death before embryonic day 10.5 (Okunade et al., 2007). Embryo development 
occurs normally until the neural tube fails to close at the dorsal end on ED 8.5. Golgi and ER 
swelling and increased apoptotic death was observed in SPCA1-/- embryos (Okunade et al., 
2007).  In humans, mutations in the ATP2C1 gene are found in Hailey-Hailey disease (Sudbrak 
et al., 2000). A second gene, SPCA2/Atp2c2 is expressed only in higher organisms (mammals) 
and is limited to a few tissues, including secretory and absorptive epithelia of the gastrointestinal, 
genitourinary, mammary, and salivary glands (Vanoevelen et al., 2005). Although SPCA2 
expression is limited to a few tissue/cell types, SPCA2 appears to have a broader localization 
pattern within the cell compared to SPCA1. Unlike SPCA1, which is localized to the Golgi, 
SPCA2C is found in the Golgi, ER, and secretory vesicles (Feng et al., 2010; Garside et al., 
2010; Pestov et al., 2012; Xiang et al., 2005). In lactating gland luminal epithelia, SPCA2 is 
localized predominantly to vesicles that travel to the plasma membrane rather than the Golgi and 
has a major role in increasing intracellular Ca2+ (Cross et al., 2013). Human breast 
adenocarcinoma MCF7 cells have higher SPCA2 expression compared to MCF-10A, a non-
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malignant human mammary epithelial cell line. Increased SPCA2 expression was also observed 
in a small group of breast cancer patients suggesting a potential link between SPCA2, cytosolic 
Ca2+, and metastasis (Feng et al., 2010). Indeed, they found that exogenous expression of SPCA2 
in MCF-10A cells increased cytosolic Ca2+ levels, while knocking down SPCA2 in MCF7 cells 
decreased it. They also show that the C-terminus of SPCA2 is required for Ca2+ influx, which 
was via the plasma membrane calcium channel Orai1, a mechanism they called store 
independent Ca2+ entry  (SICE; Feng et al., 2010). These studies suggest that truncations of 
SPCA2 may also be involved in SICE by activating Orai1 protein function (Feng et al., 2010).  
 
SPCA2 is encoded by the Atp2c2 gene that spans a region of 95.5 kb on human chromosome 16, 
which contains 27 exons. SPCA2 is 946 amino acids long (Vanoevelen et al., 2005). SPCA2 is 
expressed in pancreatic acinar cells, but characterization of SPCA2 expression indicated a 
significantly smaller protein (Garside et al., 2010) than the predicted full length SPCA2 
(Vanoevelen et al., 2005). Expression analysis of this smaller SPCA2 isoform suggested a novel 
function from the full length SPCA2 as it was localized to both the Golgi and ER. Relevant to 
acinar cell physiology, SPCA2 expression was markedly decreased in Mist1-/- mice, which show 
defects in Ca2+ handling (Garside et al., 2010). While it is clear that the pancreatic isoform, 
termed SPCA2C, contains at least the carboxy terminus of SPCA2, without knowledge of the 
exact transcriptional start site and exon/intron splicing; it is unclear what functional significance 
SPCA2C has in Ca2+ homeostasis. To appropriately study the function and regulation of 
SPCA2/Atp2c2 in the pancreas, it is imperative to determine if Atpc2c2 is the result of altered 
splicing or a pancreatic-specific transcriptional start site (TSS).  
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The goals of this study were to determine the complete Atp2c2 transcript encoding SPCA2C and 
determine if SPCA2C affects Ca2+ homeostasis. My results show Atp2c2 is transcribed from a 
unique TSS in pancreatic acinar tissue, encoding only the carboxy terminal portion of SPCA2. In 
addition, over expressing SPCA2C is accompanied by persistent elevation in cytosolic Ca2+, 




2.2.1 Mouse handling and initiation of cerulein-induced pancreatitis 
!
C57Bl/6 mice were used for all experiments except transgene analysis. Mice were handled 
according to guidelines approved by the Animal Care and Use Subcommittee at the University of 
Western Ontario (Protocols 2008-116 and 2008-027). Transgenic mice carrying the -
1181+57Atp2c2 promoter region upstream of LacZ reporter gene were generated through 
pronuclear injection of CBA/C57Bl/6 hybrid zygotes followed by implantation into CD1 pseudo 
pregnant mice (completed by the London Transgenic Facility, Western University). Founder 
mice (F0) were mated to C57Bl/6 mice, and 3-4-week-old F1 mice characterized for transgene 
expression. 2-4-month-old male C57Bl/6 animals were used for gene and RNA-sequencing 
(RNA-seq) analysis. The targeted deletion of Mist1 gene has previously been described (Pin et 
al., 2001). Cerulein-induced pancreatitis (CIP) was initiated as described (Kowalik et al., 2007) 
with 4-8 hourly intraperitoneal injections of 50 µg/kg cerulein (cholecystokinin analog) and mice 
sacrificed 4, 8, 32 and 72 hours after initial injection.  
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2.2.2 RNA isolation, qRT-PCR, and RNA-Seq 
!
RNA was isolated from pancreatic tissue of C57/Bl6 mice or pancreatic tissue of Mist1-/- mice as 
described (Johnson et al., 2009). RNA was isolated from whole tissue using TRIzol (Invitrogen, 
Burlington, ON), following the manufacturer's instructions. Real-time qRT-PCR was performed 
on cDNA samples. To make cDNA samples, 1 µg of total RNA was reverse transcribed using 
Improm-II Reverse Transcriptase and random primers (Promega, Madison, WI). Quantitative 
real time PCR (qRT-PCR) was performed using the Roche LightCycler 1.5 carousel-based 
system (Roche Diagnostics, Laval, PQ). Duplicate reactions were performed for each sample 
using 1µl cDNA in 19 µl SYBRTM Green Master Mix as per manufacturer's instructions. 
Reactions were started at 94°C for 10 minutes, followed by 45 cycles of 94°C for 10s, 60°C for 
48°C for 40s, 72°C for 10s. Relative quantification using the calibrator normalized method with 
standard curves for efficiency correction was carried out using Mitochondrial ribosomal protein 
L1 (Mrpl1) was used as a normalization control. ViiA 7 RUO software (Applied Biosystems) 
was used to calculate the amount of RNA relative to saline treatment for the equivalent time 
points.  
 
2.2.3 Plasmid construction 
!
The putative promoter region upstream of the ATG codon in exon 24 of the Atp2c2 gene, which 
corresponds to +2,580 (RNA sequence) or +54,891 (DNA sequence) in the full length Atp2c2 
genomic sequence was designed based on the UCSC Genome browser identification of Atp2c2 




To generate a transgene promoter construct, -1811+57Atp2c2cpGL3 was digested with Xho1 and 
Sma1 and cloned into pWHERE (Invitrogen, San Diego, CA; Figure 2.1) digested with the same 
enzymes. Finally, a pcDNA3.1 expression vector containing the exact Atp2c2c reading frame was 
generated by Gene Art (Thermo Fisher Scientific, Waltham, MA) based on sequence information 
from NCBI (Accession #AC_000030.1). The Atp2c2c sequence was followed by a FLAG 
antigenic tag sequence (5'GATTACAAGGATGACGACGATAAG 3'; pcDNA-SPCA2FLAG) and 






















































(A) Plasmid map. (B) Sequence of the Atp2c2c promoter region used. Complete sequences of the 
5' upstream region from Atp2c2c that was used for -1181+57Atp2c2cpWHERE. E-box consensus 
sites highlighted in black represent potential MIST1 binding sites.  
Figure 2.1 Plasmid construct pWHERE with -1181+57Atp2c2c. 
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2.2.4 Cell culture 
!
HEK293A cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) high glucose 
media (HyClone, Logan, UT) containing 10% (v/v) FBS and antibiotics (penicillin G 100U.mL, 
streptomycin 100 µg/mL). When cultures reached 70-80% confluence, cells were transfected 
using JetPrime transfection kit (PolyPlus, NY) with Atp2c2c promoter-LacZ plasmids described 
above, or pcDNA3.1-SPCA2CFLAG and or/ pcDNA3.1-SPCA2MYC, following manufactures 
instructions. Promoter-less pWHERE plasmid was used as a control. Forty-eight hours after 
transfection cells were fixed in 4% (v/v) formalin in PBS. 
 
2.2.5 Immunofluorescence analysis 
!
HEK293A cells were transfected as described above with pcDNA3.1-SPCA2CFLAG and/or 
pcDNA3.1-SPCA2MYC. Forty-eight hours after transfection, HEK293A cells were fixed with 4% 
(v/v) formalin in PBS. Cells were permeabilized with 1% TritonX-100 in PBS and incubated in 
blocking solution (5% BSA, 1% triton in PBS). Mouse "-FLAG (diluted 1:500, Sigma) or rabbit 
"-MYC (1:1000, Sigma), was diluted in blocking solution. Fluorescently labelled (TRITC or 
FITC) secondary goat antibodies were diluted 1:250 in PBS (Jackson Immunoresearch Labs, 
West Grove, PA or Sigma, Oakville, ON, Canada). Confocal images were acquired using a Leica 
SP5 Confocal microscope and the colocalization finder plugin for ImageJ 
(http://I.usa.gov/IPn0ruI) was used to determine overlap of fluorochromes.  
 
2.2.6 !-galactosidase staining 
!
Cells were transfected as stated above with Atp2c2c promoter-LacZ or empty pWHERE plasmid. 
48 hours after transfection cell were fixed in 4% (v/v) formalin in PBS. Pancreata were dissected 
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from 2-month-old 1181+57Atp2c2 transgenic mice and either fixed in 4% formalin for whole 
mount !-galactosidase staining or flash frozen in optimal cutting temperature (OCT) compound 
(Sakura Finetek, CA, USA). OCT-embedded tissue was section at 20 µm using a Shandon 
cryostat. Whole mount fixed tissues were placed in x-gal solution (4 mM potassium ferricyanide, 
2 mM MgCl, 0.08% x-gal in PBS) for up to 12 hours. Tissue sections or cells were fixed in 4% 
formalin, washed and immersed in x-gal solution for up to one hour. Slides were cover slipped 
and sealed with Permount mounting medium (Fisher Scientific, NJ). Stained sections were 
viewed under a Leica microscope DM5500B and whole mount tissues visualized under Leica 
M205 FA microscope.  
 
2.2.7 Ca2+ imaging 
!
HEK293A cells were transfected as described above with pcDNA3.0-GFP, pcDNA3.1-
SPCA2CFLAG, or pcDNA3.1-SPCA2MYC (encodes full length SPCA2; kindly provided by R. Rao; 
Feng et al., 2010). Forty-eight hours after transfection cells were loaded (incubated) with Fura2-
AM at 1µM in culture media [Dulbecco's Modified Eagle Medium (DMEM) high glucose media 
(HyClone) containing 10% (v/v) FBS and antibiotics (penicillin G 100U.mL, streptomycin 100 
µg/mL, amphotericin B 0.25 µg/mL; Gibco-BRL, Grand Island, NY)] for 30 minutes at 37 °C 
and 5% CO2. After loading, cells were rinsed once in Hank's Buffered Saline Solution (HBSS; 
140 mM NaCl, 4.7 mM MgCl, 10 mM HEPES, 1.8 mM CaCl) and then allowed to rest for 10 
minutes at room temperature in HBSS before recoding was started. Cells were excited at 340 nm 
and 380 nm, and Fura2 emissions at 505 nm were measured per individual cell. Changes in the 
Fura2 fluorescence ratio using excitation wavelengths of 340/380 nm were taken as a measure of 
changes in intracellular Ca2+ levels while individual groups of cells were stimulated with 10 µM 
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carbachol for 5 minutes at a pressure of 2 Pa by puffing. Five-minute puffing experiments were 
completed no more than three times per plate, and never on the same group of cells.  
 
2.2.8 Statistics  
N values are provided for each study within the figure legends. Data is shown +/- standard error 
of the mean (SEM) and significance was determined using a one-way ANOVA and Tukey's 




2.3.1. The pancreatic isoform of SPCA2 is transcribed from an alternative transcriptional start 
site in Atp2c2. 
The pancreatic isoform of Atp2c2/SPCA2 is significantly smaller (Garside et al., 2010) than the 
published full-length molecule that has been reported in the literature (Vanoevelen et al., 2005). 
However, it is unclear whether the pancreatic transcript (termed Atp2c2c; c for carboxy) is the 
result of an alternative transcriptional start site (TSS) or alternative splicing of the larger Atp2c2 
transcript. To resolve this question, the Atp2c2 genomic region was visualized with the UCSC 
Genome browser (https://genome.ucsc.edu) using RNA-seq data on total pancreatic tissue from 
2-month old mice (Figure 2.2A). Examination of the complete Atp2c2 gene showed no sequence 
enrichment in exons 1-23, indicating that these exons were not transcribed within the pancreatic 
genome. Sequence alignment was observed ~41 bp into exon 24 (Figure 2.2B), corresponding to 
+2403 in the full-length transcript, and including all of the remaining exons (24-27) of the 
Atp2c2 gene. Several Expressed Sequence Tags (ESTs) have been identified for Atp2c2, but only 
EST AK007419.1, previously identified in a 10-day-old pancreatic EST library, showed 
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alignment to Atp2c2c (Figure 2.2A, B). Alignment of the AK007419.1 sequence with the full 
length Atp2c2 identifies a single missing G nucleotide, which is not missing in our RNA-seq 
data, indicating that Atp2c2c perfectly aligns with the last 702 bp of Atp2c2. Based on the RNA-
seq and AK007419.1 sequence, I designated the first bp of the Atp2c2c transcript as +41 bp into 
exon 24 of the Atp2c2 gene. Examination of the Atp2c2c sequence identified an open reading 
frame that initiates from an ATG codon at +57 into Atp2c2c and produces a protein that perfectly 
aligns with the last 136 amino acids of SPCA2 (designated SPCA2C; Figure 2.2C). SPCA2C 
contains the residues that form the last four transmembrane domains, part of the cation ATPase 
domain and a cation binding site found within SPCA2 (Figure 2.3). 
 
Examination of other Atp2 genes showed no unique splicing variants but a potential alternative 
TSS for Atp2b1 (Figure 2.4). Examination of RNA-seq data from other regions of the 
gastrointestinal tract (GEO accession number: GSE36025) showed some enrichment along the 
entire Atp2c2 gene with greater sequence enrichment of exons near the 3' end of the Atp2c2 gene 
(Figure 2.5), suggesting that other tissues may contain unique isoforms for Atp2c2 as well as 
heterogeneity in the Atp2c2 isoform expressed. However, none of these tissues express only the 































              M  S  A  A  V 
73 ATCATAGGGGGGACCCTCTTTATCTTCTGGAGAGAGATCCCAGCGAACGGCACCAGCACCCCACGTACAACC 
       I  I  G  G  T  L  F  I  F  W  R  E  I  P  A  N  G  T  S  T  P  R  T  T 
145 ACCATGGCCTTCACCTGCTTCGTGTTTTTCGACCTCTTCAATGCCCTGAGCTGTCGCTCTCAGACCAAGCTG 
  T  M  A  F  T  C  F  V  F  F  D  L  F  N  A  L  S  C  R  S  Q  T  K  L 
217 ATATTTGAGATTGGCTTTTTCCGGAACCGCATGTTCCTGTACTCAGTCCTTGGGTCCCTCCTGGGGCAGCTG 
  I  F  E  I  G  F  F  R  N  R  M  F  L  Y  S  V  L  G  S  L  L  G  Q  L 
289 GCCGTGATCTATGCCCCGCCCCTACAAAAGGTCTTCCAGACTGAAAACCTGAGCGCGCTCGACCTGCTGCTG 
  A  V  I  Y  A  P  P  L  Q  K  V  F  Q  T  E  N  L  S  A  L  D  L  L  L 
361 CTGACGGGCCTGGCCTCGTCTGTCTTCATTCTGTCGGAGCTGCTCAAGCTCTGGGAAAAGTTCTTGTCCAGA 
  L  T  G  L  A  S  S  V  F  I  L  S  E  L  L  K  L  W  E  K  F  L  S  R  
433 GCCAGGCCCACTCAGATGCTCCCGGAAGCTGTGTAACGGAACCAGTGTGTCAAGGCCCTGACTGACCTGTGT 













 (A) RNA-seq visualization of the Atp2c2 gene reveals sequence enrichment only with exons 24 
to 27. The only EST that corresponds with this sequence is AK007419 (arrow). (B) Higher 
resolution RNA-seq data indicates that Atp2c2c starts within the 4th exon, exactly where the 
AK007419 EST begins (downward arrow). However, Atp2c2c contains the single G nucleotide 
missing within the published sequence for AK007419 (open arrow). (C) The Atp2c2c sequence 
produces an open reading frame that generates a 136 amino acid protein that aligns with the 
carboxy terminus of SPCA2.  





















Full-length SPCA2 contains cation ATPase, E1-E2 ATPase and nine transmembrane domains. 
Putative cation binding sites are denoted by arrow heads, which represent multiple closely 
located residues in three-dimensional space. The putative actuator (A), phosphorylation (P), and 
nucleotide-binding (N) domain as conserved in many P-type ATPases (Kuhlbrandt, 2004; 
Vanoevelen et al., 2005) are indicated with dotted sections denoting breaks in protein sequence 
but not structure. The predicted SPCA2C contains the residues that form the last four 
transmembrane domains and a portion of the cation ATPase domain. 



































(A) Schematic representation of Atp2 gene expression based on RNA-seq values and visualized 
using the UCSC genome browser. Arrows indicate putative TSSs not corresponding to the full-
length genes, (B) Visualization of RNA-seq for Atp2 gene not significantly affected during CIP. 
























(A) Schematic representation of Atp2c2 gene expression on RNA-seq values of 8-week-old 
mouse colon, large intestine, small intestine and stomach tissues visualized using the UCSC 
genome browser. (B) Magnified region focusing on the last half of the Atp2c2 gene. 
Figure 2.5 Examination of Atp2c2 expression in other regions of the gastrointestinal tract. 
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 2.3.2. The region upstream of Atp2c2c acts as a promoter  
!
The region upstream of the Atp2c2c TSS was examined for putative transcription factor binding 
motifs using the Alibaba-Gene Regulation Data Base and Nsite -- softberry 
(http://www.softberry.com). Several potential binding motifs were identified including NFκ-! 
TNF"-K.3 (NF-κB), Sp 1-Ku80 (Sp1), and NF-IL6-CCR1 (NF-IL6) consensus site. However, 
no consensus TATA box sequence was observed within this region. Therefore, to confirm that 
the 23rd intron and initial part of the 24th exon of the Atp2c2 gene drive expression of Atp2c2c, 
the -1181+57 sequence region was inserted upstream of a nuclear LacZ cassette (-
1181+57pWHERE). Distinct !-galactosidase expression was observed upon transfection in 
HEK293A cells (Figure 2.6A), confirming promoter activity. To determine if the -
1181+57pWHERE promoter reporter construct was active in vivo, several transgenic lines were 
generated through pronuclear injection of the -1181+57Atp2c2cpWHERE construct (Figure 2.6). 
In total, nine founder lines were identified. Evaluation of pancreatic tissue using whole mount !-
galactosidase analysis revealed no detectable expression above control levels. To perform more 
sensitive analysis, RT-PCR analysis was performed for LacZ mRNA (Figure 2.6C). No 
detectable LacZ expression could be discerned. These findings suggest that the 1181 bp promoter 
region for Atp2c2c does not contain sufficient regulator elements required for pancreatic-specific 


































(A) LacZ histochemistry of HEK293A cells transiently transfected with CMV-LacZ, pWHERE 
with no promoter, or pWHERE containing the +1181-+57Atp2c2c region in front of LacZ. (B) 
Representative PCR for transgene in genomic DNA from one litter of potential founder mice 
identifying three positive samples. Control is genomic DNA spiked with the equivalent of 10 
copies (10C) of the transgenic plasmid. (C) RT-PCR for LacZ RNA expression in founder mice, 
Mrpl was used as loading control and non-transgenic DNA spiked with 5 or 10 copies (C) of -




Figure 2.6 The sequence from the genomic region upstream of the Atp2c2c transcript start site 
exhibits promoter activity 
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 2.3.3. Atp2c2c expression is reduced after inducing pancreatitis in mice. 
!
Atp2c2c expression is significantly reduced in mice lacking the transcription factor MIST1 
(Garside et al., 2010), which is a model of increased pancreatitis susceptibility with deficits in 
Ca2+ homeostasis (Luo et al., 2005). Based on this decrease in expression of Mist1-/- mice, I 
predicted Atp2c2 expression may be altered in response to cerulein-induced pancreatitis (CIP). 
Cerulein is a CCK analogue that at pharmacological levels (i.e. ~50 µg/kg) initiates a pancreatitis 
response involving premature enzyme activation, altered cell signalling, and initiation of 
inflammatory genes (Williams, 2008). RNA-seq showed a rapid decrease in Atp2c2c expression 
4 hours after initiating CIP (Figure 2.7A), which was confirmed by qRT-PCR (Figure 2.7C). 
Atp2c2c expression remained low in CIP treated mice relative to saline-treated mice even as long 
as 72 hours after initial cerulein injection. Atp2c2c expression showed a markedly different 
response compared to the genes encoding other Ca2+ ATPases (Fig 2.7D and Table 2.1). All 
other Atp2 genes showed either no difference or increased expression 4 hours into CIP treatment. 
The increased gene expression for several Ca2+ ATPase isoforms suggests acinar cells may  
upregulate genes that promote a decrease in cytosolic Ca2+. Analysis of the RNA-seq data for 
genes affecting Ca2+ 4 hours into CIP identified expression of 193 out of a possible 254 genes 
(76%) linked to Ca2+ regulation in either saline or cerulein-treated tissue based on Gene 
Ontology (GO) categorization. Twenty-six genes (10.3% of all known-related Ca2+ genes or 
13.5% of those Ca2+ genes expressed in the pancreas) are significantly up regulated in that time, 
with an additional 21 genes (8.3% or 10.9% respectively) down-regulated. Therefore, >24% of 
all genes expressed in the pancreas that affect Ca2+ levels are altered within 4 hours of initiated 
CIP. Using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, these genes were 
mapped to pathways affecting cytosolic Ca2+ (Figure 2.8). The effects of altered expression were 
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predicted for each gene that would affect cytosolic Ca2+ based on the published protein function 
(Table 2.1.). A distinct trend was observed in which genes encoding proteins that elevate 
cytosolic Ca2+, such as CCKAR and IP3R3, were significantly reduced. Conversely, several 
Ca2+ATPase encoding genes, including Atp2a3 and Atp2b1, were significantly increased. 

















































RNA-seq at low (A) and high (B) resolution for Atp2c2c expression 4 hours after initiating CIP. 
(C) qRT-PCR confirms significantly reduced Atp2c2c expression until at least 72 hours into CIP. 
(D) Visualization of Atp2 gene expression using the UCSC genome browser and RNA-seq tracks 
developed from whole pancreatic RNA obtained 4 hours into cerulein or saline treatment. 
Atp2c2c expression is significantly decreased by CIP treatment, while Atp2a2, Atp2a3, Atp2b1, 
and Atp2c1 are all significantly increased.  






















Figure 2.8 Relative changes in transcript abundance of genes in Ca2+ signaling pathways 
after induced pancreatitis in mice. 
Schematic linking the various genes that regulate cytosolic Ca2+ (based on GO analysis) into a 
series of interconnected pathways. Genes in yellow show significantly increased expression 
during CIP while genes in blue are significantly decreased during CIP.  
! 58!
 Table 2.1 Expression of Ca2+ regulating genes 4 hours after inducing CIP 
Gene log2 (fold change) Effect on cytosolic Ca2+ Referencea 
Itpkc 6.25 Remove Li et al. (2013) 
Sphk1 5.01 ---  
Ncs1 4.03 Remove Nakamura et al. (2011) 
Cacnb2 2.68 Add Breitenkamp et al. (2014) 
Trpc1 2.57 Add Willoughby et al. (2014) 
Micu3 1.91 Remove Plovanich et al. (2013) 
Atp2a2 1.69 Remove Ringpfeil et al., (2001) 
Calm2 1.67 ---  
Atp2b1 1.38 Remove Strehler and Treiman (2004) 
Atp2a3 1.23 Remove Bobe et al. (2004)  
Adora2b 1.02 ---  
Calm1 0.99 ---  
Plcg2 0.95 Add Sreb et al. (1985) 
Adcy4 0.90 ---  
Adcy9 0.83 ---  
Ppp3r1 0.78 Remove Guerini (1997) 
Plcd1 0.77 Add Jaken and Yuspa (1988); Punnonen et al. (1993) 
Chrm3 0.75 Add Wess et al (2007) 
Cherp 0.70 Add Laplante et al. (2000) 
Vdac3 0.68 Remove Huang et al. (2013) 
Orai2 -0.66 Add Mercer et al. (2006) 
Mcu -0.73 Remove Patron et al. (2013) 
P2rx1 -0.84 Add North et al. (2002) 
Orai3 -1.01 Add Mercer et al. (2006) 
Itpr2 -1.08 Add Yamamoto-Hino et al. (1994) 
Itpka -1.09 ---  
Prkaca -1.17 ---  
Ptger3 -1.36 Add Morimoto et al. (2014) 
Atp2c2 -2.19 ?  
Grpr -2.20 Add Xiao et al. (2003) 
Gna14 -2.89 Add Hubbard and Hepler (2006) 
Chrm1 -3.03 Add Wess et al. (2007) 
Cckar -4.22 Add Pandol et al. (1985) 
aEffect on cytosolic Ca2+ was denoted based on function reported in literature 
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2.3.4. SPCA2C over-expression in HEK293A cells increases cytosolic Ca2+ levels. 
!
To test the theory that SPCA2C increases cytosolic Ca2+ levels, HEK293A cells were transfected 
with GFP +/- plasmids encoding a full length MYC-tagged SPCA2 (SPCA2MYC), or a FLAG-
tagged C-terminal truncated protein that completely mimicked the coding region SPCA2C 
(pcDNA3.1-SPCA2CFLAG). Examination of protein localized by co-IF analysis for SPCA2CFLAG 
and SPCA2MYC showed overlapping localization of the two proteins (Figure 2.9). However, there 
were also regions of unique accumulation, indicating different cellular localizations of the full 
length and SPCA2C isoforms. HEK293A cells expressing SPCA2CFLAG showed a significant 
increase in resting cytosolic Ca2+ relative to GFP or SPCA2MYC-expressing cells using Fura2 
ratiometric analysis (Figure 2.10A, B). In addition, expression of SPCA2CFLAG resulted in 
greater increases in cytosolic Ca2+ following carbachol stimulation (Figure 2.10A, C) while 
SPCA2MYC showed only a trend towards significance. These results suggest that SPCA2C 














               
 
TABLE 1. Expression of Ca2þ-regulating genes 4 hours after inducing CIP
Gene log2 (fold change) Effect on cytosolic Ca2þ Referencea
Itpkc 6.25602 Remove Li et al. (2013)
Sphk1 5.01899 —
Ncs1 4.03756 Remove Nakamura et al. (2011)
Cacnb2 2.68014 Add Breitenkamp et al. (2014)
Trpc1 2.57667 Add Willoughby et al. (2014)
Micu3 1.91612 Remove Plovanich et al. (2013)
Atp2a2 1.69111 Remove Ringpfeil et al. (2001)
Calm2 1.67262 —
Atp2b1 1.38563 Remove Strehler and Treiman (2004)
Atp2a3 1.23098 Remove Bobe et al. (2004)
Adora2b 1.02344 —
Calm1 0.999638 —
Plcg2 0.956653 Add Streb et al. (1985)
Adcy4 0.902953 —
Adcy9 0.831247 —
Ppp3r1 0.78638 Remove Guerini (1997)
Plcd1 0.774936 Add Jaken and Yuspa (1988); Punnonen et al. (1993)
Chrm3 0.750425 Add Wess et al. (2007)
Cherp 0.709924 Add Laplante et al. (2000)
Vdac3 0.68958 Remove Huang et al. (2013)
Orai2 "0.660906 Add Mercer et al. (2006)
Mcu "0.738988 Remove Patron et al. (2013)
P2rx1 "0.843921 Add North (2002)
Orai3 "1.01062 Add Mercer et al. (2006)




Ptger3 "1.36579 Add Morimoto et al. (2014)
Grpr "2.20381 Add Xiao et al. (2003)
Gna14 "2.89861 Add Hubbard and Hepler (2006)
Chrm1 "3.03857 Add Wess et al. (2007)
Cckar "4.22087 Add Pandol et al. (1985)
aEffect on cytosolic Ca2þ was determined based on function reported in literature.
Fig. 5. Intracellular protein accumulation of SPCA2MYC and SPCA2CFLAG. Co-localization of SPCA2CFLAG and SPCA2MYC following
transfection of HEK293A cells shows cellular regions that express either SPCA2CFLAG (green; closed arrow) or SPCA2MYC (red; open arrow),
or both (white). Images represent optical Z-axis slices that are separated by 3mm. Magnification bar is 9mm in all parts.
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Co-localization of SPCA2CFLAG and SPCA2MYC following transfection of HEK293A cells shows 
cellular regions that express either SPCA2CFLAG (green; closed arrow) or SPCA2MYC (red; open 
arrow), or both (white). Top row images represent optical Z-axis slices that are separated by 3 
































































(A) Ratiometric Fura2 fluorescence analysis of single cell responses following transfection of 
GFP or GFP +/- SPCA2CFLAG. Lines indicate the duration of 10 µM carbachol stimulation. (B) 
Measurement of resting cytosolic Ca2+ levels (before stimulation) in cells expressing GFP (n=34) 
or GFP+SPCA2CFLAG (n=22), or GFP+SPCA2MYC (n=12) or (C) the maximal response to 
carbachol stimulation show increased cytosolic Ca2+ levels and release only in cells transfected 
with SPCA2CFLAG (n=12) compared to GFP (n=16) and GFP+SPCA2MYC (n=3). Cells 
transfected with the full length SPCA2 show a trend towards increased maximal Ca2+ release. 
Values expressed as mean +/- SEM; *p<0.05, **<p0.001. 




The importance of Ca2+ as a second messenger for pancreatic acinar exocytosis and cell function 
is well established. Ca2+ ATPases, including those of the PMCA and SERCA families, have key 
roles in acinar cell biology (Lee et al., 1997; Prasad et al., 2004). We have previously shown that 
SPCA2 is expressed to high levels in the pancreas (Garside et al., 2010), but little is known about 
its function in this tissue. In this study, I show that the novel pancreatic isoform of SPCA2 
(SPCA2C) is transcribed from a novel TSS within the Atp2c2 gene that generates a transcript 
that includes only the last four exons of the full length Atp2c2 gene. The SPCA2C protein 
sequence aligns with the carboxy terminus of SPCA2.  
 
Importantly, SPCA2C shows decreased expression during CIP, and is part of a larger molecular 
response by the acinar cell to possibly reduce basal and stimulated cytosolic Ca2+ levels 
following acute pancreatic injury. Most of the Atp2 genes encode several isoforms of Ca2+ 
ATPase proteins, giving rise to extensive cell-specific expression patterns for these genes. In 
most cases, these isoforms are the result of alternative splicing. In the case of Atp2c2c, the 
alternative isoform expressed within the pancreas is the result of a TSS that exists within the 24th 
exon of the gene. Our previous reports of a pancreatic specific Atp2c2c transcript suggested a 
size of ~1.2kb (Garside et al., 2010), significantly larger than the 702 bp transcript identified in 
this study. This is likely due to the different methodologies used. RNA-seq analysis is 
significantly more accurate than Northern blot analysis, allowing the identification of a TSS 
within a few base pairs, and does not include the polyA tail that increases the size of the mature 
transcript. The identification of this TSS is based on high resolution RNA-seq data. We have also 
published on the characterization of epigenetic modifications that are known to exist specifically 
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at TSSs. This includes enrichment of histone markers such as H3K4Me3, H3K36Me3, and 
acetylated H3. Both H3K36Me3 and H3 acetylation extend along the gene corresponding to 
transcription (Gunderson et al., 2011; Schwartz et al., 2009), which has been observed for the 
Atp2c2c gene. The TSS has also been observed to be enriched for RNA polymerase II (C. 
Sullivan Thesis).  
 
The 252 bp region upstream of the Atp2c2c TSS was sufficient to promote transcription. 
Surprisingly, this region does not promote expression in vivo suggesting additional promoter and 
enhancer regions are required to recapitulate Atp2c2c expression in the pancreas. Indeed lack of 
MIST1 prevents SPCA2C expression (Garside et al., 2010), which suggests that the sequence 
used for analysis of the promoter region did not include regions where MIST1 binds. While the -
1181+57 Atp2c2c region tested includes several putative E boxes (binding sites for basic helix-
loop-helix proteins such as MIST1), none of these correspond to the preferred MIST1 binding 
site, and analysis of the intronic region between exons 24 and 25 identified an E-box with the 
canonical CATAGTG (Tran et al., 2007) sequence preferentially targeted by MIST1.  
 
Importantly, delineation of the complete transcript of the Atp2c2c identified an open reading 
frame (ORF) within the transcript that encodes a 136 amino acid protein that perfectly aligns 
with the carboxy terminus of the full length SPCA2, hence the designation of SPCA2C. Previous 
work had shown that the pancreas-specific isoform contains the C-terminus of the protein 
(Garside et al., 2010), but had not identified the exact sequence of the protein. Sequence 
alignment confirms that SPCA2C completely lacks the first five transmembrane domains, the 
E1-E2 hydrolase domain, a Ca2+ binding site, as well as other domains common to P-type 
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ATPases, suggesting that SPCA2C does not act as a Ca2+ ATPase in acinar cells. Nor is it likely 
to act as a competitor for the full length SPCA2 since RNA-seq data indicate non-detectable 
amounts of this isoform in pancreatic tissue.  
 
In other cell types, SPCA2 affects both Ca2+ accumulation within the Golgi apparatus and store-
independent Ca2+ entry (Faddy et al., 2008; Feng et al., 2010; Vanoevelen et al., 2005) and 
truncated versions of SPCA2 affect Orai1 function in cell lines (Cross et al., 2013), suggesting a 
Ca2+ signaling role for SPCA2C. We have now confirmed that SPCA2C has both a cell 
localization pattern and effect on cytosolic Ca2+, that is unique from the full length SPCA2 
protein. Co-localization of epitope tagged SPCA2 and SPCA2C indicates that their localization 
is not identical. Since RNA-seq suggests that SPCA2C is the only isoform of Atp2c2 expressed 
in the pancreas (>99% of total amount), the previous documentation of endogenous SPCA2 
accumulation likely indicates only SPCA2C (Garside et al., 2010). Previous studies have shown 
a direct interaction of SPCA2 with Orai1 channels and the ability of C-terminal regions of 
SPCA2 to affect SICE (Feng et al., 2010). This study also suggests a global molecular response 
in acinar cells to reduce cytosolic Ca2+ levels. Genes encoding proteins that normally increase 
cytosolic Ca2+ are decreased within four hours of inducing CIP. This includes decreases in 
Atp2c2c, which is unlike the other Atp2 genes that either do not change expression or increase 
during CIP. The decreased Atp2c2c expression supports a function that is opposite to other Ca2+ 
ATPases and is in line with a role for SPCA2C in increasing cytosolic Ca2+. As mentioned, 
SPCA2 interacts with Orai1-composed plasma membrane Ca2+ channels, promoting SICE and 
Ca2+ influx into the cytosol (Feng et al., 2010).  
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Importantly, the regulation of SICE by SPCA2 is mediated through the carboxy terminus of 
SPCA2 (Feng et al., 2010). Our findings support a role in which expression of SPCA2C 
increases cytosolic Ca2+ and Ca2+ release following carbachol treatment. Recent studies indicate 
that inhibition of Orai1 channels during pancreatitis is protective (Wen et al., 2015), and 
reducing expression observed of Atp2c2c during CIP may be protective via decreased Orai1 
activation. Ultimately, a more complete analysis of SPCA2C function and how it affects SICE 
and GPCR-mediated Ca2+ release is needed to fully understand its role in pancreatic function. 
Targeted knockouts of Atp2c2 have not been reported to date. However, this study suggests that 
targeting the full length Atp2c2 gene will not uncover a pancreatic phenotype, since using typical 
gene trapping strategies will leave the truncated gene and alternate TSS intact. Therefore, our 
identification of the novel TSS will enable more appropriate strategies for targeting Atp2c2.  
 
In conclusion, this study determines that the truncated form of Atp2c2 is transcribed from a novel 
TSS within the 24th exon and produces a protein that retains the C-terminus of the full-length 
protein. Transcription from this TSS appears to be regulated in part by MIST1 and repressed 
during pancreatic injury. Future studies are required to determine how SPCA2C regulates acinar 




The Secretory Pathway Calcium ATPase 2C interacts with Orai1 and 
regulates Ca2+ influx through SICE and other mechanisms 
!
The work in this Chapter was published as "The pancreas-specific form of secretory pathway 
calcium ATPase 2 regulates multiple pathways involved in calcium homeostasis" Fenech et al., 
(2019) in BBA-Molecular Cell Biology. Other authors contributing to this manuscript include M. 
Carter, P. Stathopulos and C. Pin. M. Fenech performed experiments, contributed to study 
design, data analysis, preparation and revision of manuscript. M. Carter contributed to IF in 
Figure 3.6. P. Stathopulos performed protein sequence comparison for SPCA2C in Figure 3.1A, 
contributed to study design, provided theoretical input and revised the manuscript. C. Pin 




Cellular calcium (Ca2+) is a critical second messenger required for cellular processes involved in 
cell function, survival and apoptosis (Kruger et al., 2000; Li et al., 2014; Zhou et al., 1996). 
Cytosolic Ca2+ levels need to be tightly regulated both temporally and spatially as constitutively 
high levels of cytosolic Ca2+ are detrimental to the cell. Therefore, several mechanisms are in 
place to keep sources of Ca2+ available yet sequester Ca2+ away from the cytosol, thereby 
allowing transient Ca2+ increases when required.  
Proper Ca2+ signalling is particularly critical for regulated exocytosis in pancreatic acinar cells. 
At rest, Ca2+ATPases, buffering proteins and Ca2+ channels all work to maintain low cytosolic 
Ca2+ (i.e. ~100 nM) relative to the endoplasmic reticulum (ER) lumen (i.e. ~1 mM) and 
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extracellular space (i.e. ~2mM; Finch et al., 1991; Futatsugi et al., 2005; Hurwitz, 1996; Pralong 
et al., 1988). Ca2+ exchangers are not expressed in pancreatic acinar cells to high amounts. 
Exocytosis occurs due to secretagogue binding to cell surface receptors, leading to activation of 
the inositol 1,4,5-trisphosphate (IP3) pathway and promotion of Ca2+ transients in the apical pole 
of the cell (Bezprozvanny et al., 1991; Finch et al., 1991; Futatsugi et al., 2005; Straub et al., 
2000). IP3 receptors (IP3R) and ryanodine receptors (RyR) on the ER facilitate Ca2+ efflux from 
the ER, while plasma membrane Ca2+ATPases (PMCA) and sarco/endoplasmic reticulum 
Ca2+ATPases (SERCA) quickly clear Ca2+ from the cytosol. The combination of IP3R/RyR and 
ATPase activity promotes oscillatory Ca2+ signals critical for enzyme exocytosis (Ponnappa et 
al., 1981; Tepikin et al., 1992). As Ca2+ is steadily removed from the ER and shuttled out of the 
cytoplasm by PMCAs, there is a net loss of Ca2+ stores in the ER. The depletion of Ca2+ within 
the ER triggers store operated Ca2+ entry (SOCE). ER Ca2+ is monitored by stromal interaction 
molecule 1 (STIM1), which senses Ca2+ through an EF-hand domain that resides in the ER 
lumen. When ER Ca2+ concentrations decrease, STIM1 undergoes a conformational change 
involving oligomerization and translocation to ER-Plasma membrane junctions, where it 
activates Orai1 allowing extracellular Ca2+ influx into the cytosol for refilling of ER stores (Liou 
et al., 2005; Roos et al., 2005; Wu et al., 2006). Orai1 forms Ca2+ release-activated channels 
(CRAC) and is required for SOCE (Prakriya et al., 2006).  
Orai1 also directly interacts with secretory pathway Ca2+ATPase 2 (SPCA2), a member of a third 
family of Ca2+ATPases. The SPCA2-Orai1 interaction occurs independent of ER Ca2+ store 
depletion, constitutively acting to increase cytosolic levels. This pathway has been termed store 
independent Ca2+ entry (SICE), and increased SPCA2 expression correlates with increases in 
cytosolic Ca2+ concentrations. (Feng et al., 2010) This represents a unique dual function for 
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SPCA proteins, as they may utilize their Ca2+ATPase function to promote Ca2+ uptake into the 
Golgi apparatus or promote SICE independent of primary active transport.  
My previous studies showed only a truncated form of SPCA2, termed SPCA2C, is expressed 
within pancreatic acinar cells (chapter 2). Assessment of the role of SPCA2C in Ca2+ 
homeostasis has been limited, but its expression pattern suggests unique functions in the 
pancreas. SPCA2C is transcribed from an alternative start site that includes only the last four 
exons of the SPCA2 coding sequence, thereby eliminating domains required for SPCA2 to 
function as a Ca2+ATPase (Chapter 2). Acinar cells are highly sensitive to altered Ca2+ 
homeostasis. Improper Ca2+ signalling and regulation disrupts exocytosis and promotes cellular 
damage associated with pancreatitis (Li et al., 2014; Zhou et al., 1996). Inhibition of Orai1 or 
Ca2+ influx mediated by other channels decreased the severity of pancreatitis (M. S. Kim et al., 
2011; Vigont et al., 2015; Wen et al., 2015), and decreased accumulation of SPCA2C is observed 
following initiation of secretagogue-induced pancreatitis (Chapter 2). Since SPCA2C is the only 
isoform expressed in the pancreas, it is important to determine its involvement in store-operated 
or store-independent Ca2+ entry, Ca2+ signaling and Ca2+ homeostasis.  
The goal of this study was to determine if SPCA2C maintains the non-traditional roles exhibited 
by the full length SPCA2 in the context of Ca2+ movement. In HEK 293A cells, SPCA2C 
expression localized to the ER and increased ER Ca2+ stores and Ca2+ influx after ER store 
depletion. Using HEK293T cells with stable expression of Orai1 and HEK293A, we determined 
that SPCA2C interacts with Orai1 to mediate SICE. Importantly, this role in Ca2+ influx upon 





3.2.1. Protein sequence comparison 
!
The NCBI reference codes for the Xenopus tropicalis (frog), Notechis scutatus (snake), Mus 
musculus (mouse), Homo sapiens (human), Sus scrofa (pig), Bos taurus (cow) and Felis 
catus (cat) amino acid sequences used in the alignment are NP 001072524.1, XP 026539825.1, 
NP_081198.1, NP_055676.3, XP_003126874.1, XP_002694791.2 and XP 023101802.1, 
respectively. The sequence alignment was performed using Clutal Omega (Sievers et al., 2011) 
and PSIPRED (McGuffin, Bryson, & Jones, 2000) was used for predicting structure.  
 
3.2.2. Plasmid construction  
!
A pcDNA3.1-SPCA2CFLAG expression vector was generated by Gene Art (Thermo Fisher 
Scientific, Waltham, MA), using the mouse Atp2c2 sequence (NCBI accession #:AC_000030.1). 
A FLAG antigenic tag sequence  
(5' GATTACAAGGATGACGACGATAAG 3') was placed in frame at the 3' end of the Atp2c2 
coding sequence. pcDNA3.1-SPCA2CmRFP was generated by inserting PCR-amplified Atp2c2c 
into the XhoI and BamHI sites, using forward primer sequence 3' 
CTAGGCGGCCGCGCTCCACGGACT 5' and reverse primer sequence  
3' CTAGCTCGAGCACAGCTTCC 5' in pcDNA3.1-mRFP. pcDNA3-mRFP was acquired from 
Addgene (Addgene plasmid # 13032; http://n2t.net/addgene:13032; RRID:Addgene_13032; 
Figure 3.1). All plasmid insert sequences were verified by the London Regional Genomics 






























  BamHI                   M  S  A                                 
73 GCTGTCATCATAGGGGGGACCCTCTTTATCTTCTGGAGAGAGATCCCAGCGAACGGCACCAGCACCCCACGT 
         A  V  I  I  G  G  T  L  F  I  F  W  R  E  I  P  A  N  G  T  S  T  P  R 
145 ACAACCACCATGGCCTTCACCTGCTTCGTGTTTTTCGACCTCTTCAATGCCCTGAGCTGTCGCTCTCAGACC 
  T  T  T  M  A  F  T  C  F  V  F  F  D  L  F  N  A  L  S  C  R  S  Q  T 
217 AAGCTGATATTTGAGATTGGCTTTTTCCGGAACCGCATGTTCCTGTACTCAGTCCTTGGGTCCCTCCTGGGG 
  T  T  I  F  E  I  G  F  F  R  N  R  M  F  L  Y  S  V  L  G  S  L  L  G  
289 CAGCTGGCCGTGATCTATGCCCCGCCCCTACAAAAGGTCTTCCAGACTGAAAACCTGAGCGCGCTCGACCTG 
  Q  L  A  V  I  Y  A  P  P  L  Q  K  V  F  Q  T  E  N  L  S  A  L  D  L  
361 CTGCTGCTGACGGGCCTGGCCTCGTCTGTCTTCATTCTGTCGGAGCTGCTCAAGCTCTGGGAAAAGTTCTTG 
  L  L  L  T  G  L  A  S  S  V  F  I  L  S  E  L  L  K  L  W  E  K  F  L 
433 TCCAGAGCCAGGCCCACTCAGATGCTCCCGGAAGCTGTGCTCGAG ATGGCT… 












(A) pcDNA3-mRFP was aquired from Addgene. (B) Sequence amplified by PCR to insert into 
pcDNA3. Both the plasmid and PCR product were digested with BamHI and XhoI then ligated 
together.   
Figure 3.1 Plasmid map of pcDNA3-SPCA2CmRFP. 
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3.2.3. Cell culture  
!
Human embryonic kidney (HEK)293A cells were maintained in Dulbecco’s Modified Eagle 
Medium (DMEM) with 4.5 g/L D-glucose, L-Glutamine containing 10% (v/v) FBS and 
antibiotics (penicillin G 100U.mL, streptomycin 100 µg/mL). HEK293T cells stably expressing 
YFP-tagged Orai1 (HEK-Orai1YFP) were a generous gift from Dr. Monica Vig (Tata Institute of 
Fundamental Research, India; Vig et al. 2006). HEK-Orai1YFP cells were maintained in DMEM 
with 4.5 g/L Glucose, L-glutamine and sodium pyruvate; containing 10% (v/v) FBS and 
antibiotics [penicillin G 100U.mL, streptomycin 100 µg/mL, gentamicin 400 µg/mL (Wisent, St. 
Bruno, QC)]. When cultures reached 70-80% confluence, cells were transfected using JetPrime 
transfection kit (Polyplus, NY), with pcDNA3.1-SPCA2CFLAG, pcDNA3.1-SPCA2MYC (encodes 
full length SPCA2; kindly provided by R. Rao; Feng et al. 2010). or pCMV6- Stim1mCherry, which 
encodes a monomeric cherry fluorescence protein fused to the N-terminus of STIM1, 
immediately downstream of the ER signal peptide (Luik, Wu, Buchanan, & Lewis, 2006; J. Zhu, 
Lu, Feng, & Stathopulos, 2018). For Nuclear factor of activated T-cells (NFAT) experiments, 
HEK cells were transfected, as described above, with pcDNA-NFAT-EGFP and pcDNA3.1-
SPCA2CmRFP or pcDNA3.1-SPCA2MYC. Cells were incubated in transfection mixture for 24 hours 
before analysis. As a control, HEK293A cells transfected with pcDNA -NFAT-EGFP only were 
treated with 2 µM thapsagargin (TG) in 2 mM Ca2+ for 30 minutes at 37°C and 5% CO2, then 
fixed in 4% formalin for 10 minutes. 
!
3.2.4. Calcium imaging  
!
48 hours after transfection, HEK-Orai1YFP +/- pcDNA3.0-GFP and/or pcDNA3.1-SPCA2CFLAG, 
or pcDNA3.1-SPCA2MYC cells were loaded with Fura2-AM at 1-3 µM in culture media for 30 
minutes at 37°C and 5% CO2. After loading, cells were rinsed once in Hank’s Buffered Saline 
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Solution (HBSS) supplemented with 1.8 mM Ca2+ (unless otherwise stated) and allowed to 
equilibrate to 37°C for a minimum of 10 minutes. Fura2 emission was measured in individual 
cells (as described in 2.2.7). To examine the effect of SPCA2C on Ca2+ release in response to 
GPCR signaling, individual groups of cells were stimulated with 10 µM carbachol for 5 minutes 
at a pressure of 2 Pa by puffing. Five-minute puffing experiments were completed no more than 
three times per plate and never on the same group of cells. To examine SOCE and intracellular 
Ca2+ stores, cells were treated with 2 µM TG and 2 mM EGTA followed by either ionomycin (1 
µM) or Ca2+ (2 mM, 4 mM, 6 mM) addition back to HBSS media. To examine SICE, cells were 
loaded with Fura2 as described above and a resting level of cytosolic Ca2+ achieved in 0 mM 
Ca2+ HBSS was determined. Ca2+ was added to the media in incremental amounts (1.0 mM or 
2.0 mM Ca2+) and intracellular Ca2+ recorded for three minutes. Ca2+ influx rate was calculated 
as:  
                                            RΔ340/380 = (RF340/380 - RI340/380)/60 
where RF is the final 340/380 ratio. RI represents the initial  
340/380 ratio and 60 is the time in seconds for recording after Ca2+ was added to media.  
 
3.2.5. Protein collection, western blotting and co-immunoprecipitation  
!
Cells were transfected as described with 5 µg of pcDNA3.1-SPCA2CFLAG + 0 – 5 µg of pCMV6-
Stim1mCherry. Cells were harvested by trypsinization 72 hours after transfection, washed  
with cold phosphate buffered saline (PBS) and incubated in a mild lysis buffer (150 mM NaCl, 
50 nM HEPES pH 7.4, 25 µg/ml digitonin) for 10 minutes. Samples were centrifuged at 2,000 
RCF, and supernatant collected for the cytosolic protein fraction. The remaining insoluble pellet 
was washed with PBS, resuspended in a second lysis buffer (150 mM NaCl, 50 nM HEPES pH 
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7.4, 1% NP40), and incubated 40 minutes with mild agitation. Samples were centrifuged at 7,000 
RCF, and the supernatant was taken as the membrane protein fraction. All antibodies, sources 
and dilutions are listed in Table 3.1. Western blot analysis was performed as described (Johnson 
et al., 2009). Briefly, 15-60 µg of protein was separated by SDS- PAGE and transferred to 
polyvinylidene diflouride (PVDF) membrane (BioRad, Hercules, CA). Following a 1-hour 
incubation in blocking solution [5% non-fat skim milk in tris-buffered saline and 0.1% Tween 20 
(TBST)], membranes were incubated in primary antibodies diluted in TBS overnight at 4 °C. 
Following several washes with TBST, membranes were incubated in secondary antibodies 
diluted in TBS for 1 hour at room temperature. Protein expression was visualized using Bio-Rad 
Clarity Western ECL substrate on a Bio-Rad VersaDoc Imaging System (BioRad; Hercules, 
CA).  
 
For co-immunoprecipitation (co-IP) experiments, 400 µg of protein from HEK293A or HEK- 
Orai1YFP cells transfected with pcDNA3.1-SPCA2CFLAG +/- pCMV6-Stim1mCherry were incubated 
with G-Sepharose beads (Invitrogen Dynabeads) and Orai1 antibody (Sigma, Oakville, ON) 
overnight at 4°C. Samples were washed 4x in second lysis buffer. IP samples were resolved by 
SDS-PAGE and transferred to PVDF membrane. Western blotting was performed as described 
above.  
 
3.2.6. Immunofluorescence analysis  
!
HEK293A cells were transfected as described above with pcDNA3.1-SPCA2CFLAG and/or 
pCMV6-Stim1mCherry. Forty-eight hours after transfection, HEK293A cells were fixed with 4% 
(v/v) formalin in PBS. IF was performed as described (section 2.2.5). All antibodies used (Table 
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3.1) were diluted in blocking solution (PBS, 5% (w/v) bovine serum albumin (BSA), 1% 
TritonX-100). Fluorescently labelled secondary goat antibodies were diluted 1:250 in PBS 
(Jackson Immunoresearch Labs, West Grove, PA or Sigma). Images acquired using Leica TCS 
SP5 II microscope. For nuclear factor of activated T-cells (NFAT) experiments, formalin-fixed 
cells were stained with DAPI (1:1000 in PBS) for 5 minutes and then visualized for RFP 
(SPCA2C) or EGFP (NFAT). IF was performed on cells transfected with pcDNA-SPCA2MYC as 




N values are provided within the figure legends for each experiment. Data shown are +/- 
standard error of the mean (SEM) and significance was determined using unpaired t-tests or two-













 Table 3.1 Antibodies used in this study 










Antibody Reactivity Dilution Company Methodology 
STIM1 rabbit, "-mouse, rat, human 1:1000 Sigma IF 
FLAG mouse, all  1:500 Sigma IF, IB 
Orai1 rabbit, "-human 1:1000 Sigma IB, IP 
Selenoprotein S mouse, "-human 1:250 Santa Cruz IF 
GM130 mouse, "-human 1:250 Abcam IF 
ATP5f1 mouse "-human 1:250 Santa Cruz IF 
E-catinin mouse, "-human  1:250 Santa Cruz IF 




3.3.1. SPCA2C interacts with Orai1 and increases cytosolic Ca2+ levels. 
!
Since SPCA2C is the predominant isoform expressed in pancreatic acinar cells, I first 
investigated whether it served a similar function to the full length SPCA2. Previous work 
showed SPCA2 interacts with Orai1 to enhance SICE through its C- terminal domain (Feng et 
al., 2010), which is identical to SPCA2C. To determine if this C-terminal domain function is 
conserved among phylogeny, we performed in silico analysis comparing the C- terminal domain 
of SPCA2 from different species. At least 8 polar and non-polar residue positions within the 20 
residue C-terminal domain, which is downstream of the final transmembrane helix, are fully or 
partially conserved among different species (Figure 3.2A) suggesting the function of the C-
terminal domain is likely retained and important in higher and lower vertebrates. Additionally, 
PSIPRED (McGuffin et al., 2000) analysis indicated that this C-terminal region of SPCA2 has a 
propensity to form an "-helix (Figure 3.2A). It is noteworthy that intermolecular "-helix 
interactions between STIM1 and Orai1 underlie Orai1 channel assembly and gating in SOCE 
(Stathopulos et al., 2013; Yang et al., 2012).  
 
Given our bioinformatics analysis suggesting the C-terminal domain of SPCA2 may form a 
structural motif conducive to activation of Orai1 channels, I assessed whether SPCA2C interacts 
with Orai1. To determine if SPCA2C directly interacted with Orai1, co-IP was performed on 
membrane-enriched protein fractions following SPCA2CFLAG transfection into HEK293A cells, 
which do not express Orai1, or HEK 293A cells stably expressing an Orai1YFP fusion protein 
(HEK-Orai1YFP). IF indicated SPCA2CFLAG accumulates throughout HEK-Orai1YFP cells with 
some overlap with Orai1 (Figure 3.2B). Co-IP showed SPCA2C is readily pulled down by Orai1 
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IP (Figure 3.2C). Remarkably, co-expression of STIM1 competed away the SPCA2C-Orai1 
interaction and reduced accumulation of SPCA2CFLAG in the membrane only when Orai1 was 
present (Figure 3.2C). IF for SPCA2CFLAG +/- STIM1 protein supported the finding that STIM1 
affected SPCA2C membrane localization. Without STIM1, SPCA2C showed co-localization 
with Orai1 (Figure 3.2D). However, the cellular localization of SPCA2CFLAG became more 
diffuse and did not overlap with Orai1 when STIM1mCherry was present. Therefore, SPCA2C 
appears to bind Orai1 through a similar region as STIM1.  
 
We next examined the ability for SPCA2C to increase resting cytosolic Ca2+. Epitope-tagged 
versions of full length SPCA2 (SPCA2MYC) or SPCA2C (SPCA2CFLAG) were expressed in HEK- 
Orai1YFP cells. Similar to HEK293A cells, HEK-Orai1YFP cells do not normally express SPCA2 
or SPCA2C (data not shown). Examination of cytosolic Ca2+ levels, in 1.8 mM extracellular 
Ca2+, using Fura2 ratiometric imaging showed both SPCA2MYC (R340/380 = 0.43 ± 0.02) and 
SPCA2CFLAG (R340/380= 0.58 ± 0.03) significantly increased resting cytosolic Ca2+ concentrations 
in HEK-Orai1YFP cells compared to GFP alone (R340/380 = 0.26 ± 0.01; Figure 3.2E). The increase 
in cytosolic Ca2+ levels in HEK-Orai1YFP cells was also significantly higher when comparing 
cells expressing SPCA2CFLAG to SPCA2MYC (p<0.05; Figure 3.2E), suggesting SPCA2C may 
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(A) Multiple sequence alignment of the C-terminal domain of SPCA2 from higher to lower 
vertebrates. Basic, acidic, non-polar and polar residues are coloured blue, red, brown and 
magenta, respectively. Completely (*), highly (:) and partially (.) conserved residues are 
indicated below the residue position. The carboxyl terminal residue number of each of the 
sequences is shown at right. The PSPIRE predicted secondary structure composition of the 
human SPCA2 C-terminal domains is indicated below the alignment. C, carboxyl terminus. (B) 
IF for SPCA2CFLAG following transfection of HEK-Orai1YFP cells shows some co-localization of 
Orai1YFP and SPCA2CFLAG (arrow). Scale bar = 10 µm. (C) Co-IP for Orai1 in HEK293A or 
HEK-Orai1YFP cells expressing mRFP or SPCA2CFLAG +/- STIM1mCherry. Western blot for Orai1 
or SPCA2CFLAG (predicted weight 17 kDa) in membrane-enriched fractions (left panels) or 
following IP for Orai1 (right panels). Black arrow indicates Orai1YFP (predicted weight 59kDa); 
other bands reflect IgG.  (D) IF for SPCA2CFLAG in HEK-Orai1YFP cells +/- STIM1mCherry. 
Arrows indicate co-localization of Orai1YFP and SPCA2CFLAG. Scale bar = 10 µm. (E) Resting 
cytosolic Ca2+ levels recorded in HEK-Orai1YFP cells expressing GFP only (n=12), SPCA2MYC 
(n=15) or SPCA2CFLAG (n=13). Cytosolic Ca2+ measurements were made using Fura2. Values 
expressed as mean +/- SEM; *p<0.05; **p<0.01. (F) Rates of Ca2+ influx in HEK293A cells 
expressing Orai1YFP (n = 22 [0 mM]), 22 [1.0 mM], and 29 [2.0 mM]) or Orai1+SPCA2 (n = 26 
[0 mM Ca2+], 22 [1.0 mM], and 32 [2.0 mM]).  
Figure 3.2 SPCA2C interacts with Orai1 and increases cytosolic Ca2+ levels. 
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3.3.2. SPCA2C interacts with Orai1 to increase SICE 
 
To determine if SPCA2C's ability to increase cytosolic Ca2+ was due to an increased rate of Ca2+ 
influx across the plasma membrane through SICE, GFP was expressed +/- SPCA2CFLAG in 
HEK-Orai1YFP cells and incubated in nominally Ca2+-free media followed by addition of Ca2+  
back to the media. Incremental addition of Ca2+ to the media resulted in a significant increase in 
the rate of Ca2+ influx in SPCA2CFLAG-expressing cells compared to GFP-only expressing cells. 
At 1 mM Ca2+, SPCA2CFLAG-expressing cells showed a 2.7-fold increase in Ca2+ influx (ΔR 
(340/380)/sec = 3.95x10-4± 6.79x10-5) vs. GFP-expressing cells (ΔR (340/380)/sec = 1.48x10-4 ± 
4.11x10-5). At 2 mM extracellular Ca2+, Ca2+ influx was still almost 2-fold higher in SPCA2C 
(ΔR(340/380)/sec = 5.95x10-4 ± 8.5x10-5) vs. GFP-expressing cells (ΔR(340/380)/sec = 3.57x10-4 ± 
7.03x10-5; Figure 3.2F). These results suggest that SPCA2C enhances Ca2+ uptake into the cell 
through SICE.  
 
3.3.3. SPCA2C localizes to the ER in HEK293A cells 
 
IF showed SPCA2CFLAG is not only co-localized with Orai1YFP but also has an extensive pattern 
of expression throughout the cell. We previously showed SPCA2C has a different subcellular 
expression pattern than full length SPCA2 (Garside et al., 2010) suggesting diverse roles for 
SPCA2C in affecting Ca2+ homeostasis. To determine the subcellular localization of SPCA2C, 
HEK293A cells were transfected with pcDNA3-SPCA2CmRFP and IF performed for organelle-
specific markers (Figure 3.3). I chose to determine SPCA2C cellular localization in HEK293A 
cells since the Orai1YFP limited fluorochrome analysis. Co-localization of SPCA2CmRFP with 
markers for the ER (Figure 3.3A; Selenoprotein S) and Golgi (Figure 3.3B; GM130) was readily 
observed. More than 75% of cells expressing SPCA2CmRFP showed partial, if not complete, 
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overlap with ER localized markers, while 50% of the cells showed complete or partial Golgi 
marker co-localization, indicating the expression pattern was not simply due to over-expression. 
Quantitative co-localization analysis was not reliable as IF images showed SPCA2CmRFP 
localization is not limited specifically to the ER or Golgi. Conversely, limited localization of 
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SPCA2CmRFP GM130 Merge 










Co-localization of SPCA2CmRFP (SPCA2CmRFP; red) with Selenoprotein S (row A; green), 
GM130 (row B; green), or E-Catenin (row C; green). Arrows indicate areas of co-
localization.  Scale bar = 10 µm.  










Figure'4.4.'SPCA2C'increases'ER'Ca2+ stores'in'HEK:Orai1YFP cells.'(A) Ratiometric
Fura2-analysis-showing-the-response-to-thapsigargin (TG)-or-ionomycin-treatment-in-HEK=
Orai1YFP cells-expressing-GFP-(n=22)-or-GFP+SPCA2C-(n=23).-Maximal-change-in-cytosolic-
Ca2+ based-on-Fura2-340/380-ratio-in-response-to-(B) TG-or-(C) ionomycin.-Values-




















































































































 (A) Ratiometric Fura2 analysis showing the response to TG or ionomycin treatment in HEK-
Orai1YFP cells expressing GFP (n=22) or GFP+SPCA2CFLAG (n=23). Maximal change in 
cytosolic Ca2+ based on Fura2 340/380 ratio in response to (B) TG or (C) ionomycin (1 µm). 
Values expressed as mean +/- SEM; *P<0.05. (D) Ratiometric Fura2 traces showing response to 
carbachol stimulation in HEK293A cells expressing GFP (n=8) or GFP+SPCA2CFLAG (n=8). (E) 
Maximal change in cytosolic Ca2+ based on Fura2 340/380 ratio in response to carbachol in 
HEK293A cells expressing GFP (n=8) or GFP+SPCA2CFLAG (n=8), or GFP+SPCA2MYC (n=6).  
Values expressed as mean +/- SEM; *p<0.05.  
Figure 3.4 SPCA2C increases ER Ca2+ stores in HEK-Orai1YFP cells. 
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3.3.4. SPCA2C increases ER Ca2+ stores 
 
The localization of SPCA2C to the ER suggests it affects Ca2+ stores and Ca2+ release from this 
organelle. To examine ER Ca2+, HEK-Orai1YFP cells expressing GFP +/- SPCA2C were 
incubated in 1.8 mM extracellular Ca2+ then treated with TG, which inhibits SERCA pumps, 
thereby promoting emptying of ER-associated Ca2+ stores (Sagara & Inesi, 1991). ER Ca2+ levels 
were assessed by monitoring the transient increase in cytosol Ca2+ after TG treatment using 
Fura2, as done previously (Feng et al., 2010; He et al., 1997). Cells expressing SPCA2CFLAG 
showed a significant increase in cytosolic Ca2+ following TG treatment relative to GFP-
expressing cells (ΔR340/380 = 0.289 ± 0.013 vs. 0.139 ± 0.016; p<0.05, Figure 3.4A, B) suggesting 
SPCA2C increased Ca2+ levels in the ER. Subsequent treatment with ionomycin to empty all 
other Ca2+ stores showed no significant differences in cytosolic Ca2+ between GFP or 
SPCA2CFLAG-transfected cells (ΔR340/380 = 0.063 ± 0.001 and 0.103 ± 0.001, respectively; Figure 
3.4A, C) indicating increased Ca2+ levels following SPCA2C expression were specific to the ER.  
 
TG has been reported to also inhibit the full length SPCA2 (Yamamoto et al., 2016), so it is 
possible the increases in cytosolic Ca2+ upon TG treatment are the result of combined ER and 
Golgi emptying of Ca2+. Therefore, ER Ca2+ stores were further tested by treating cells with 
carbachol, an acetylcholine receptor agonist that induces ER store-specific Ca2+ release through 
IP3-mediated IP3R activation. Cells were incubated in 1.8 mM extracellular Ca2+, then treated 
with carbachol. In both SPCA2CFLAG and GFP expressing HEK-Orai1YFP cells, peak release of 
Ca2+ occurred rapidly upon carbachol stimulation (Figure 3.4D). However, significantly more 
Ca2+ was released in response to carbachol in SPCA2CFLAG-expressing cells compared to GFP 
expressing HEK-Orai1YFP cells (ΔR340/380= 0.276 ± 0.04 vs. 0.080 ± 0.02, Figure 3.4D, E). HEK-
! 90!
Orai1YFP cells expressing full length SPCA2MYC also showed a significantly greater release of 
Ca2+ in response to carbachol relative to GFP-expressing cells (ΔR340/380= 0.226 ± 0.05 vs. 0.080 
± 0.02, Figure 3.4E).  
 
3.3.5. SPCA2C increases Ca2+ influx across the plasma membrane after ER store emptying 
 
While increased ER Ca2+ levels in cells expressing SPCA2CFLAG could be due to enhanced Ca2+ 
uptake from the cytosol, SPCA2C does not contain the domains required for Ca2+ATPase 
activity capable of moving Ca2+ against the steep concentration gradient. Since SPCA2C 
localized to the ER, interacted with Orai1 and promoted increased ER Ca2+ stores,  
SPCA2C’s effect on SOCE was examined. If SPCA2 is involved in SOCE, increased Ca2+ 
uptake and re-localization to interact with Orai1 should be observed upon Ca2+ store depletion. 
Using Fura2 ratiometric imaging, cytosolic Ca2+ influx was measured in HEK-Orai1YFP cells 
expressing GFP +/- SPCA2CFLAG during incremental add back of Ca2+ following store depletion 
with TG and EGTA. HEK-Orai1YFP cells expressing SPCA2C showed significantly greater Ca2+ 
influx following addition of Ca2+ back to the media, compared to GFP-only expressing (ΔR340/380 
at 6 mM Ca2+= 0.08 ± 0.005 vs. 0.03 ± 0.005; p<0.05, Figure 3.5A, B), indicating that SPCA2C 
influences Ca2+ influx rates after store depletion. Similar experiments with HEK-Orai1YFP cells 
expressing SPCA2CFLAG + STIM1mCherry resulted in significantly greater resting levels of 
cytosolic Ca2+ at rest compared to STIM1mCherry-only expressing cells (R340/380= 0.803 ± 0.027 vs. 
0.683 ± 0.017; p<0.0001, Figure 3.5C, D). However, no further increase in ER Ca2+ release or 
SOCE occurred when STIM1mCherry and SPCA2CFLAG were co-expressed (ΔR340/380 at 6 mM 
Ca2+= 0.24 ± 0.03 and 0.24 ± 0.02; respectively, Figure 3.5D). Next, we examined the 
localization of SPCA2C in response ER Ca2+ store depletion. As observed previously, some co-
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localization between SPCA2CFLAG and Orai1YFP was readily observed under resting Ca2+ levels 
(Figure 3.2A). Upon TG treatment and concomitant chelation of extracellular Ca2+ using EGTA, 
no increase in SPCA2CFLAG-Orai1YFP co-localization occurred (Figure 3.6B). Conversely, HEK-
Orai1YFP cells expressing STIM1mCherry showed prominent Orai1-STIM1 puncta upon TG 
treatment, consistent with SOCE (Figure 3.6C, D). When STIM1mCherry and SPCA2CFLAG were 
co-expressed in HEK-Orai1YFP cells and treated with TG, STIM1mCherry and Orai1YFP again 
formed distinct foci that were largely devoid of SPAC2CFLAG accumulation (Figure 3.6E, F). 
These results suggest the ability of SPCA2C to increase ER Ca2+ and affect the response to ER 
store depletion may be independent of Orai1. Indeed, we previously showed SPCA2C increased 


















































































































(A) Ratiometric Fura2 traces showing response to TG followed by increasing extracellular Ca2+ 
to the media in HEK-Orai1YFP expressing GFP +/- SPCA2CFLAG, or (C) STIM1mCherry/GFP +/- 
SPCA2CFLAG. (B) Maximal changes in cytosolic Ca2+ following Ca2+ addback quantified for 
SPCA2CFLAG+GFP (n=33) or GFP alone (n=28). (C) Ratiometric Fura2 traces showing response 
to TG and Ca2+ addback in HEK-Orai1YFP expressing STIM1mCherry/GFP +/-SPCA2CFLAG. (D) 
Quantification of resting Ca2+ levels, response to TG, and maximal change in cytosolic Ca2+ 
following Ca2+ addition quantified for SPCA2CFLAG+STIM1mCherry+GFP (n=25) or 
STIM1mCherry+GFP (n=33). Values expressed as mean +/- SEM; *p<0.0001. 
 






































































Fluorescent localization of (A, B) SPCA2CRFP or (C, D) STIM1mCherry in HEK-Orai1YFP cells 
under (A, C) physiological Ca2+ conditions (1.8 mM Ca2+) or (B, D) following thapsigargin (TG) 
treatment. STIM1mCherry protein forms puncta co-localizing with Orai1YFP (white arrow) 
following emptying of ER stores by treatment with 2 µM TG. Scale bar = 2.5 µm. Co-IF for 
STIM1mCherry and SPCA2CFLAG (E) under physiological Ca2+ conditions (1.8 mM Ca2+) or (F) 
following TG treatment in HEK-Orai1YFP (green) cells expressing SPCA2CFLAG (blue) and 
STIM1mCherry (red). Scale bar = 2.5 µm. 
Figure 3.6 SPCA2C localization in HEK-Orai1YFP cells does not change when ER stores 
are depleted. 
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3.3.6. SPCA2C can increase Ca2+ influx after store depletion independent of Orai1 
 
To determine if Orai1 is required for increased Ca2+ influx under resting condition or following 
ER Ca2+ store depletion, HEK293A cells were transfected with SPCA2CFLAG (Figure 3.7). Fura2 
imaging was used to assess Ca2+ uptake with the addition of extracellular Ca2+ independent of 
ER Ca2+ store depletion (i.e. SICE). HEK293A cells expressing SPCA2CFLAG showed no 
significant increases in Ca2+ influx rate with the addition of extracellular Ca2+ (Figure 3.7A) 
suggesting the ability of SPCA2C to enhance SICE is dependent on the presence of Orai1. 
However, as observed in HEK-Orai1YFP cells, Ca2+ release from ER stores after treatment with 
TG and EGTA was significantly higher in HEK293A cells expressing SPCA2CFLAG compared to 
cells expressing GFP only (ΔR340/380= 0.133 ± 0.018 vs. 0.036 ± 0.009; p<0.0001, Figure 3.7B, 
C), and treatment with ionomycin showed no difference in Ca2+ release from other organelles 
(Figure 3.7D). Upon addition of Ca2+ back to the media after store depletion by TG and EGTA, 
Fura2 measurements showed HEK293A cells expressing SPCA2CFLAG had significantly 
increased Ca2+ influx (ΔR340/380 at 6 mM= 0.070 ± 0.005 vs. 0.029 ± 0.002; p<0.001, Figure 
3.7C, E), indicating SPCA2C increased Ca2+ influx across the plasma membrane, after store 







the addition of extracellular Ca2+ independent of ER Ca2+ store de-
pletion (i.e. SICE). HEK293A cells expressing SPCA2C showed no sig-
nificant increases in Ca2+ influx rate with the addition of extracellular
Ca2+ (Fig. 6A) suggesting the ability of SPCA2C to enhance SICE is
dependent on the presence of Orai1. However, as observed in HEK-
Orai1YFP cells, Ca2+ release from ER stores after treatment with TG and
EGTA was significantly higher in HEK293A cells expressing SPCA2C
compared to cells expressing GFP only (ΔR340/380= 0.133 ± 0.018 vs.
0.036 ± 0.009; p < 0.0001, Fig. 6B, C), and treatment with iono-
mycin showed no difference in Ca2+ release from other organelles
(Fig. 6D). Upon addition of Ca2+ back to the media after store depletion
by TG and EGTA, Fura2 measurements showed HEK293A cells ex-
pressing SPCA2C had significantly increased Ca2+ influx (ΔR340/380 at
6mM=0.070 ± 0.005 vs. 0.029 ± 0.002; p < 0.001, Fig. 6C, E),
indicating SPCA2C increased Ca2+ influx across the plasma membrane,
after store depletion, even in the absence of Orai1.
This data suggests SPCA2C functions to increase cytosolic Ca2+ in
all situations. Previous studies indicated full length SPCA2's ability to
increase cytosolic Ca2+ lead to increased NFAT localization [17]. To
determine if the elevation of cytosolic Ca2+ signaling upon SPCA2C
expression promotes a similar nuclear localization of NFAT, we co-
transfected SPCA2C-mRFP and NFAT-EGFP into HEK293A cells and
Fig. 5. SPCA2C localization in HEK-Orai1YFP cells does not change when ER stores are depleted. Fluorescent localization of (A, B) SPCA2CmRFP or (C, D) STIM1mCherry
in HEK-Orai1YFP cells under (A, C) physiological Ca2+ conditions (1.8mM Ca2+) or (B, D) following thapsigargin (TG) treatment. STIM1mCherry protein forms puncta
co-localizing with Orai1YFP (white arrow) following emptying of ER stores by treatment with 2 μM TG. Scale bar= 2.5 μm. Co-IF for STIM1mCherry and SPCA2CFLAG
(E) under physiological Ca2+ conditions (1.8mM Ca2+) or (F) following TG treatment in HEK-Orai1YFP cells expressing SPCA2CFLAG and STIM1mCherry. Scale
bar= 2.5 μm.
Fig. 6. SPCA2C increases Ca2+ entry during rest and after
store depletion in the absence of Orai1. (A) Rate of Ca2+
influx in cells exposed to increasing extracellular Ca2+
(GFP: n=29 [0mM], 25 [1.0mM], 34 [2.0mM];
GFP+SPCA2: n=29 [0mM], 33 [1.0 mM], 30
[2.0 mM]). (B) Ratiometric Fura2 traces showing re-
presentative trace in response to TG and Ca2+ addback in
HEK293A cells expressing GFP +/- SPCA2C. Maximal
response to (C) TG, (D) ionomycin, or (E) increasing
Ca2+. *p < 0.0001. (F) Western blot showing no Orai1
expression in HEK293A cells. HEK293A cells expressing
Orai1 have been included as a positive control, and wes-
tern blotting for α-actinin provided as a loading control.
Significantly more protein has been loaded for HEK293A
cells to ensure no Orai1 expression is observed.










(A) Rate of Ca2+ influx in cells exposed to increasing extracellular Ca2+ (GFP: n = 29 [0 mM], 25 
[1.0 mM], 34 [2.0 mM]; GFP+SPCA2: n = 29 [0 mM], 33 [1.0 mM], 30 [2.0 mM]). (B) 
Ratiometric Fura2 traces showing representative trace in response to TG and Ca2+ addback in 
HEK 293 cells expressing GFP +/- SPCA2C. Maximal response to (C) TG, (D) ionomycin (1 
µM), or (E) increasing Ca2+. (F) Western blot showing no Orai1 expression in HEK293A cells. 
HEK293A cells expressing Orai1YFP have been included as a positive control, and western 
blotting for "-actinin provided as a loading control. Significantly more protein has been loaded 
for HEK293A cells to ensure no Orai1 expression is observed. Values expressed as mean +/- 
SEM; *P<0.0001. 
Figure 3.7 SPCA2C increases Ca2+ entry during rest and after store depletion in the 
absence of Orai1. 
! 99!
3.3.7. SPCA2C does not increase nuclear translocation of NFAT 
 
This data suggests that SPCA2C functions to increase cytosolic Ca2+. Previous studies indicated 
the ability of full length SPCA2 to increase cytosolic Ca2+ leads to increased NFAT localization 
(Feng et al., 2010). To determine if the elevation of cytosolic Ca2+ signaling upon SPCA2C 
expression promotes a similar nuclear localization of NFAT, we co-transfected SPCA2CmRFP and 
EGFP-NFAT into HEK293A cells and examined NFAT localization (Figure 3.8). On its own, 
NFAT localizes to the cytoplasm (Figure 3.8A). As a control, we treated EGFP-NFAT 
expressing cells with TG, which resulted in almost complete NFAT translocation (Figure 3.8B). 
Interestingly, expression of SPCA2CmRFP did not enhance NFAT localization (Figure 3.8C), 
suggesting the increased in cytosolic Ca2+ levels were not high enough to stimulate translocation 
under the conditions tested. We performed similar experiments with a full length SPCA2 
(SPCA2CMYC; Figure 3.8D). While nuclear localization was increased (Figure 3.8E), 



















































HEK293A cells were transfected with NFAT-EGFP (n=109) alone (A) or in combination with 
SPCA2CmRFP (n=89; C) or SPCA2MYC (n=112; D) and localization assessed by fluorescent 
microscopy. As a positive control. NFAT-EGFP only-expressing cells were treated with TG 
(n=112; B). Arrows indicate individual nuclei of transfected cells. (E) Quantification of the 
percent of transfected cells that showed NFAT nuclear localization. Numbers in brackets indicate 
the total number of cells counted over three experiments. Letters indicate statistically different 









Regulation of Ca2+ homeostasis is crucial for proper cell function, requiring several pathways to 
rapidly move Ca2+ into and out of the cytosol. One family of proteins involved in Ca2+ 
homeostasis is the secretory pathway Ca2+ATPases, which consists of SPCA1 and SPCA2. Both 
SPCA proteins have been linked to Ca2+ homeostasis pathways not requiring ATPase function 
(Cross et al., 2013; Feng et al., 2010; Smaardijk et al., 2018). In this study, we characterized the 
function of SPCA2C, the only isoform of SPCA2 expressed in pancreatic acinar cells. SPCA2C 
contains the last four transmembrane domains of the full-length SPCA2 protein but lacks most of 
the domains required for Ca2+ATPase activity. Our results indicated forced expression of 
SPCA2CFLAG increased Ca2+ influx in HEK293A cells through a store-independent mechanism 
dependent on Orai1, similar to full length SPCA2. However, SPCA2CFLAG also increased resting 
cytosolic Ca2+ concentrations, elevated Ca2+ levels in the ER, and promoted increased store-
mediated Ca2+ influx, all independent of Orai1. These results suggest SPCA2C affects multiple 
pathways regulating cytosolic Ca2+ and does so through known and unknown mechanisms.  
 
SPCA2CFLAG readily interacts with Orai1YFP when expressed in HEK-Orai1YFP cells. This is 
consistent with previous findings that showed only the C-terminal of SPCA2, which is 
maintained in SPCA2C, was required for Orai1 interaction (Feng et al., 2010). The previous 
study also indicated that only C- terminal portions of SPCA2 elicited increased Ca2+ influx, 
(Feng et al., 2010) confirming interactions between Orai1 and the C-terminal part of SPCA2 are 
functionally relevant on their own. Indeed, our results showed SPCA2C enhanced Orai1’s ability 
to promote SICE. Unlike SPCA2, which localizes predominantly to the Golgi, we showed 
SPCA2C has a different localization pattern, accumulating also in the ER. This is consistent with 
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studies that examined localization of C terminal truncations of SPCA2 that showed a broad 
subcellular localization compared to full length SPCA2 (Smaardijk et al., 2017), and is also 
similar to the localization we previously documented in pancreatic acinar cells (Garside et al., 
2010). This difference in localization patterns between SPCA2 and SPCA2C may account for the 
ability of SPCA2C to promote increased cytosolic Ca2+ levels relative to the full-length SPCA2 
levels. We suggest full length SPCA2 would normally have limited interaction with Orai1 due to 
a lack of co-localization, and, therefore, different SPCA2 isoforms may be required for the 
different physiological roles related to Orai1and other Ca2+ influx channels. By localizing to the 
main Ca2+ storage department within the cell, SPCA2C has an increased opportunity to interact 
and effect Ca2+ levels throughout the cell.  
 
The differential expression pattern may also account for differences in cell type-specific 
requirements for SICE. SPCA2C is the only SPCA2 isoform expressed to appreciable levels in 
acinar cells. The expression of SPCA2C and ability to interact with Orai1 may indicate a greater 
physiological role for SICE in maintaining Ca2+ at appropriate levels, where ER Ca2+ stores are 
essential for enzyme exocytosis. Linking SPCA2C specifically to acinar cell physiology may 
also explain differences observed in NFAT localization following expression of SPCA2 or 
SPCA2C. While our analysis of SPCA2 did not result in complete NFAT nuclear localization, 
some was observed in the majority of cells. Conversely, SPCA2C did not increase NFAT nuclear 
localization even though cytosolic Ca2+ levels were increased. Previous studies suggested that 
breast cancer cell line phenotypes are a pathological consequence of over-expressing SPCA2 and 
the resultant increase in NFAT translocation (Feng et al., 2010). We are currently examining 
whether alterations in SPCA2C expression can affect acinar cell biology.  
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Despite its ability to interact with Orai1, SPCA2C’s contribution to Orai1 function appears to be 
limited to SICE. Expressing SPCA2C increased cytosolic and ER Ca2+, and increased influx of 
Ca2+ following ER-store depletion regardless of Orai1 expression. Previous studies examining 
the ability of full length SPCA2 (Feng et al., 2010; Smaardijk et al., 2018) and SPCA1 
(Smaardijk et al., 2018) to increase Ca2+ influx, indicated this occurred solely through SICE and 
specifically increased Golgi, but not ER Ca2+ stores (Smaardijk et al., 2018, 2017). SPCA2 
expression did not affect ER stores, (Feng et al., 2010) while over-expression of SPCA1 
promoted Golgi swelling and stress (Smaardijk et al., 2018, 2017). These results suggest that at 
least SPCA1 may have a pathophysiological role in SICE. Given SPCA2C’s expression pattern 
in the pancreas, and its decreased expression following induction of injury (chapter 2), we 
suggest that SPCA2C, unlike SPCA1, has a unique physiological role in SICE.  
 
It is tempting to suggest Orai1 interactions with SPCA2C and STIM1 reflect a switch from a 
normal physiological role to a stress-induced response. Co-expression of STIM1mCherry and 
SPCA2CFLAG in HEK-Orai1YFP cells eliminated Orai1-SPCA2C interaction and disrupted the 
cellular localization of SPCA2CFLAG. Therefore, it appears STIM1 and SPCA2C bind to similar 
molecular regions on Orai1. The "-helical secondary structure predicted for the C-terminal 
domain of SPCA2C is similar to the predominant secondary structure adopted by STIM1. Thus, 
SPCA2C binding with Orai1 may be mediated by intermolecular helix interactions as 
characterized for STIM1 and Orai1. This apparent competition is consistent with previous 
findings that complexes containing Orai1 and SPAC2 do not contain STIM1. (Feng et al., 2010) 
Also, we did not observe a change in STIM1-Orai1-mediated SOCE or localization when 
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SPCA2CFLAG was expressed. However, SPCA2CFLAG localization was affected by the presence 
of STIM1mCherry, suggesting an interaction with Orai1 helps localize SPCA2C to the membrane. 
In confirmation of a role for Orai1 in SPCA2C localization, knock down of Orai1 in SCp2 cells 
restricted SPCA2 localization to perinuclear region, with, less puncta near the membrane (Cross 
et al., 2013). In addition, while SPCA2C promotes increases in Ca2+ uptake following store 
depletion, these increases are modest, and emptying of ER stores did not result in increased co-
localization of Orai1YFP and SPCA2CFLAG. The re-localization of SPCA2CFLAG upon 
STIM1mCherry expression does not appear to be strictly to the Golgi. Indeed, SPCA2CFLAG 
localization occurs throughout the cytoplasm and analysis of cytosolic fractions revealed a 
decrease in overall SPCA2CFLAG accumulation (data not shown) suggesting it is being degraded.  
 
Surprisingly, membrane localization of SPCA2CFLAG was not disrupted by STIM1mCherry in the 
absence of Orai1YFP. Therefore, while Orai1 interactions may be required for membrane 
localization of SPCA2C, this requirement is only necessary when Orai1 is stably expressed. This 
seeming conundrum may be due to altered expression of proteins involved in Ca2+ influx when 
Orai1YFP is stably expressed. We and others have shown that HEK-Orai1YFP cells have reduced 
cytosolic Ca2+ compared to parental HEK293A cells, which may be due to reduced expression of 
other channels that promote Ca2+ uptake. Therefore, STIM1 does not compete with proteins 
required for SPCA2C membrane localization in the absence of Orai1.  
 
While we could not detect Orai1 protein in HEK293A cells, we cannot rule out potential 
interactions with other Orai proteins. To my knowledge, no studies have examined endogenous 
Orai2 or Orai3 protein function in HEK293A cells. However, cell-specific differences in the 
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types of Ca2+ channels activated by ER Ca2+ store depletion have been documented (Hong et al., 
2011; Kim et al., 2011; Vigont et al., 2015), and these different channels may interact with 
SPCA2C. For example, transient receptor potential cation 1/3/6 (TRPC1/3/6) channels heavily 
influence SOCE. (Hong et al., 2011; Kim et al., 2011; Vigont et al., 2015) Increased Ca2+ levels 
are associated with the initiation of pancreatitis and altering intracellular Ca2+ in the context of 
pancreatitis affects the progression and severity of acinar cell injury. Targeted deletion of the 
Trpc3 gene (Kim et al. 2011) or blocking Orai1 with a specific inhibitor (Wen et al., 2015) 
significantly decreased SOCE in acinar cells and decreased the severity of experimental 
pancreatitis in mice. Currently, clinical trials are underway using an Orai1 inhibitor in the 
treatment of pancreatitis. We showed a significant decrease in SPCA2C expression within four 
hours of inducing experimental pancreatitis in mice suggesting SPCA2C function is perturbed in 
response to injury. In addition, we have observed a complete loss of SPCA2C in Mist1-/- mice, 
which have altered Ca2+ homeostasis, reduced exocytosis function, and an increased 
susceptibility to pancreatic disease.  
 
In conclusion, this is the first evidence that SPCA2C affects multiple, non-ATPase related 
pathways that control Ca2+ homeostasis. Given SPCA2C is the predominant isoform expressed in 
pancreatic acinar cells, our work suggests that it plays an important physiological role in 
regulating Ca2+ within these cells. Whether decreased expression during injury is protective by 
reducing the potential for increased Ca2+ influx, or damaging, is unknown. Altering expression of 
SPCA2C in pancreatic acinar cells, as well as during experimentally induced pancreatitis, is 
currently being explored.  
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Chapter 4 
The role of SPCA2C in calcium homeostasis in pancreatic biology and 
pathology 
 
The work in this chapter has yet to be submitted for publication but some experiments were 
carried out by Mckenzie Carter, including western blot analysis on HA tagged SPCA1C-BioID, 
streptavidin, and Orai1 in BioID experiments (Figure 4.9), under the supervision of M.Fenech. 
RNA-seq analysis of patient-specific pancreatic tumor xenografts was performed by Dr. 
Nicholas Fraunhoffer (Figure 4.1B). The rest of the experimental work in this chapter was 




The previous two chapters identified the relevance of SPCA2C to basic biological processes 
using HEK293A cells and asked whether it regulates Ca2+ signalling pathways affected by the 
full length SPCA2. These findings suggest SPCA2C contributes to pathways both related and 
unrelated to those known to involve SPCA2. Therefore, the goal of this chapter was to gain a 
wider perspective of SPCA2C function. Two approaches were taken to assess SPCA2C in the 
context of Ca2+ homeostasis: i) assess SPCA2C function following over-expression in pancreatic 
cell lines and ii) define the SPCA2C interactome.  
 
The role of SPCA2C in Ca2+ homeostasis of pancreatic physiology was examined in 266.6 cells. 
266.6 cells resemble a partially differentiated pancreatic acinar cell phenotype, derived from 
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mice. They express several digestive enzymes and respond to carbachol stimulation (Mareninova 
et al., 2006; Ornitz et al., 1985). 266.6 cells were chosen over AR42J cells, another pancreatic 
cell line derived from rat tissue, since it is difficult to exogenously express transfected genes in 
AR42J cells through standard transfection protocols. Alternatively, SPCA2C was examined in 
cell lines derived from patient-specific pancreatic tumor xenografts (PDTX). Each cell line was 
derived from patient resected tumors. These cells provide a small sample of pancreatic cancers 
that can be used to study i) if SPCA2C expression differs among cancer-derived samples, and ii) 
if Ca2+ homeostasis differs according to the expression levels of SPCA2C. In both 266.6 and 
PDTX lines, SPCA2C’s effect on Ca2+ homeostasis was determined through over-expressing 
SPCA2C. 
 
Since the results of Chapters 2 and 3 suggested SPCA2C regulates Ca2+ through more than just 
interacting with Orai1, an unbiased screen was performed in HEK-Orai1YFP cells to identify 
putative interacting partners of SPCA2C. A proximity-dependent biotin identification (BioID) 
with SPCA2C was used to identify candidate proteins that closely associate with SCPA2C in 
HEK-Orai1YFP cells. BioID involves generating a BirA fusion protein that mediates biotinylation 
of primary amines on proximate (i.e. within ~10-50 nm) proteins when incubated with biotin 
(Appendix 1.1). Therefore, expression of SPCA2C-BioID in the presence of biotin for 15-24 
hours will generate a "history" of candidate protein-protein interactions. Biotinylated proteins 
can then be isolated and identified by mass spectrometry (Roux et al., 2013). Compared to other 
approaches, such as affinity capture or coimmunoprecipitation, BioID allows the capture of 
transient protein interactions and identifies candidate proteins that interact indirectly (i.e. through 
a complex) with SPCA2C. The BioID approach uses extremely tight biotin-streptavidin 
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interactions, which avoids the difficulties associated with directly detecting weak and more 
transient interactions. BioID has been successfully used to identify novel interactors for a variety 
of proteins (Abbasi & Schild-Poulter, 2019; Kim & Roux, 2016; Roux et al., 2012; Varnaite & 





4.2.1 Plasmid construction 
!
The MCS-SPCA2C-BioID-HA expression vector was generated by inserting PCR-amplified 
Atp2c2c coding sequence into the NheI and BamHI sites, using forward primer sequence 5' 
CTAGGCTAGCGACGATCCTGAACAGA 3' and reverse primer sequence 5' 
AGTCGAGGATCCCTCCACGGAGTC 3' into the BioID vector back bone (MCS-BioID2-HA), 
which was acquired from Addgene (Addgene plasmid # 74224; http://n2t.net/addgene:74224; 
RRID:Addgene_74224; Figure 4.1). The plasmid sequence was verified using the London 
Regional Genomics Facility (Western University, London, ON).  
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 MCS-BioID2-HA  
6113bp 
1 GCTAGCGCTCCACGGAGTGTCGGGGACACGATCCTGAACAGAGCCCTGATCCTGAGGGTCCTCATGTCGGCC 
  NheI                   M  S  A 
73 GCTGTCATCATAGGGGGGACCCTCTTTATCTTCTGGAGAGAGATCCCAGCGAACGGCACCAGCACCCCACGT 
         A  V  I  I  G  G  T  L  F  I  F  W  R  E  I  P  A  N  G  T  S  T  P  R 
145 ACAACCACCATGGCCTTCACCTGCTTCGTGTTTTTCGACCTCTTCAATGCCCTGAGCTGTCGCTCTCAGACC 
  T  T  T  M  A  F  T  C  F  V  F  F  D  L  F  N  A  L  S  C  R  S  Q  T 
217 AAGCTGATATTTGAGATTGGCTTTTTCCGGAACCGCATGTTCCTGTACTCAGTCCTTGGGTCCCTCCTGGGG 
  T  T  I  F  E  I  G  F  F  R  N  R  M  F  L  Y  S  V  L  G  S  L  L  G 
289 CAGCTGGCCGTGATCTATGCCCCGCCCCTACAAAAGGTCTTCCAGACTGAAAACCTGAGCGCGCTCGACCTG 
  Q  L  A  V  I  Y  A  P  P  L  Q  K  V  F  Q  T  E  N  L  S  A  L  D  L 
361 CTGCTGCTGACGGGCCTGGCCTCGTCTGTCTTCATTCTGTCGGAGCTGCTCAAGCTCTGGGAAAAGTTCTTG 
  L  L  L  T  G  L  A  S  S  V  F  I  L  S  E  L  L  K  L  W  E  K  F  L 
433 TCCAGAGCCAGGCCCACTCAGATGCTCCCGGAAGCTGTGGGATCC TTCAAG… 











(A) MCS-BioID2-HA was purchased from Addgene. PCR amplification was used to generate the 
sequence shown in (B). Both the plasmid and PCR product were digested with NheI and BamHI 
and subsequently ligated together. 
Figure 4.1 Plasmid map of SPCA2C-BioID-HA. 
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4.2.2 Cell culture, transfection and biotinylation  
!
HEK293A cells were cultured at 37 °C in 5% CO2 as previously stated (section 2.2.4). For 
biotinylation experiments, cells were transfected when they reached 70-80% confluence with 
MCS-SPCA2C-BioID-HA or MCS-BioID-HA using JetPrime Transfection Kit (Polyplus, NY). 24 
hours after transfection cells were incubated for 24 hours with media supplemented with 50 µM 
biotin.  
 
Cancer cells were cultured in DMEM/F12 media (ThermoFisher, Waltham, MA) supplemented 
with 10 mM nicotinamide (Sigma Aldrich, Oakville, ON), 5 mg/mL D-glucose (Sigma- 
Aldrich, Oakville, ON), 5 mL/L insulin-transferrin-selenium (Corning BV, Corning, NY ), 5% 
Nu-serum IV (Corning BV, ), 25 µg/mL bovine pituitary extract (BPE; ThermoFisher, Waltham, 
MA), 20 ng/mL Epidermal Growth Factor (EGF; Corning BV, ), 5 nmol/L 3,3',5-Triiodo-L-
Thyronine (T3; Sigma-Aldrich, Oakville, ON), 1 µmol/L dexamethasone (Sigma-Aldrich, 
Oakville, ON), 100 ng/mL cholera toxin (Sigma-Aldrich, Oakville, ON), and antibiotics 
(penicillin G 100U.mL, streptomycin 100 µg/mL, amphotericin B 0.25 µg/mL; Gibco-BRL, 
Grand Island, NY). 
 
4.2.3 Calcium imaging 
!
Ca2+ imaging was done as previously described (section 3.2.4). Following transfection, cells 
were loaded with 2 µM Fura2-AM in culture media for 30 minutes at 37 °C and 5% CO2. Cells 
were washed once with HBSS supplemented with 1.8 mM Ca2+ (unless otherwise stated) and 
incubated at 37oC for 10 minutes in HBSS before beginning each experiment. Fura2 emissions 
were measured as previously described (Section 3.2.4) in individual cells. Resting cytosolic Ca2+ 
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levels were established over 100 seconds. To assess unstimulated Ca2+ influx, cells were treated 
with 2 mM EGTA (Ca2+ chelator). The difference between Fura2 ratios before and after addition 
of EGTA was taken as an indicator of the level of constitutive Ca2+ influx. To measure ER Ca2+ 
stores, cells were treated 2 µM thapsagargin (TG) after the EGTA treatment. To measure all 
other Ca2+ stores, cells were subsequently treated with 1 µM ionomycin. Relative Ca2+ stores 
levels were determined by the difference between max peak of Fura2 ratios after TG or 
ionomycin and Fura2 ratios before treatment for the ER and other stores, respectively.  
 
4.2.4 Protein collection and western blotting  
!
Cytosolic and membrane enriched protein fractions were collected as previously described 
(section 3.2.5). Proteins were resolved on 12% polyacrylamide gels and transferred to a PVDF 
membrane (ThermoFisher, Waltham, MA). After blocking in 5% non-fat dried milk (NFDM) in 
tris-buffered saline and 0.1% Tween 20 (TBST) for 30 min, membranes were incubated with 
primary antibodies diluted in 5% NFDM in TBS overnight at 4°C. Antibodies included rabbit "-
Orai1 (1:500; Cell Signaling Technologies, Danvers, MA) or mouse "-hemagglutinin (HA; 
1:500; Abcam, Cambridge, MA). Primary antibodies were detected using horseradish peroxidase 
(HRP)-conjugated "-rabbit (1:10,000; Cell Signaling Technologies, Danvers, MA) or "-mouse 
(1:10,000; Cell Signaling Technologies) secondary antibodies (diluted in in TBS) for 1 hour. For 
detection of biotinylated proteins, membranes were blocked with 1% (w/v) bovine serum 
albumin (BSA) and 0.2% (v/v) Triton X-100 in PBS for 30 minutes. Membranes were incubated 
with HRP-conjugated streptavidin (1:10,000; Abcam, Cambridge, MA) diluted in 1% (w/v) 
BSA, 0.2% (v/v) Triton X-100 in phosphate buffered saline (PBS) for 40 minutes. Antibody 
signals were detected using enhanced chemiluminescence.  
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4.2.5 Immunofluorescence analysis  
!
HEK293A cells were transfected with MCS-SPCA2C-BioID-HA or MCS-BioID-HA and 
incubated with biotin as described above. Twenty-four hours after incubation in biotin, cells 
were fixed in 4% (v/v) formalin. To detect SPCA2C-BioID-HA and BioID-HA, cells were 
incubated for 30 minutes in blocking solution [PBS, 5% BSA, 1% (v/v) tritonX-100], and 
subsequently incubated for 1 hour at room temperature with primary mouse "-HA (1:500; 
Abcam, Cambridge, MA) diluted in blocking solution. Cells were washed with PBS, and 
subsequently incubated for 1 hour with FITC labeled secondary goat "-mouse antibody (1:250; 
ThermoFisher, Waltham, MA) diluted in PBS. Biotinylated proteins were detected by incubating 
samples in Alexa Flour 594-conjugated streptavidin (1:1000; ThermoFisher, Waltham, MA) 
diluted in blocking solution for 1 hour. Nuclei were visualized by incubating cells in DAPI 
(diluted 1:1000 in PBS; ThermoFisher) for 5 minutes. Images were acquired using a Leica 
DM5500B Microscope.  
 
4.2.6 Preparation of extracts for BioID 
!
Four 72 cm2 flasks were prepared for each experimental and control condition. HEK-Orai1YFP 
cells were transfected with MCS-SPCA2C-BioID-HA or MCS-BioID-HA as noted in 4.2.2. 
Twenty-four hours later, cells were washed in PBS. Whole cell extracts were prepared using 
lysis buffer (50 mM Tris#Cl pH 7.4, 500 mM NaCl, 0.2% SDS (w/v), 1 g/mL leupeptin, 10 g/mL 
aprotinin, 1 g/mL pepstatin, 1 mM DTT). Triton X-100 [final concentration 2% (w/v)] was 
added to dilute SDS and prevent it from precipitating at 4°C. Samples were sonicated on ice, 
twice for 30 seconds at output level 4 (Sonic Dismemborator Model 100). 50 mM Tris#Cl pH 7.4 
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was added to double the volume, and samples underwent another round of sonication. Samples 
were centrifuged for 10 minutes at 16,500 RCF at 4°C. Supernatants were transferred to new 
microcentrifuge tubes.  
 
4.2.7 Streptavidin Pull-Down of biotinylated proteins 
!
Streptavidin-conjugated proteins were isolated as previously described (Mehus et al., 2016). 
Briefly, whole cell extracts were incubated with equilibrated magnetic Dynabeads (MyOne 
Strepavadin C1; Invitrogen) overnight at 4°C. Beads were washed twice in wash buffer 1 (2% 
SDS w/v), once in wash buffer 2 [0.1% (w/v) deoxycholic acid, 1% (v/v) Triton X-100, 1 mM 
EDTA, 500 mM NaCl, 50 mM HEPES; pH7.5] and once in wash buffer 3 [0.5% (w/v) 
deoxycholic acid, 0.5% (w/v) NP-40, 1 mM EDTA, 250 mM LiCl, 10 mM Tris#Cl; pH 7.4]. A 
50µL aliquot was removed for western blot analysis, and the remaining sample resuspended in 
50 mM Tris#Cl, pH 7.4. Beads were re-centrifuged and resuspended in 50 mM ammonium 
bicarbonate. 
 
4.2.8 On-bead trypsin digests 
!
Proteins bound to magnetic beads were reduced using 100 mM DTT for 30 minutes and then 
alkylated at RT for 30 minutes in the dark with 1 M iodoacetamine (IAA; Sigma-Aldrich, 
Oakville, ON). Proteins were digested by agitating samples at 37°C for 4 hours with LysC 
(FUJIFILM Wako Pure Chemical Corporation, USA), overnight with Tryp-LysC (Promega, 
Madison, WI), and finally 4 hours in mass-spectrometry-grade trypsin (Promega, Madison, WI). 
The missed cleavage rate for samples was an average of 12.7%. Magnetic beads were 
centrifuged and pelleted with a magnet. Supernatants were dried by speed vacuum before 
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resuspension in 0.1% trifluoroacetic acid (Fisher, Ottawa, ON). Samples were desalted using 
C18 Zip Tips (Sigma-Aldrich, Oakville, ON) before drying by speed vacuum again and 
subsequently resuspended in 0.1% formic acid (Fisher, Ottawa, ON). 
 
4.2.9 Liquid chromatography (C) electrospray ionizing (ESI) tandem mass spectrometry (MS) 
!
Samples were submitted to the University of Western Ontario Biological Mass Spectrometry 
Laboratory (BMSL, London, CA) for analysis by high-resolution LC-ESI-MS/MS. Peptides 
were identified using an ACQUITY M-Class UHPLC system (Waters) connected to an Orbitrap 
Elite mass spectrometer (ThermoFisher, Waltham, MA). Approximately 1 µg of sample was 
injected onto an ACUITY UPCL M-Class Symmetry C18 Trap Column, 5 µm, 180 µm x 2 mm, 
trapped for 6 minutes at a flow rate of 5 µl/minute in 99% solution A 0.1% formic acid (FA) in 
water) and 1% solution B (0.1% FA in acetonitrile (SCN)). ACUITY UPLC M-Class peptide 
BEH C18 columns (130 Å, 1.7 µm, 75 µm x 250 mm) were used to separate peptides. Separation 
was performed at a flow rate of 300 nL/minute at 7-23% solution B for 179 minutes, 23-35% 
solution B for 60 minutes, then 95% solution B and washing. Samples were run in positive ion 
mode.  
 
4.2.10 Mass spectrometry data analysis  
!
Raw MS files were searched in PEAKS studio version X (Bioinformatics Solutions Inc., 
Waterloo, ON, Canada) using the Human Uniprot database to match peptides to proteins 
sequences. Maximum missed cleavages were set to 3 fragment mass deviation at 20 ppm, 
fragment mass error tolerance was set to 0.8 Da. Protein and peptide false discover rate (FDR) 
was set to 1%. Cysteine carbamidomethylation was set as a fixed modification while oxidation 
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(Met), amide deamidation (Asp/Gln), and acetylation (protein) were set as variable modifications 





N values are provided within the figure or figure legends for each experiment. Data is shown as 
mean +/- standard error of the mean (SEM), and statistical significance was determined using 




4.3.1 Pancreatic cell types express TRPC3 and STIM1 proteins involved in SOCE. 
!
To determine if the proteins required for SOCE and SICE are present in 266.6 and PDTX cell 
lines, western blot analysis was performed on whole cell extracts from these lines. PDTX lines 
include the AO-IPC, AR-IPC, H-NOR, L-NOR, 01-048 cells. HEK-Orai1YFP cells transfected 
with STIM1mCherry or parental HEK293A cells were included as controls (Figure 4.2A). Orai1 
was only detected in HEK-Orai1YFP cells, while TRPC3 and STIM1 were detected in HEK293A, 
266.6 and all PDTX lines (Figure 4.2A). RNA-seq analysis (data provided by Dr. Nicholas 
Fraunhoffer) suggested AO-IPC cells have relatively high STIM1 expression and low TRPC3 and 
ATP2C1 expression. While 01-048 cells exhibited the highest expression of TRPC3 and 
ATP2C1, L-NOR cells express TRPC3, STIM1 and ATP2C1 all at relatively low levels (Figure 
4.2). ORAI1 expression was not detected in any cell line. RNA sequencing analysis indicates 
ATP2C2 expression levels also differ between PDTX cell lines. AO-IPC cells have the highest 
ATP2C2 expression among all PDTX lines, while 01-048 cells express relatively low amounts 
(Figure 4.2). To determine if there was a correlation between ATP2C2 expression and cytosolic 
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Ca2+ levels, one high expressing (AO-IPC) and two low-expressing (L-NOR and 01-048) PDTX 
lines were chosen for analysis.   
 
Fura2 ratiometric imaging was used to measure resting cytosolic Ca2+ levels in each cell line. 
Representative Fura2 ratiometric traces are provided for each type in Figure 4.3. At rest, AO-IPC 
cells (ATP2C2HI cells) had significantly higher resting cytosolic Ca2+ levels compared to L-NOR 
cells (ATP2C2LO; Fura2 340/380 ratio = 0.83 ± 0.006 vs. 0.81 ± 0.007; p<0.001; Figure 4.3 and 
4.4A). The resting Ca2+ levels of 01-048 cells were significantly higher than L-NOR (Fura2 
340/380 ratio = 0.85 ± 0.008 vs. 0.81 ± 0.007; p<0.001; Figure 4.4A) and not significantly 
different compared to AO-IPC cells. This suggests that the relative levels of ATP2C2 do not 






































































(A) Representative western blot analysis for Orai1, TRPC3 and STIM1 in 266.6 cells and PDTX 
lines. HEK-ORAI1YFP transfected with STIM1 (positive control) and HEK293A cells (negative 
control) were included. Theoretical size of Orai1/Orai1YFP, STIM1/STIM1mCherry and TRPC3 is 
~33/59 kDa, ~77/106 kDa, and ~100 kDa, respectivly. (B) Heat map from RNA-seq analysis of 
gene expression from the various PDTX lines showing ATP2C2, STIM1, ATP2C1 and TRPC3 
expression in pancreatic cancer cell lines. Lower row Z-scores (blue) indicate relatively less 
mRNA expression.  
Figure 4.2 Expression of SOCE regulators in pancreatic cancer cell lines. 
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(A) ATP2C2HI (AO-IPC) and (B) ATP2C2LO (L-NOR and 01-048F1) cell lines were loaded with 
2 µM Fura2 and resting Ca2+ levels assessed. Cells were supplemented with 2 mM EGTA (I) 
followed by 2 µM TG 100 s later (II). Once cells reached steady Ca2+ states, 1 µM ionomycin 
(III) was added. Traces are representative of the average response observed in n=3 experiments. 
These results are used for quantitative analysis in Figure 4.4.  













































































Ratiometic Fura2 imaging was used to (A) quantify resting Ca2+ levels, (B) assess levels of 
constitutive Ca2+ influx by monitoring the loss of cytosolic Ca2+ after external Ca2+ chelation 
using 2 mM EGTA (C) measure ER Ca2+ store levels based on TG treatment, and (D) measure 
non-ER Ca2+ store levels based on 1 µM ionomycin treatment. Letters represent significant 
differences among groups. Error bars represent mean +/- SEM. Data are means from 3 separate 
experiments. Total number of cells for AO-IPC (n=52), 01-048 (n=45), and L-NOR (n=50).  
Figure 4.4 Analysis of Ca2+ signaling in PDTX lines L-NOR, 01-048, and AO-IPC. 
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Next, Fura2 ratiometric imaging was used to test Ca2+ influx into cells. Cells were treated with 2 
mM EGTA to chelate all extracellular Ca2+, therefore eliminating Ca2+ influx. The difference 
between cytosolic Ca2+ levels (approximated by the change in Fura2 ratios) before and after the 
addition of EGTA reflects the relative level of constitutive Ca2+ influx involved in maintaining 
basal cytosolic Ca2+ concentrations. Ca2+ influx in AO-IPC (ATP2C2HI cells) was significantly 
greater than in 01-048 (ATP2C2LO; Fura2 $340/380 ratio = 0.016 ± 0.003 vs. 0.008 ± 0.001; 
p<0.05; Figure 4.4B). There were no significant differences in Ca2+ influx rates between L-NOR 
(ATP2C2LO) and AO-IPC (ATP2C2HI), however, there was a trending decrease in L-NOR Ca2+ 
influx rates and no significant differences between 01-048 (ATP2C2LO) cells (Figure 4.4B).  
 
To determine the relative levels of Ca2+ in ER stores, cells were treated with TG. Ca2+ release 
from the ER after TG addition was significantly higher in AO-IPC (ATP2C2HI) cells compared to 
01-048 (ATP2C2LO; Fura2 $340/380 ratio = 0.3 ± 0.01 vs. 0.13 ± 0.006; p<0.0001; Figure 4.4C) 
and L-NOR cells (Fura2 $340/380 ratio = 0.3 ± 0.01 vs. 0.22 ± 0.009; p<0.0001; Figure 4.4C). 
01-048 cells released significantly more Ca2+ from ER stores then L-NOR cells (Fura2 $340/380 
ratio = 0.13 ± 0.006 vs. 0.22 ± 0.009; p<0.0001; Figure 4.4C).  These data suggests that at higher 
expression levels of ATP2C2 may correlate with increased stores of ER Ca2+. However, this 
correlation does not extend to the two ATP2C2LO cell lines, suggesting that the relative levels of 
ATP2C2 do not alone dictate the level of Ca2+ in ER stores.  
 
The relative levels of Ca2+ stored in all other organelles were tested by treating cells with 
ionomycin after ER stores were emptied using TG. AO-IPC cells had significantly lower Ca2+ 
release after ionomycin treatment when compared to 01-048 cells (Fura2 $340/380 ratio = 0.08 ± 
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0.011 vs. 0.13 ± 0.01; p<0.0001; Figure 4.4C). 01-048 cells had significantly greater release of 
Ca2+ after ionomycin treatment compared to L-NOR cells (Fura2 $340/380 ratio = 0.13 ± 0.01 
vs. 0.02 ± 0.002; p<0.05; Figure 4.4D). These results suggest higher cytosolic Ca2+ levels, 
constitutive Ca2+ influx across the plasma membrane and Ca2+ release from ER stores in AO-IPC 
cells may be correlated to higher levels of ATP2C2 expression. However, ATP2C2 levels need to 
be viewed in light of other Ca2+ handeling proteins, any correlation may be complicated by 
differential expression of other mediators of Ca2+ handling in the cells. In addition, analysis of 
Atp2c2 expression does not distinguish full length ATP2C2 from ATP2C2C. Therefore, to test if 
SPCA2C can increase Ca2+ levels and responses, the effects of SPCA2C over-expression was 
examined on cytosolic Ca2+ levels, Ca2+influx and ER Ca2+ stores using transient transfection in 
01-048 cells. The 01-048 cell line was chosen because these cells have relatively low ATP2C2 
expression.  
 
4.3.2 Increased SPCA2C expression increases resting cytosolic Ca2+ in 01-048 cells 
!
To determine if SPCA2C over-expression in 01-048 cells affects cytosolic Ca2+ levels, pcDNA3-
SPCA2CmRFP was transfected with pcDNA-GFP into 01-048 cells and cytosolic Ca2+ levels 
measured by Fura2 analysis. 01-048 cells over-expressing SPCA2C had significantly increased 
cytosolic Ca2+ levels compared to control GFP-only transfected cells (Fura2 340/380 ratio = 0.87 
± 0.004 vs. 0.84 ± 0.010; P < 0.05; Figure 4.5A, B) consistent with the findings that SPCA2C 









































































 (A) Ratiometric Fura2 analysis in 01-048 cells transfected with SPCA2CmRFP and GFP (n=20) or 
GFP alone (control; n=16). Resting levels were measured for the first 100 s before supplemented 
with 2 mM EGTA to measure relative level of constitutive Ca2+ influx, followed by 2µM TG to 
measure ER Ca2+ stores. Once cytosolic Ca2+ reached a steady state, 1 µM ionomycin (I) was 
added, to measure non-ER Ca2+ stores.  Traces are representative of the average response 
observed in n=3 experiments. Resting levels (B) maximal change in cytosolic Ca2+ based on 
Fura2 340/380 ratio in response to addition of EGTA (C) TG (D) and ionomycin (E)were 
measured. Values are expressed as means +/- SEM; *P<0.05.  
Figure 4.5 Increasing SPCA2C expression elevates resting cytosolic Ca2+ levels in 01-048 
cells. 
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To determine if increased cytosolic Ca2+ levels in SPCA2C-over expressing cells were due to 
increased constitutive Ca2+ influx, 2 mM EGTA was added to the extracellular media to chelate 
Ca2+, halting Ca2+ influx. The relative loss in cytosolic C2+ upon chelation of extracellular Ca2+ 
with EGTA was not different for 01-048 cells over-expressing SPCA2CmRFP compared to control 
GFP only transfected cells (Figure 4.5C), consistent with findings in HEK293A, cells which 
showed increased SPCA2C expression does not increase constitutive Ca2+ influx rates at rest 
without Orai1 expression. Finally, 01-048 cells were treated with TG and ionomycin to examine 
Ca2+ levels in ER stores and non-ER stores, respectively. No significant differences were 
observed when comparing the relative Ca2+ release after TG or ionomycin treatment in SPCA2C-
expressing vs. non-expressing 01-048 cells (Figure 4.5C, D). These experiments indicate over-
expression of SPCA2C in 01-048 cells increased cytosolic Ca2+ levels but did not increase ER 
Ca2+ stores. This may suggest an alternative function for SPCA2C in this line or reflect altered 
expression of other Ca2+ handling proteins.  
 
4.3.4 SPCA2C over-expression increases cytosolic Ca2+ and Ca2+ influx across the plasma 
membrane in 266.6 cells. 
!
To determine if SPCA2C affects pancreatic acinar cell cytosolic Ca2+ levels and Ca2+ handling, 
SPCA2CmRFP was transiently over-expressed in 266.6 cells. Examination of resting cytosolic 
Ca2+ levels using Fura2 ratiometric imaging showed significantly increased cytosolic Ca2+ levels 
in 266.6 cells over-expressing SPCA2C compared to control GFP transfected cells (Fura2 
340/380 ratio = 0.82 ± 0.008 vs. 0.75 ± 0.014; p<0.0001; Figure 4.6A, B). To determine if 
increased cytosolic Ca2+ levels were due to increased constitutive Ca2+ influx, EGTA was added 
to the extracellular media. 266.6 cells over-expressing SPCA2C showed a greater drop in 
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cytosolic Ca2+ upon chelation of extracellular Ca2+ compared to control GFP transfected cells 
(Fura2 340/380 ratio = 0.04 ± 0.002 vs. 0.02 ± 0.003; p<0.01; Figure 4.6C) suggesting that over-
expression of SPCA2C may be increasing the number of interactions with Ca2+ channels on the 
plasma membrane, thereby enhancing constitutive Ca2+ influx. However, ER Ca2+ levels 
appeared to be significantly lower in SPCA2C over-expressing 266.6 cells based on Ca2+ release 
following TG treatment compared to GFP control cells (Fura2 340/380 ratio = 0.08 ± 0.008 vs. 
0.12 ± 0.015; p<0.001; Figure 4.6D). No significant difference in non-ER stores Ca2+ levels was 
observed based on ionomycin treatment.  
 
Since TG can also promote Ca2+ release from the Golgi, ER store-specific Ca2+ release was 
assessed by treating cells with carbachol. There was no difference in Ca2+ release from ER stores 
in response to carbachol between 266.6 cells expressing SPCA2C or control GFP only cells 
(Figure 4.7), suggesting increased SPCA2C expression in 266.6 cells does not increase Ca2+ 
levels in the ER stores. 
 
Combined, these results suggest increased expression of SPCA2C in 266.6 cells increased resting 
cytosolic Ca2+ levels and Ca2+ influx across the plasma membrane.  However, unlike HEK293A 
















Figure'4.7.'Increasing'SPCA2C'expression'elevates'resting'cytosolic'Ca2+ levels'and'Ca2+ influx'in'266.6. (A)#
Ratiometric Fura2#analysis#in#266.6#cells#transfected#with#SPCA2CmRFP and#GFP#(n=42)#or#GFP#alone#(control;#
n=43).#Resting#levels#were#measured#for#the#first#100#s#before#supplemented#with#2#mM EGTA#to#measure#














































































Figure 4.6 Increasing SPCA2C expression elevates resting cytosolic Ca2+ levels and Ca2+ 
influx in 266.6 cells.  
 (A) Ratiometric Fura2 analysis in 266.6 cells transfected with SPCA2CmRFP and GFP (n=42) or 
GFP alone (control; n=43). The number of cells examined was extended over three experiments. 
Resting levels were measured for the first 100 s before addition of 2 mM EGTA to assess the 
level of constitutive Ca2+ influx, followed by 2 µM TG to measure the levels of the ER Ca2+ 
stores. Once cytosolic Ca2+ reached a steady state, 1 µM ionomycin was added, to measure Ca2+ 
release from non-ER Ca2+ stores. Traces are representative of the average response from n=3 
separate experiments. Resting levels (B) maximal change in cytosolic Ca2+ based on Fura2 
340/380 ratio in response to addition of EGTA (C) TG (D) and ionomycin (E)were measured. 










































































Figure 4.7 Increased SPCA2C expression does not affect carbachol stimulated Ca2+ 
response in 266.6 cells. 
Fura2 ratiometric analysis of 266.6 cells transfected with SPCA2CmRFP and GFP or GFP alone 
(control). Resting levels were measured for the first 60s before buffer was supplemented with 1, 
10, or 50 µM carbachol (A, B, C; respectively). Traces are representative single cell responses. 
Ca2+ release from the ER was approximated by the difference in Fura2 340/380 ratio from 
resting to max peak after carbachol addition. Experiments were conducted 3 times, number of 
cells total for GFP control (1 µM, n=13; 10 µM, n=34; 50 µM, n=35) and SPCA2CmRFP (1 µM, 
n=34; 10 µM, n=30; 50 µM, n=39; E). Values are expressed as means +/- SEM.  
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4.3.5 Characterization of the expression, localization and functionality of SPCA2C-BioID-HA 
in HEK23A cells. 
!
My data suggests, SPCA2C affects Ca2+ homeostasis through mechanisms both involving and 
independent of Orai1. Therefore, to identify other SPCA2C interactors that might be involved in 
Ca2+ homeostasis, a BioID protein-proximity detection assay was performed. The BioID assay 
was carried out in HEK-Orai1YFP cells, as they provide an internal established control for 
interactions between SPCA2C and Orai1.  
 
To validate SPCA2C-BioID-HA expression and its ability to biotinylate interacting protein 
partners, MCS-SPCA2C-BioID-HA and empty MCS-BioID-HA vectors were transiently 
transfected into HEK293A cells. 24 hours after transfection media was supplemented with biotin 
for 24 hours. IF analysis for HA showed SPCA2C-BioID-HA localized within cytosolic regions 
and near the cell periphery, consistent with SPCA2CFLAG and SPCA2CmRFP localization observed 
in section 3.3.3. Streptavidin-Alex Fluor 568 revealed that the biotinylation in SPCA2C-BioID 
expressing cells was localized within the cytosol, near the cell periphery (Figure 4.8A), which is 
different than the nuclear localization observed for the biotinylation pattern using empty BioID-
HA vector expressing cells (Figure 4.8B). 
 
To confirm localization of SPCA2C-BioID-HA to the correct cellular compartment, samples of 
cytosol and membrane enriched fractions were used in western blot analysis. The western blot 
confirmed expression of SPCA2C-BioID-HA and biotinylation in the membrane fraction of 
MCS-SPCA2C-BioID-HA transfected cells. The western blot showed that the membrane fraction 
of BioID-HA transfected cells contained relatively few bands (Figure 4.9A). Furthermore, the 
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streptavidin-banding pattern in SPCA2C-BioID-HA whole cell protein lysates was retained after 
isolation of biotinylated protein with streptavidin coated Dynabeads (Figure 4.9B).  
 
4.3.6 Identification of SPCA2C candidate protein interactors using BioID. 
!
Using transient transfection of SPCA2C-BioID-HA and BioID-HA (control) in HEK-Orai1YFP 
cells, a large-scale BioID experiment was performed, testing for biotinylation prior to MS 
submission (Figure 4.10B). Biotin modifications are rare in mammalian cells, with the exception 
of pyruvate carboxylase, acetyl-CoA carboxylase 1 and 2, propionyl-CoA carboxylase alpha 
chain, and methylcrotonoyl-CoA carboxylase subunit alpha (Roux et al., 2012). The presence of 
the carboxylases in the MS results confirms the successful capture of biotinylated proteins. 
Indeed, one or more of these carboxylases were detected in my system.  
 
A list of 480 proteins was detected by mass spectrometry (MS) in the SPCA2C-BioID-HA pull-
down. These proteins were referenced against the list of 336 proteins detected in the empty 
control BioID pull-down (Figure 4.10A). Proteins listed in both SPCA2C-BioID-HA and BioID-
HA MS lists were omitted from further analysis. In total, 263 proteins were uniquely identified 
in the SPCA2C-BioID-HA group. Orai1 was among the list of SPCA2C-BioID-HA proteins, 















































Figure 4.8 Expression of BioID and SPCA2C-BioID in HEK293A cells. 
SPCA2C-BioID-HA (A) or BioID-HA (B) fusion protein was transiently expressed in HEK293A 
cells. Cells were incubated in 50uM biotin for 24 hours then fixed. Immunofluorescence was 





























Figure 4.9 Characterization of SPCA2C-BioID-HA functionality for biotin-labelling 
proteins in HEK-Orai1YFP cells. 
MCS-SPCA2C-BioID-HA and MCS-BioID-HA fusion plasmids were separately expressed in 
HEK-Orai1YFP cells incubated in 50 µM biotin for 24 hours. Western blot was performed on 
cytosolic and membrane enriched protein lysates for "-HA, "-Orai1 (blot showing Orai1YFP) and 
streptavidin-HRP (A). Whole cell lysates were incubated in streptavidin-coupled dynabeads and 
western blot performed for anti-HA and streptavidin-HRP (B) to show presence of SPCA2C-
BioID-HA and biotinylated proteins, using a streptavidin pull-down before mass spectrometry.  
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To determine if the BioID screen validated previous findings on cellular localization and 
function, bioinformatics pathway analysis was performed using this list of 263 proteins using the  
online web tool gProfiler (https://biit.cs.ut.ee/gprofiler/gost). GO analysis of cellular 
compartments (GO:CC) identified the ER membrane as a highly enriched pathways based on the 
list of putative interactors (Padj = 5.04x10-35; Figure 4.10D). This supports previous IF analysis 
localizing SPCA2C to the ER. KEGG pathway analysis also identified ER-related processes such 
as protein processing in the ER and protein export (Padj = 1.9x10-6 Figure 4.10C), again 
supportive of our previous findings that SPCA2C localizes and functions in the ER. Finally, 
Human Protein Atlas (HPA) analysis terms included pancreas; exocrine glandular cells and 
salivary gland; glandular cells (Padj = 1.22x10-5 and Padj = 0.0015, respectively; Figure 5.10B). 
These terms support expectations that SPCA2C is important in acinar cell physiology.  
 
4.3.7 Using the Contaminant Repository for Affinity Purification to create a stringent list of 
interaction candidates. 
!
Since BioID and affinity purification coupled to MS are now widely used approaches for the 
identification of protein-protein interactors, a Contaminant Repository for Affinity Purification 
has been created online (Mellacheruvu et al., 2013; https://www.crapome.org). Using this 
resource improves characterization of background associated with a given experimental protocol. 
This list contains more than 3300 proteins, which makes it a very stringent control. However, 
because the list is extensive, it may falsely eliminate true interactors of SPCA2C. Nevertheless, 
using a more stringent approach that omitted proteins found in the contaminant list and the 
BioID negative control, a refined list of 71 candidate interacting proteins was identified (Figure 
4.11A). This list also included positive control Orai1. Bioinformatic analysis was performed and 
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a refined list of GO, KEGG and Reactome pathways identified. Even after this stringent 
refinement, GO cell compartment analysis still suggested localization of interacting partners to 
the ER (Padj = 1.34x10-20; Figure 4.11D), which strongly supports our previous localization and 
functional analysis of SPCA2C in cells. Some terms identified by KEGG analysis, such as 
ribosomes and glycolysis, could be artifacts of the BioID screen. KEGG pathway analysis 
suggested candidate protein interactors play a role in SNARE interaction in vesicular transport 
(Padj = 0.028; Figure 4.12C). Vesicular transport in the exocytosis of enzymes is the main 
function of pancreatic acinar cells and relies heavily on proper Ca2+ regulation, which Reactome 
analysis suggests as a likely function of the identified candidate interactors (Padj = 0.02; Figure 
4.11B).  
 
As mentioned, the contaminant repository may eliminate bona fide SPCA2C interaction partners. 
Therefore, all putative interactors in the less stringent list of 263 proteins should not be 
discredited completely. In future work, verifying the protein interactions identified by the BioID 




































































Figure 4.10 KEGG, GO and HPA pathways based on protein interaction candidates from 
BioID screen. 
(A) Venn diagram comparing the overlap of peptides obtained in BioID-HA and SPCA2C-
BioID-HA MS analysis. Bioinformatic analysis of the 263 unique proteins biotinylated by 
SPCA2C-BioID-HA, after excluding negative control protein. The pathways identified in Gene 
Ontology (B) KEGG (C), and HPA (D) analysis suggest specific roles and localization patterns 































































Figure 4.11 KEGG, GO and Reactome pathways based on protein interaction candidates 
identified using the BioID screen. 
(A) Venn diagram comparing the number of proteins identified in the BioID-HA control and 
SPCA2C-BioID-HA compared to the contaminant repository list. Analysis of the 71 identified 
proteins unique to SPCA2C-BioID-HA, after excluding negative control and common 
contaminate proteins, by determining enriched terms and pathways from Gene Ontology (B) 




Both SPCA2 and SPCA2C have been linked to Ca2+ homeostasis pathways requiring Orai1. 
However, our functional data in Chapters 2 and 3 suggest SPCA2C is also involved in regulating 
Ca2+ through non-Orai1 mediated pathways as well. Therefore, in this Chapter, two approaches 
were taken to gain a broader understanding of SPCA2C function. First, the effects of over-
expressing ATP2C2 on cytosolic Ca2+ levels before and after stimulation were examined in 
pancreatic cell lines. Similar to findings in breast cancer (Dang et al., 2017; Feng et al., 2010), 
pancreatic PDTX cell lines differed in expression levels of ATP2C2 RNA, and a PDTX cell line 
expressing high ATP2C2 RNA levels had increased cytosolic Ca2+ levels, constitutive Ca2+ 
influx and ER Ca2+ release in response to TG compared to PDTX cell lines with a lower 
expression of ATP2C2 RNA expression level. SPCA2C over-expression in both PDTX cells or 
266.6 cells, increased resting cytosolic Ca2+ levels. However, there was also no change in ER 
Ca2+ levels with SPCA2C over-expression, which is different than findings in HEK293A cells. 
Second, a BioID screen was performed in HEK-Orai1YFP cells to identify other interactors of 
SPCA2C that might be related to Ca2+ homeostasis. The BioID screen also supports localization 
of SPCA2C to the ER as a primary function and confirmed the interaction with Orai1. In 
addition, the screen identified 71 (most stringent) to 263 (least stringent) putative SPCA2C 
interacting proteins for future analysis. These results strongly support a complex, yet significant 
role for SPCA2C in multiple Ca2+ regulating pathways. 
 
ATP2C2HI expression levels in PDTX lines had increased constitutive Ca2+ influx and ER Ca2+ 
stores, compared to ATP2C2LO PDTX lines. However, although resting cytosolic Ca2+ levels 
were greater in ATP2C2HI 01-048 cells compared to ATP2C2LO L-NOR cells, there was no 
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difference between ATP2C2HI 01-048 cells and ATP2C2LO AO-IPC cells; which suggests that 
Ca2+ regulation in these cells may be influenced by differential expression of other Ca2+ 
regulators. Furthermore, since there is no reliable SPCA2C antibody available, it is difficult to 
assess if increased Atp2c2 RNA transcript directly increases SPCA2 or SPCA2C protein 
abundance. Also, the assay did not distinguish whether full-length ATP2C2 or ATP2C2C is 
expressed in the PDTX lines. The full-length or a longer isoform of SPCA2 may be expressed in 
the PDTX lines, which could produce an alternative function in these cells. Alternate isoforms of 
SPCA2 could be less effective at increasing cytosolic Ca2+ levels, as full-length SPCA2 was 
shown to increase cytosolic Ca2+ to a lesser degree compared to SPCA2C (chapter 2). 
 
Over-expression of SPCA2C in 01-048 cells, which endogenously express relatively low, but not 
absent amounts of Atp2c2, increased cytosolic Ca2+ levels but not constitutive Ca2+ influx or ER 
Ca2+ stores. This is different than previous findings in HEK293A cells where SPCA2C over 
expression increased both cytosolic and ER stored Ca2+. While this discrepancy could be due to 
SPCA2C localizing differently between 01-048 and HEK293A cells, intracellular SPCA2C 
localization analysis by co-IF did not differ from HEK293A cells. Alternatively, while these 
pancreatic cancer cells are derived from pancreatic acinar cells (Xu et al., 2019), they are 
pathologically enhanced cells with changes to their original expression levels of Ca2+ related 
proteins likely, which is evidenced by differential expression of STIM1, TRPC3, and ATP2C1 
between cells. Furthermore, the overall organization and function of Ca2+ signaling proteins may 
be changed. An example of this change is the fact that 01-048 cells did not respond to carbachol, 
an acetylcholine agonist, which should induce intracellular oscillatory Ca2+ signals. In an attempt 
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to resolve this issue, I examined SPCA2C over-expression in 266.6 cells as a physiological 
model of pancreatic acinar cells. 
 
SPCA2C over-expression in the physiological pancreatic cell line, 266.6 cell line increased 
resting cytosolic Ca2+ levels. However, unlike in HEK293A cells, Ca2+ responses to treatment 
with TG were lower when SPCA2C was over-expressed. This suggests that over-expression of 
SPCA2C may decrease ER stored Ca2+ in 266.6 cells. However, when ER store-specific Ca2+ 
release was stimulated by carbachol, an acetylcholine receptor agonist that results in IP3-
mediated IP3R activation, no difference in Ca2+ release from ER stores between 266.6 cells over-
expressing SPCA2C or control GFP cells was observed. Note that there is already endogenous 
expression of SPCA2C in 266.6 cells, which could be masking any differences between the 
control and over-expression cells. Over-expression of SPCA2C may elicit a protective 
mechanism by the cell to ensure ER Ca2+ stores do not cause cellular distress.  
For example, a novel ER Ca2+ channel encoded by the transmembrane and coiled-coil domains 1 
(TMCO1) gene forms active tetrameric channels that extrude Ca2+ from the ER above a certain 
Ca2+ concentration, thereby preventing ER Ca2+ overload (Wang et al., 2016). 
 
The unbiased screen for putative SPCA2C interacting protein partners identified pathways that 
reflect localization and function of SPCA2C to the ER. Bioinformatics analysis supported 
previous findings from Chapters 2 and 3 that SPCA2C localizes to the ER and GO cellular 
compartment analysis suggests that SPCA2C also localizes to vesicles.  KEGG pathway analysis 
suggests a link to the SNARE complex pathway. These two findings suggest a role for SPCA2C 
in regulated exocytosis of enzymes in pancreatic acinar cells, as well as, Ca2+ regulation.  
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Indeed, Reactome pathway analysis of candidate interacting partners identified Ca2+ ion 
homeostasis as an enriched pathway, supporting our findings from previous cell experiments that 
SPCA2C is involved in cytosolic and ER Ca2+ levels. Furthermore, after excluding the BioID 
negative control proteins and common contaminants repository list, all 71 proteins identified by 
BioID were sorted based on protein class with 8.8% of proteins belonging to Ca2+ binding 
proteins. Among the list of 71 candidate proteins 9 were functionally characterized as binding 
Ca2+ directly or to be involved in Ca2+ homeostasis (Appendix table 1.2). To confirm an 
interaction between SPCA2C and candidates identified by the BioID screen other methods such 
as co-IP or frequency resonance energy transfer (FRET) could be used, followed by evaluation 
of the functional relevance of such an interaction via mutation. Following up on putative 
interactions identified by BioID analysis will be key in further elucidating the functional 
mechanisms of SPCA2C.  
 
For example, among the 9 proteins identified, Aspartyl/asparaginyl beta-hydroxylase isoform 8 
(ASPH) is of particular interest because it has been characterized as a membrane-bound Ca2+ 
sensing protein and structural component of the ER-plasma membrane junctions. ASPH 
regulates the activity of CRAC channels in T-cells (Srikanth et al., 2012). An interaction 
between SPCA2C and ASPH could be readily confirmed using co-IP in HEK293A cells.  
 
RyR was also identified by the BioID assay. As discussed in section 1.4.1, RyR play an 
important role in shaping Ca2+ signals in pancreatic acinar cells. There have also been reports of 
RyR playing a role in activating Orai1-composed CRAC channels to influence Ca2+ signaling 
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and homeostasis (Lin et al., 2016). Therefore, the RyR is another interesting candidate, which 
should be confirmed by co-IP.   
 
In conclusion, increased expression of SPCA2C in 266.6 cells, a model of pancreatic acinar cell 
physiology, suggests that it plays an important physiological role in regulating cytosolic Ca2+ 
levels and basal Ca2+ influx within these cells. In pancreatic pathology, ATP2C2HI was associated 
with increases in constitutive Ca2+ influx and increased ER Ca2+ store levels in PDTX cell lines, 
suggesting that relative increases in endogenous expression of SPCA2 increases ER Ca2+ store 
levels and constitutive Ca2+ influx.  Furthermore, this is the first evidence that SPCA2C may 
affect pathways of vesicle trafficking and enzyme exocytosis, which rely on Ca2+ signalling to 
function. Further studies are needed to confirm SPCA2C protein-protein interactions and the 









The following discoveries were made through my research presented in this thesis: 
1.& SPCA2C is transcribed from an alternative transcriptional start site.  
2.& The region upstream of Atp2c2c acts as a promoter, driving expression of SPCA2C. 
3.& Atp2c2c expression is significantly decreased after inducing pancreatitis in mice. 
4.& SPCA2C shows a more expansive area of localization in the cell compared to SPCA2, 
also localizing to the ER. 
5.& SPCA2C interacts with Orai1 and increases store-independent Ca2+ entry. 
6.& SPCA2C increases ER stored Ca2+ stores and Ca2+ influx across the plasma membrane 
after ER store depletion in HEK293A cells. These roles are independent of Orai1.  
7.& Patient-derived tumour xenograft (PDTX) lines from pancreatic tumours express variable 
levels of ATP2C2. These lines also express TRPC3, STIM1, and ATP2C1, but mRNA and 
protein levels are not correlated. 
8.& Relative levels of ATP2C2 expression partially correlate to cytosolic Ca2+, constitutive 
Ca2+ influx and ER Ca2+ levels. Exogenous SPCA2C over-expression increases cytosolic 
Ca2+ levels in an ATP2C2LO PDTX cell lines.  
9.& SPCA2C over-expression increases cytosolic Ca2+ and constitutive Ca2+ influx in 266.6 
cells, a mouse pancreatic acinar cell line.  
10.&Candidate SPCA2C binding partners belong to pathways that regulate Ca2+ ion 
homeostasis and localize to the ER and secretory vesicles.  
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5.2 General Discussion 
 
The purpose of this thesis was to determine the function of SPCA2C in Ca2+ homeostasis. 
Previous work on SPCA2C suggested roles in Ca2+ homeostasis that lie outside ATPase function. 
Since Ca2+ is a critical regulator of multiple cellular processes, and the pancreas relies on precise 
Ca2+ regulation, I functionally characterized SPCA2C in both pancreatic and non-pancreatic 
cells. My research shows that SPCA2C regulates cytosolic Ca2+ levels and contributes to 
pathways influencing ER Ca2+ levels. Through an unbiased screen, I identified a number of 
proteins that putatively interact with SPCA2C that will form the basis of future hypothesises and 
research projects. Combined, this work confirmed a functional importance and identified novel 
roles for SPCA2C in calcium biology.  
 
5.2.1 The regulation of cytosolic Ca2+ levels by SPCA2C 
 
The experiments in this thesis strongly support a role for SPCA2C in increasing cytosolic Ca2+ 
levels. In HEK293A cells, SPCA2C over-expression increased cytosolic levels independent of 
Orai1 expression. A Ca2+ regulatory role was also demonstrated in mouse acinar 266.6 cells, and 
the 01-048 PDTX cell line. The passage of Ca2+ across the plasma membrane cannot be due to 
Ca2+ATPase activity as the C-terminal truncation of SPCA2C completely lacks the E1-E2 
hydrolase domain, and several transmembrane domains containing a Ca2+ binding site. Although 
it is possible that the four remaining transmembrane domains of SPCA2C form a Ca2+ channel 
alone or after homo-multimerization, this scenario seems unlikely give the Ca2+ permeation 
pathways in full length Ca2+ATPases is primarily formed by transmembrane helices outside the 
transmembrane domains retained in SPCA2C (Palmgren & Nissen, 2011). Therefore, SPCA2C 
must contribute to Ca2+ influx through alternative pathways. 
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Surprisingly, SPCA2C is able to increase cytosolic Ca2+ with limited localization to the plasma 
membrane. Most SPCA2C is localized to the ER or Golgi. This localization suggests SPCA2C 
activates Ca2+ channels on the plasma membrane to influence Ca2+ influx through 
communication between the ER and plasma membrane, possibly through closely apposed 
regions and/or junctional complexes. Such a model is supported by the putative protein 
interactors identified in the BioID screen, including Aspartyl/asparaginyl beta-hydroxylase 
(ASPH), which has shown to be a structural component of ER-plasma membrane junctions 
(Srikanth et al., 2012). Although the ability of SPCA2C to influence SICE initially appears to be 
dependent on Orai1, resting cytosolic Ca2+ levels were still elevated in HEK293A cells not 
expressing Orai1. Furthermore, cytosolic levels were also increased when SPCA2C was over-
expressed 266.6 and 01-048 cells, which do not express Orai1. Therefore, this work suggests that 
SPCA2C constitutively increases cytosolic Ca2+ levels by either directly or indirectly regulating 
more than one Ca2+ channel on the plasma membrane, while primarily localizing to the ER. 
 
5.2.2 SPCA2C's contribution to other Ca2+ regulating pathways including ER Ca2+ stores 
 
In all cell types studied in this thesis, SPCA2C localizes more often to the ER, rather than the 
Golgi apparatus. ER-localized SPCA2C expression patterns are similar to localization previously 
documented in pancreatic acinar cells (Garside et al., 2010) and consistent with studies that 
examined localization of C-terminal truncations of SPCA2 (Jones, 1999). Furthermore, GO 
compartment analysis of proteins identified in the BioID experiment suggest localization of 
SPCA2C to the ER. Thus, there is strong evidence that the main function of SPCA2C is driven 
through localization to this subcellular compartment. Ca2+ release from the ER propagates all 
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global cellular signals (Berridge, 2007). For example, Ca2+ release from the ER is particularly 
important for exocytosis in pancreatic acinar cells, which relies on proper spatiotemporal global 
Ca2+ signals. Importantly, disruptions in ER Ca2+ release are strongly tied to pancreatic 
pathology (Zhou et al., 1996). Since my studies support a role for SPCA2C in regulating ER 
Ca2+ concentrations, this suggests that SPCA2C may be dysfunctional in pancreatic pathologies 
such as pancreatitis. In HEK293A cells, which do not express SPCA2 or SPCA2C, SPCA2C 
over-expression increases ER Ca2+ stores. However, in the pancreatic acinar 266.6 cells and the 
PTDX line 01-048 cell line, SPCA2C over-expression did not increase ER Ca2+ levels. This 
difference may be due to endogenous expression of SPCA2C or the full length SPCA2 in 266.6 
and 01-048 cells. Over-expression of SPCA2C in cells that already express SPCA2C may not 
further increase functionality within the cell (i.e. increasing cytosolic and ER stores within the 
cell). In fact, artificially high CCK signalling can actually inhibit exocytosis (Roettger et al., 
1997). Alternatively, the discrepancy could be due to mechanisms that protect against ER Ca2+ 
overload in these pancreatic cell types. Such mechanisms have been described previously to be 
mediated by transmembrane and coiled-coil domains 1 (TMCO1) protein, which forms an active 
channel to extrude Ca2+ when ER levels become too high (Wang et al., 2016).   
 
My work provides strong support for a role for SPCA2C in pathways that exclude Orai1 and 
ATPase function. Several putative SPCA2C-interacting partners were identified using BioID. 
KEGG and GO analysis supported our Fura2 ratiometric imaging experiments, as it also suggests 
SPCA2C is involved in Ca2+ ion homeostasis in the ER. Furthermore, GO cellular compartment 
analysis identified vesicles and KEGG pathway analysis identified SNARE interactions involved 
in vesicular transport as enriched pathways based on a stringently refined protein candidate list. 
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These terms listed by the bioinformatics analysis of interaction candidates support a theory that 
SPCA2C might be involved in vesicle transport. Vesicle transport in pancreatic acinar cells is 
regulated by Ca2+ signalling and is very important to pancreatic physiology. Future studies 
should involve exploring the role of SPCA2C in pathways specific to Ca2+ mediated vesicle 
transport. For example, carbachol-induced exocytosis assays in SPCA2C knock-down or over-
expression experiments could be done in 266.6 cells. These experiments could be followed up 
with exocytosis experiments in primary acinar cells from a pancreas-specific Atp2c2c knockout 
model.  
 
5.2.3 Interacting partners of SPCA2C 
 
This study confirmed interaction between SPCA2C and Orai1 in HEK293A cells and that the 
effect of SPCA2C on SICE in HEK293A cells can be Orai1-dependent. Despite the ability of 
SPCA2C to interact with Orai1, SPCA2C was able to increase cytosolic and ER stores 
independent of Orai1. Specifically, SPCA2C was able to increase cytosolic Ca2+ in 266.6 and 01-
048, which also do not express Orai1. HEK293A cells, 266.6 and 01-048 cells all express 
TRPC3, a SOCE associated Ca2+ channel. TRPC3 plays a role in pancreatic pathology. Blocking 
TRPC3 in mouse models of induced pancreatitis decreases the severity of cellular injury (Hong 
et al., 2011; Kim et al., 2011; Vigont et al., 2015). Therefore, it is attractive to suggest SPCA2C 
enhances cytosolic Ca2+ levels using TRPC3 as an interacting protein partner. Unfortunately, 
HEK-Orai1YFP cells do not expresses TRPC3 to detectable levels and so it was not identified as a 
candidate protein by the BioID experiment. Further experiments should verify an interaction 
between these two proteins. A candidate cell line to test this in would be the 266.6 cells as they 
represent acinar cells, express SPCA2C endogenously, and express high levels of TRPC3. 
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Although the BioID screen did not detect TRPC3, several other interesting potential interacting 
proteins were identified. Among a refined list of 71 candidates, 9 were functionally characterized 
as binding Ca2+ directly or to be involved in Ca2+ homeostasis. Of course, these interactions will 
have to be confirmed by other methods such as FRET or co-immunoprecipitation. HEK-Orai1YFP 
cells were a good model for the first BioID experiment because they included an internal positive 
control that is Orai1. Furthermore, SPCA2C over-expression analysis first conducted in 
HEK293A cells lead us to believe SPCA2C was interacting with other endogenously expressed 
Ca2+ channels in these cells. Performing the BioID screen in these cells assisted in uncovering 
dozens of candidate interactors.  
 
5.3 Study limitations and future directions 
 
Through over-expression data, my work illustrates SPCA2C regulates Ca2+ homeostasis in multiple 
cell lines. However, overexpression of SPCA2C in acinar cells may limit the ability to determine 
SPCA2C’s effect on the exocrine pancreas in vivo. My data suggests SPCA2C is important in 
regulating cytosolic and potentially ER Ca2+ levels, which would make it important for pancreatic 
acinar cell function. However, SPCA2C over-expression in pancreatic acinar cells in vivo may 
disrupt proper Ca2+ regulation by abnormally increasing calcium in cytosol and/or ER and acinar 
cells may undergo apoptosis or necrosis in response. This could lead to the onset of acute 
pancreatitis. SPCA2C expression is significantly decreased early in induced pancreatitis in mice, 
possibly due to a protective mechanism by cells to combat dysregulated Ca2+ levels and decrease 
injury. This also supports a scenario that over-expressing SPCA2C would increase the severity of 
pancreatitis.  I attempted to address such a question by generating transgenic mice that would over-
express SPCA2C specifically in pancreatic acinar cells. Although a number of potential founder mice 
were identified with a Atp2c2c transgene in their DNA, no Atp2c2c/SPCA2CFLAG expression could 
be detected in isolated pancreatic tissue from these mice. In a second attempt to over-express 
SPCA2C in vivo, I used intrapancreatic ductal infusion of an adeno-associated virus carrying a 
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transgene to over express SPCA2C. However, again, I was unable to detect SPCA2CFLAG expression 
in protein isolated from these mice. In both cases, I suspect that the transgene was silenced in vivo 
and therefore not able to express SPCA2CFLAG to detectable levels. Since over-expression of 
SPCA2C in vivo proves to be a challenging route for further analysis, I think pancreas-specific 
Atp2c2c knockout models will be a critical next step to confirm the importance of SPCA2C in acinar 
cell function.  
  
A conditional Atp2c2c knock-out mouse model will also be useful to follow up on the pathways 
identified by bioinformatic analysis of proximity protein candidates, which supports a role for 
SPCA2C in vesicular biology. To date, neither SPCA2 or SPCA2C has been studied within the 
context of vesicle maturation/transport or zymogen granule exocytosis in pancreatic acinar cells. 
Exocytosis assays from primary acinar cells isolated from an Atp2c2c knockout model in mice, as 
mentioned above, could be used to further explore a role for SPCA2C in vesicle transport or 
zymogen granule exocytosis in pancreatic acinar cells. RAB8A and VAS1, two proteins involved in 
vesicle transport and membrane fusion, were identified by the BioID analysis. Confirming an 
interaction between SPCA2C and these proteins by co-IP could help uncover the role of SPCA2C in 
this pathway. Other attractive protein interaction candidates were identified by BioID analysis; for 
example, coiled-coil domain-containing protein 47 (CCD47), which is involved in the regulation of 
Ca2+ homeostasis in the ER (Yamamoto et al., 2014). The information on CCD47 is limited, 
however, it remains in interesting candidate to investigate further. Initial screening using qRT-PCR 
can be done to determine if CCD47 is expressed to appreciable levels in pancreatic acinar cells. 
Additional experiments should include confirming an interaction between CCD47 and SPCA2C, as 
well as, examining the effect of an SPCA2C-CCD47 interaction on Ca2+ conductance, or ER 
Ca2+ store levels in cells. 
 
We have identified a novel isoform of SPCA2 in the pancreas of mice, however, there is still 
limited data on SPCA2 isoforms found in humans. The DNA sequence similarity between 
SPCA2 human and mice is 84.7% conserved (determined by Clustal Omega; Sievers et al. 2011). 
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Nevertheless, to ensure that the functions I uncover using the mouse homolog of the SPCA2C 
isoform is translatable to humans, when and where SPCA2C is expressed in human tissues 




This study defined a pancreas-specific isoform of SPCA2, termed SPCA2C, which is transcribed 
from an alternative transcriptional start site and functions in the ER and possibly plasma 
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SPCA2C-BioID-HA fusion protein was transiently expressed in HEK293A cells. Cells were 
incubated in 50uM biotin for 24 hours and total cell lysates were collected. Cell lysates were 
incubated in streptavidin-coupled dynabeads. Isolated proteins were sent for mass spectrometry.  
Appendix 1 . Experimental design and work flow of BioID. 
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Appendix 2. Summary table showing candidate SPCA2C interacting proteins identified using 





Areac #Uniqued #Spece  PTMf Avg. 
Mass 
(Da)g 
CKAP4 221.6 29 1.32E+07 14 31 
 
66023 
TLN1 209 7 2.42E+06 10 14 Carbamidomethylation 269765 
TPD54 201.26 56 2.00E+07 11 26 Deamidation (NQ) 22238 
RRBP1 199.85 12 8.89E+06 14 26 Carbamidomethylation 152472 
ZCCHV 197.63 11 3.35E+06 8 10 Carbamidomethylation 101431 
KTN1 195.88 12 4.01E+06 14 18 Deamidation (NQ) 156275 
HS71L 193.39 13 1.77E+06 1 36 
 
70375 
DDX17 188.61 14 6.34E+06 7 17 Carbamidomethylation 80273 
4F2 183.62 22 8.79E+06 9 17 
 
67994 
ITB1 180.73 13 8.85E+06 9 25 Carbamidomethylation; 
Deamidation (NQ) 
88415 
SPB1 179.94 10 5.64E+06 7 8 Carbamidomethylation 96558 
TERA 179.26 16 4.66E+06 8 20 Carbamidomethylation 89322 
STX5 175.23 20 1.46E+07 7 17 Carbamidomethylation 39673 
TOIP1 172.02 16 6.06E+06 8 14 
 
66248 
HXK1 170.3 13 1.45E+07 10 14 Carbamidomethylation 102486 
LYRIC 161.31 29 5.13E+06 10 15 
 
63837 
VAPB 158.77 30 3.55E+07 5 32 Carbamidomethylation; 
Deamidation (NQ) 
27228 
TMX1 154.62 22 8.32E+07 7 33 Carbamidomethylation 31791 
RL18 153.09 20 7.87E+06 4 9 
 
21634 
PTN1 152.9 13 1.44E+07 5 17 
 
49967 
RL19 148.83 17 1.53E+07 4 11 Deamidation (NQ) 23466 
DNM1L 147.06 10 7.21E+06 6 13 
 
81877 
UBXN4 147 20 2.88E+07 6 38 Carbamidomethylation 56778 
F1142 146.06 15 1.70E+06 4 10 Carbamidomethylation 55468 
RL40 145.95 46 1.79E+06 2 21 di-Glycine 14728 
CCD47 144.48 14 1.48E+07 5 17 
 
55874 
LBR 144.2 7 3.23E+06 4 9 
 
70703 
MAVS 143.7 13 3.26E+06 4 10 
 
56528 
PSMD4 143.35 18 4.55E+06 4 10 Carbamidomethylation; 
Deamidation (NQ) 
40737 
IF5A1 142.67 36 8.80E+06 5 23 Deamidation (NQ) 16832 
RL7A 139.84 20 4.13E+06 5 9 Carbamidomethylation 29996 
! 186!
RAB8A 137.12 29 8.52E+05 3 13 Deamidation (NQ) 23668 
MAN1 137.1 7 4.02E+06 5 7 Carbamidomethylation 99997 
NUPL2 136.22 14 4.27E+06 5 9 Carbamidomethylation 44872 
RL32 134.81 27 1.72E+07 4 14 Carbamidomethylation; 
di-Glycine 
15860 
VAS1 129.88 7 8.16E+05 2 4 
 
52026 
SRPR 129.77 15 4.01E+06 6 7 Carbamidomethylation 69811 
RAB1A 127.93 23 2.66E+06 2 14 Deamidation (NQ) 22678 
CALX 127.02 9 5.67E+06 4 7 
 
67568 
STIP1 124.98 8 2.41E+06 3 4 Carbamidomethylation 62639 
CHM4B 123.72 25 1.84E+06 4 6 
 
24950 
CLCC1 121.55 9 1.41E+06 4 4 Carbamidomethylation 62023 
CLGN 121.24 7 2.64E+06 3 5 
 
70039 
PDIA3 120.89 8 2.75E+06 3 4 
 
56782 
DNJC7 119.75 8 1.96E+06 3 5 Carbamidomethylation 56441 
MXRA7 119.39 18 2.37E+06 3 4 
 
21466 
RAB7A 116.6 17 2.39E+06 3 5 
 
23490 
NP1L1 114.24 7 3.83E+06 2 3 
 
45374 
SRP54 114.16 7 9.53E+05 3 4 
 
55705 
PP1G 113.94 8 9.39E+05 2 4 Carbamidomethylation 36984 
HM13 113.23 8 4.40E+07 4 23 
 
41488 
TBB5 111.41 9 1.97E+06 2 7 
 
49671 
ARFG1 110.47 7 6.64E+05 2 3 
 
44668 
YKT6 110.38 14 1.34E+06 3 4 
 
22418 
PUR6 107.48 7 3.60E+05 2 2 Carbamidomethylation 47079 
STT3B 107.11 6 1.97E+06 5 11 
 
93674 
RFC4 106.01 8 2.95E+05 2 2 
 
39682 
K1C18 105.72 11 2.97E+07 4 10 
 
48058 
RRS1 105.09 10 1.87E+06 2 9 
 
41193 
RAB6A 103.94 21 5.47E+06 2 8 Deamidation (NQ) 23593 
ARF5 102.46 17 1.38E+07 2 15 
 
20530 
ARF3 102.46 17 1.38E+07 2 15 
 
20601 
ARF1 102.46 17 1.38E+07 2 15 
 
20697 
VAPA 102.46 16 2.66E+05 3 8 
 
27893 
DHCR7 101.95 6 5.44E+06 2 4 
 
54489 
LIMD1 100.34 4 9.80E+04 2 2 
 
72190 
RL13 99.02 14 1.13E+06 3 5 
 
24261 
ANKL2 98.44 4 3.90E+05 3 4 Carbamidomethylation; 
Deamidation (NQ) 
104114 




K2C8 97.33 12 5.08E+05 2 12 
 
53704 
PIMT 97.32 7 8.68E+05 1 1 Carbamidomethylation 24636 
DHRS7 96.2 13 4.51E+06 2 7 Carbamidomethylation 38299 
RHG01 95.92 8 1.21E+06 3 6 
 
50436 
PHLP 95.81 10 1.38E+06 3 6 
 
34282 
SRPRB 95.79 10 8.41E+05 2 3 
 
29702 
COPD 95.17 6 1.72E+06 3 4 Carbamidomethylation 57210 
PICAL 95.1 3 3.04E+05 1 3 
 
70755 
ASPH 93.93 5 1.14E+06 3 4 
 
85863 
SC22B 93.31 11 4.04E+06 2 3 
 
24593 
KAP2 92.98 5 1.06E+06 2 3 
 
45518 
ST134 92.62 11 8.64E+05 2 3 
 
27407 
F10A1 92.62 7 8.64E+05 2 3 
 
41332 
NB5R1 92.55 12 6.50E+06 2 8 Carbamidomethylation 34095 
RBMS1 92.41 8 6.85E+05 3 5 Carbamidomethylation 44505 
STIM1 91.15 7 1.52E+06 4 6 
 
77423 
EFHD2 91.06 9 3.47E+05 2 2 
 
26697 
XRCC6 90.88 6 2.12E+05 2 4 
 
69843 
SSRA 90.86 15 5.52E+06 3 5 
 
32235 
PGRC1 90.29 21 4.65E+05 1 7 Carbamidomethylation 21671 
UBA1 90.27 3 4.68E+05 2 2 
 
117849 
MTX3 90.04 6 3.10E+05 2 2 Carbamidomethylation 35093 
DESP 89.49 1 1.36E+05 2 2 
 
331774 
RAB9A 89.29 16 4.74E+05 1 6 
 
22838 
SSRG 88 8 1.15E+06 2 2 
 
21080 
UB2J1 87.81 9 9.03E+05 2 3 
 
35199 
RL8 86.17 13 1.93E+06 3 5 
 
28025 
1433E 86.15 8 2.27E+05 1 2 Carbamidomethylation 29174 
EMD 85.94 13 2.05E+06 3 4 
 
28994 
SYAP1 85.67 4 6.62E+05 1 3 
 
39933 
STAU1 85.56 5 9.72E+05 2 2 
 
63182 
HMOX2 85.26 10 4.75E+06 2 5 
 
36033 
SH3G1 84.84 9 6.74E+05 3 3 Carbamidomethylation 41490 
HSPB1 83.68 17 7.36E+06 2 3 Deamidation (NQ) 22783 
TBB4B 83.55 6 5.03E+05 1 2 
 
49831 
NUP53 82.82 6 1.28E+06 1 2 
 
34774 
RL31 82.26 18 4.73E+05 2 2 
 
14463 
RTN4 81.3 2 2.99E+06 2 5 Carbamidomethylation 129931 
TX264 81.27 8 7.91E+05 2 3 Carbamidomethylation 34189 




PABP1 80.34 3 8.45E+04 1 1 Carbamidomethylation 70671 
PABP4 80.34 2 8.45E+04 1 1 Carbamidomethylation 70783 
RM34 80.33 24 2.17E+06 2 5 
 
10165 
CALD1 79.97 3 5.35E+05 2 3 
 
93231 
PGRC2 78.76 10 1.88E+05 1 5 Carbamidomethylation 23818 
TM109 78.35 9 1.71E+06 3 9 
 
26210 
RAB3B 78.25 10 2.51E+05 1 8 Deamidation (NQ) 24758 
RAB3D 78.25 10 2.51E+05 1 8 Deamidation (NQ) 24267 
RAB3A 78.25 10 2.51E+05 1 8 Deamidation (NQ) 24984 
RAB3C 78.25 10 2.51E+05 1 8 Deamidation (NQ) 25952 
ZYX 78.07 5 7.59E+04 2 4 
 
61277 
EI24 77.38 6 1.16E+06 2 2 Carbamidomethylation 38965 
IF2B3 77.01 3 2.60E+05 1 2 
 
63705 
RCN1 76.94 4 6.46E+05 1 2 
 
38890 
S38A2 76.73 3 1.26E+05 1 2 
 
56026 
ANXA1 76.69 4 1.90E+05 1 1 
 
38714 
PREB 76.36 4 6.44E+05 1 1 
 
45468 
PROF1 75.94 21 5.90E+05 2 3 
 
15054 
RL34 75.85 22 1.42E+07 4 9 
 
13293 
HMX3 74.94 4 0.00E+00 1 1 
 
37825 
SNX4 74.72 3 1.57E+05 1 1 
 
51909 
SAR1A 73.98 11 8.38E+06 2 6 
 
22367 
EP15R 73.41 5 3.82E+05 2 2 
 
94255 
COPG1 71.97 3 1.27E+05 2 2 
 
97718 
STBD1 71.68 5 9.23E+05 2 2 
 
39007 
HNRPR 71.49 4 2.57E+05 2 2 
 
70943 
KPYM 71.34 7 2.29E+06 2 4 Carbamidomethylation 57937 
MK67I 71.25 4 1.35E+05 1 1 
 
34222 
CND3 69.97 1 1.27E+05 1 1 
 
114334 
CP51A 69.15 3 6.02E+05 1 4 
 
56806 
NP1L4 68.7 9 3.25E+05 2 2 
 
42823 
TFCP2 68.62 3 4.38E+04 1 2 Carbamidomethylation 57256 
PRDX4 68.24 7 3.50E+05 1 2 
 
30540 
RL26 67 10 1.32E+06 3 3 
 
17258 
RL26L 67 10 1.32E+06 3 3 
 
17256 
1433T 66.93 8 0.00E+00 1 2 Carbamidomethylation 27764 
S38A1 66.2 2 7.27E+05 1 2 
 
54048 
CRCM1 66.13 4 3.72E+05 1 1 
 
32668 
RL22 65.99 10 2.50E+05 1 1 
 
14787 
LDHA 65.58 9 5.61E+05 2 4 Carbamidomethylation 36689 
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DHB12 64.97 5 5.25E+05 1 2 
 
34324 
AT1A2 64.79 2 1.50E+05 1 1 
 
112265 
AT1A3 64.79 2 1.50E+05 1 1 
 
111748 
AT1A1 64.79 2 1.50E+05 1 1 
 
112896 
PRS7 64.66 6 1.08E+06 2 4 
 
48634 
FKBP8 64.57 4 3.39E+05 1 1 
 
44562 
LDHB 64.48 4 9.38E+04 1 1 
 
36639 
MBOA7 63.54 7 6.89E+05 2 4 Carbamidomethylation 52765 
JPH1 63.11 2 1.07E+06 1 2 
 
71686 
RL14 61.66 6 7.54E+05 1 1 
 
23432 
DBNL 61.17 7 1.36E+06 2 2 
 
48207 
NBR1 61.03 1 2.57E+05 1 1 
 
107413 
PGAM2 58.63 6 3.70E+05 1 2 
 
28766 
PGAM1 58.63 6 3.70E+05 1 2 
 
28804 
PGAM4 58.63 6 3.70E+05 1 2 
 
28777 
MACOI 58.43 2 4.75E+05 1 1 
 
76178 
PLST 57.95 6 8.84E+05 2 3 Carbamidomethylation 70811 
CDKAL 55.9 2 5.01E+05 1 2 
 
65112 
PDCD5 55.7 9 3.87E+05 1 1 
 
14285 
HS90B 55.45 2 3.66E+05 1 1 
 
83264 
HS902 55.45 3 3.66E+05 1 1 
 
39365 
HS90A 55.45 2 3.66E+05 1 1 
 
84660 
H90B2 55.45 3 3.66E+05 1 1 
 
44349 
RABL3 54.99 18 2.59E+05 2 3 
 
26423 
RS7 54.65 12 3.70E+05 2 3 
 
22127 
SYMC 54.59 1 3.02E+05 1 1 
 
101116 
SQSTM 53.88 6 1.36E+06 1 3 
 
47687 
NUP98 53.48 1 1.89E+05 1 2 
 
197578 
AAAT 53.36 2 3.86E+05 1 2 
 
56598 
IF4H 52.86 12 9.72E+05 1 5 
 
27385 
RAB21 52.71 5 4.80E+05 1 2 
 
24348 
GOGA5 52.48 3 2.39E+05 1 1 
 
83024 
SC24B 52.19 1 9.83E+04 1 1 
 
137417 
OSBL8 51.94 1 2.36E+05 1 1 
 
101196 
BET1 51.41 9 2.45E+06 1 3 
 
13289 
LNP 51.3 3 7.61E+05 1 2 
 
47740 
ACATN 51.23 2 1.00E+05 1 1 
 
60909 
EIF3G 51.02 4 0.00E+00 1 1 
 
35611 
ITM2B 50.52 9 6.69E+05 1 2 
 
30338 
FIBB 50.19 3 1.19E+04 1 3 Deamidation (NQ) 55928 
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PEX19 49.64 7 1.46E+05 1 2 
 
32807 
AT2C2 49.03 1 1.28E+05 1 1 
 
103187 
MMGT1 49.03 11 1.00E+06 1 2 
 
14686 
AT131 48.94 1 2.37E+05 1 1 
 
132955 
2A5D 48.58 2 4.12E+05 1 1 
 
69992 
CSN8 48.01 7 0.00E+00 1 1 
 
23226 
F177A 47.4 6 0.00E+00 1 1 
 
23757 
BASI 47.24 2 1.89E+05 1 1 
 
42200 
NDC1 46.43 2 0.00E+00 1 1 
 
76305 
TOP1 46.38 1 2.28E+05 1 1 
 
90726 
APOL2 46.3 3 2.21E+04 1 1 
 
37092 
SERA 45.56 2 9.14E+04 1 1 
 
56651 
NCPR 43.89 3 1.98E+05 2 2 
 
76690 
TMX2 43.46 4 4.36E+05 1 2 
 
34038 
ALG9 43.4 2 4.17E+05 1 2 
 
69864 
SEC62 43.33 3 4.85E+04 1 2 
 
45862 
IF2B2 43.11 3 1.68E+05 1 1 Carbamidomethylation 66121 
KC1A 42.49 3 7.42E+04 1 1 
 
38915 
KC1AL 42.49 3 7.42E+04 1 1 
 
39086 
RALA 42.29 6 4.22E+05 1 1 
 
23567 
RBM28 41.27 2 1.44E+05 1 1 
 
85738 
CDV3 40.91 3 3.28E+05 1 1 
 
27335 
ARM10 40.77 3 2.43E+05 1 1 
 
37540 
RL36 40.53 10 2.60E+07 1 5 Carbamidomethylation 12254 
EDF1 40.44 7 4.75E+05 1 1 
 
16369 
DDX27 40.27 2 8.37E+04 1 1 Carbamidomethylation 89835 
TMX3 39.82 2 3.86E+05 1 1 
 
51872 
COPB2 39.49 2 1.87E+05 1 1 
 
102487 
PERQ2 39.29 2 1.23E+05 1 2 
 
150070 
P121B 39.11 2 5.41E+06 1 1 
 
83015 
P121C 39.11 1 5.41E+06 1 1 
 
125059 
P121A 39.11 1 5.41E+06 1 1 
 
127720 
IST1 37.71 2 1.60E+05 1 1 
 
39751 
IF4G2 37.07 1 2.46E+05 1 1 
 
102362 
SYAC 36.35 1 4.98E+04 1 1 
 
106810 
NSDHL 36.33 3 6.10E+04 1 1 
 
41900 
MFS10 36.22 3 1.34E+05 1 1 
 
48339 
TTF2 36.16 1 6.31E+03 1 1 
 
129588 
CBPD 35.9 1 1.43E+05 1 1 
 
152931 
NOP2 35.77 2 0.00E+00 1 1 Carbamidomethylation 89302 
! 191!
ATLA3 35.72 3 1.61E+05 1 1 
 
60542 
MPRI 35.13 1 2.20E+05 1 2 Carbamidomethylation 274373 
NB5R3 35.07 6 5.05E+05 1 1 
 
34235 
SC61B 35.02 16 3.29E+04 1 1 
 
9974 
SCD5 34.72 4 1.03E+05 1 1 
 
37610 
CA123 34.44 8 5.26E+05 1 1 
 
18048 
NOG1 33.66 4 2.29E+05 1 1 
 
73965 
ABCAD 32.08 0 4.13E+05 1 1 
 
576166 
HPDL 31.8 3 6.12E+04 1 2 di-Glycine 39386 
AT2A2 31.74 1 3.25E+05 1 2 
 
114757 
NUDC 31.03 3 2.04E+05 1 1 
 
38243 
RANG 30.97 4 6.08E+04 1 1 
 
23310 
HACD3 30.27 6 5.94E+05 1 5 
 
43160 
CCD66 30.25 1 0.00E+00 1 1 Deamidation (NQ) 109411 
TM131 30.09 1 3.78E+05 1 1 
 
205137 
RS16 30 7 2.14E+05 1 1 
 
16445 
RENR 29.35 2 3.05E+05 1 1 
 
39008 
F117B 29.21 5 0.00E+00 1 1 Oxidation (M) 61968 
RYR1 28.94 0 7.37E+05 1 1 Oxidation (M) 565184 
P5I11 28.73 5 2.27E+04 1 2 
 
21054 
CNKR3 28.1 3 0.00E+00 1 1 
 
61904 
C2D1A 27.82 2 0.00E+00 1 1 
 
104062 
RTN3 27.69 1 0.00E+00 1 1 
 
112611 
SMC5 27.37 1 1.45E+08 1 1 Oxidation (M) 128806 
KINH 27.29 1 4.90E+05 1 1 
 
109685 
TNC18 27.07 0 4.23E+04 1 1 
 
314520 
FIBA 26.26 1 4.20E+05 1 1 
 
94973 
NMT1 26.22 3 1.73E+05 1 1 
 
56806 
RL3 26.02 2 4.05E+05 1 1 
 
46109 
CHD5 26 0 0.00E+00 1 1 
 
223048 
CHD3 26 0 0.00E+00 1 1 
 
226590 
FBSL 25.86 1 0.00E+00 1 1 
 
110907 
SPCS2 25.66 3 2.81E+06 1 2 
 
25003 
COHA1 25.32 2 1.67E+06 1 1 Deamidation (NQ) 150419 
aPeptide spectrum match score 
bPercentage of the full open reading frame sequenced 
cArea of a peptide feature calculated by PEAKs 
dNumber of unique fragments identified for the gene 
eNumber of precursor spectrum matches matched to the supporting peptides for the protein 
fPost-translational modifications identified in the peptide fragments 
gMonoisotopic mass of the peptide 
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Area  #Unique #Spec  PTM Avg. 
Mass 
ITB1 180.73 13 8.85E+06 9 25 Carbamidomethylation; 
Deamidation (NQ) 
88415 
STX5 175.23 20 1.46E+07 7 17 Carbamidomethylation 39673 
TMX1 154.62 22 8.32E+07 7 33 Carbamidomethylation 31791 
NUPL2 136.22 14 4.27E+06 5 9 Carbamidomethylation 44872 
VAS1 129.88 7 8.16E+05 2 4 
 
52026 
CLGN 121.24 7 2.64E+06 3 5 
 
70039 
DHRS7 96.2 13 4.51E+06 2 7 Carbamidomethylation 38299 
RHG01 95.92 8 1.21E+06 3 6 
 
50436 
ASPH 93.93 5 1.14E+06 3 4 
 
85863 
SC22B 93.31 11 4.04E+06 2 3 
 
24593 
ST134 92.62 11 8.64E+05 2 3 
 
27407 
F10A1 92.62 7 8.64E+05 2 3 
 
41332 
NB5R1 92.55 12 6.50E+06 2 8 Carbamidomethylation 34095 
SSRA 90.86 15 5.52E+06 3 5 
 
32235 
MTX3 90.04 6 3.10E+05 2 2 Carbamidomethylation 35093 
RAB9A 89.29 16 4.74E+05 1 6 
 
22838 
UB2J1 87.81 9 9.03E+05 2 3 
 
35199 
HMOX2 85.26 10 4.75E+06 2 5 
 
36033 
NUP53 82.82 6 1.28E+06 1 2 
 
34774 
RM34 80.33 24 2.17E+06 2 5 
 
10165 
TM109 78.35 9 1.71E+06 3 9 
 
26210 
EI24 77.38 6 1.16E+06 2 2 Carbamidomethylation 38965 
RCN1 76.94 4 6.46E+05 1 2 
 
38890 
HMX3 74.94 4 0.00E+00 1 1 
 
37825 
CP51A 69.15 3 6.02E+05 1 4 
 
56806 
CRCM1 66.13 4 3.72E+05 1 1 
 
32668 
MBOA7 63.54 7 6.89E+05 2 4 Carbamidomethylation 52765 
MACOI 58.43 2 4.75E+05 1 1 
 
76178 
HS902 55.45 3 3.66E+05 1 1 
 
39365 
H90B2 55.45 3 3.66E+05 1 1 
 
44349 




LNP 51.3 3 7.61E+05 1 2 
 
47740 
ACATN 51.23 2 1.00E+05 1 1 
 
60909 
ITM2B 50.52 9 6.69E+05 1 2 
 
30338 
FIBB 50.19 3 1.19E+04 1 3 Deamidation (NQ) 55928 
PEX19 49.64 7 1.46E+05 1 2 
 
32807 
AT2C2 49.03 1 1.28E+05 1 1 
 
103187 
MMGT1 49.03 11 1.00E+06 1 2 
 
14686 
CSN8 48.01 7 0.00E+00 1 1 
 
23226 
F177A 47.4 6 0.00E+00 1 1 
 
23757 
APOL2 46.3 3 2.21E+04 1 1 
 
37092 
NCPR 43.89 3 1.98E+05 2 2 
 
76690 
TMX2 43.46 4 4.36E+05 1 2 
 
34038 
ALG9 43.4 2 4.17E+05 1 2 
 
69864 
SEC62 43.33 3 4.85E+04 1 2 
 
45862 
RALA 42.29 6 4.22E+05 1 1 
 
23567 
ARM10 40.77 3 2.43E+05 1 1 
 
37540 
TMX3 39.82 2 3.86E+05 1 1 
 
51872 
P121B 39.11 2 5.41E+06 1 1 
 
83015 
IST1 37.71 2 1.60E+05 1 1 
 
39751 
MFS10 36.22 3 1.34E+05 1 1 
 
48339 
CBPD 35.9 1 1.43E+05 1 1 
 
152931 
ATLA3 35.72 3 1.61E+05 1 1 
 
60542 
NB5R3 35.07 6 5.05E+05 1 1 
 
34235 
SCD5 34.72 4 1.03E+05 1 1 
 
37610 
CA123 34.44 8 5.26E+05 1 1 
 
18048 
ABCAD 32.08 0 4.13E+05 1 1 
 
576166 
HPDL 31.8 3 6.12E+04 1 2 di-Glycine 39386 
CCD66 30.25 1 0.00E+00 1 1 Deamidation (NQ) 109411 
TM131 30.09 1 3.78E+05 1 1 
 
205137 
RENR 29.35 2 3.05E+05 1 1 
 
39008 
F117B 29.21 5 0.00E+00 1 1 Oxidation (M) 61968 
RYR1 28.94 0 7.37E+05 1 1 Oxidation (M) 565184 
P5I11 28.73 5 2.27E+04 1 2 
 
21054 
CNKR3 28.1 3 0.00E+00 1 1 
 
61904 
SMC5 27.37 1 1.45E+08 1 1 Oxidation (M) 128806 
TNC18 27.07 0 4.23E+04 1 1 
 
314520 




FBSL 25.86 1 0.00E+00 1 1 
 
110907 
SPCS2 25.66 3 2.81E+06 1 2 
 
25003 
COHA1 25.32 2 1.67E+06 1 1 Deamidation (NQ) 150419 
aPeptide spectrum match score 
bPercentage of the full open reading frame sequenced 
cArea of a peptide feature calculated by PEAKs 
dNumber of unique fragments identified for the gene 
eNumber of precursor spectrum matches matched to the supporting peptides for the protein 
fPost-translational modifications identified in the peptide fragments 
gMonoisotopic mass of the peptide 
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Appendix 4. Table indicating the Ca2+ associated protein interaction candidates that appeared 
after excluding negative control and common contaminant/ background proteins. 
Gene -10lgPa Description Functiona 
VAS1  129.88 V-type proton ATPase subunit 
S1 OS=Homo sapiens 
GN=ATP6AP1 PE=1 SV=2 
Involved in membrane trafficking and Ca2+-
dependent membrane fusion. 
CLGN  121.24 Calmegin OS=Homo sapiens 
GN=CLGN PE=1 SV=1 
Required for normal male fertility. Binds 
calcium ions. 
ASPH  93.93 Aspartyl/asparaginyl beta-
hydroxylase OS=Homo sapiens 
GN=ASPH PE=1 SV=3 
Isoform 8: membrane-bound Ca2+-sensing 
protein, which is a structural component of 
the ER-plasma membrane junctions. Isoform 
8 regulates the activity of Ca(+2) released-
activated Ca(+2) (CRAC) channels in T-cells. 
NB5R1  92.55 NADH-cytochrome b5 
reductase 1 OS=Homo sapiens 
GN=CYB5R1 PE=1 SV=1 
Among its related pathways are Response to 
elevated platelet cytosolic Ca2+ and PAK 
Pathway. 
TM109  78.35 Transmembrane protein 109 
OS=Homo sapiens 
GN=TMEM109 PE=1 SV=1 
May mediate cellular response to DNA 
damage by protecting against ultraviolet C-
induced cell death. Can form voltage-gated 
calcium and potassium channels in vitro 
RCN1  76.94 Reticulocalbin-1 OS=Homo 
sapiens GN=RCN1 PE=1 SV=1 
May regulate calcium-dependent activities in 
the endoplasmic reticulum lumen or post-ER 
compartment. 
CRCM1  66.13 Calcium release-activated 
calcium channel protein 1 
OS=Homo sapiens GN=ORAI1 
PE=1 SV=2 
The protein encoded by this gene is a 
membrane calcium channel subunit that is 
activated by the calcium sensor STIM1 when 
calcium stores are depleted.  
AT2C2  49.03 Calcium-transporting ATPase 
type 2C member 2 OS=Homo 
sapiens GN=ATP2C2 PE=1 
SV=2 
This magnesium-dependent enzyme catalyzes 
the hydrolysis of ATP coupled with the 
transport of calcium. 
RYR1  28.94 Ryanodine receptor 1 
OS=Homo sapiens GN=RYR1 
PE=1 SV=3 
Calcium channel that mediates the release of 
Ca2+ from the sarcoplasmic reticulum into the 
cytoplasm 
a-10logP score from PEAKS MS analysis 
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